<SEC-DOCUMENT>0001193125-18-116946.txt : 20180413
<SEC-HEADER>0001193125-18-116946.hdr.sgml : 20180413
<ACCEPTANCE-DATETIME>20180413163253
ACCESSION NUMBER:		0001193125-18-116946
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180625
FILED AS OF DATE:		20180413
DATE AS OF CHANGE:		20180413

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKET PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001281895
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36829
		FILM NUMBER:		18754684

	BUSINESS ADDRESS:	
		STREET 1:		430 EAST 29TH STREET
		STREET 2:		SUITE 1040
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-440-9100

	MAIL ADDRESS:	
		STREET 1:		430 EAST 29TH STREET
		STREET 2:		SUITE 1040
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOTEK PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20040226
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d535515dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML><HEAD>
<TITLE>PRE 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:1%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
INFORMATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp; ) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:1%">&nbsp;</P></center> <P STYLE="margin-top:8pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material under&nbsp;&#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>ROCKET
PHARMACEUTICALS, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:2.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g535515g79v64.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>April &nbsp;&nbsp;&nbsp;&nbsp;, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Rocket Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend
the 2018 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of Rocket Pharmaceuticals, Inc. (the &#147;Company&#148;), which will be held on June&nbsp;25, 2018, at 8:30&nbsp;a.m., Eastern Time, at the offices of Gibson, Dunn&nbsp;&amp;
Crutcher LLP, located at 200 Park Avenue, New York, NY 10166. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The attached Notice of the Annual Meeting of Stockholders and proxy statement describe the
formal business that we will transact at the Annual Meeting. At this year&#146;s Annual Meeting, our stockholders will be asked to consider and act upon the following matters: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to approve an amendment to the Company&#146;s Seventh Amended and Restated Certificate of Incorporation to declassify the Board of Directors of the Company (the &#147;Board&#148;); </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to approve an amendment to the Company&#146;s Seventh Amended and Restated Certificate of Incorporation to eliminate the supermajority voting requirement with respect to the removal of directors and replace it with a
majority voting standard; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if Proposal 1 to declassify the Board is approved by the stockholders, to elect seven (7)&nbsp;directors named in the proxy statement to hold office until the Company&#146;s annual meeting of stockholders in 2019, or
until their respective successors have been duly elected and qualified; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if Proposal 1 to declassify the Board is not approved by the stockholders, to elect two (2)&nbsp;Class&nbsp;I directors named in the proxy statement to the Board for a term of three (3)&nbsp;years, or until their
respective successors have been duly elected and qualified; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to ratify the appointment of EisnerAmper LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to approve the Company&#146;s Second Amended and Restated 2014 Stock Option and Incentive Plan (the &#147;Proposed 2014 Plan&#148;); and </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to&nbsp;transact any other business that properly comes before the Annual Meeting or any adjournments and postponements thereof. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has determined that an affirmative vote on each matter that calls for an affirmative vote is in the best interest of the Company and its stockholders
and unanimously recommends a vote &#147;FOR&#148; the election of each of the nominees and &#147;FOR&#148; each of the other matters considered at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please promptly complete, sign and return the enclosed proxy card by mail or submit your voting instructions by Internet, whether or not you plan to attend
the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Since several of the items of business for the Annual Meeting have extremely high vote requirements, your vote is important,
regardless of the number of shares you own. We urge you to please vote your proxy on these important matters. Voting by proxy will not prevent you from voting in person at the Annual Meeting, but will assure that your vote is counted if you cannot
attend. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the Board and the employees of the Company, we thank you for your continued support and look forward to seeing you at the Annual
Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ Gaurav Shah</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gaurav Shah, MD </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ROCKET PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>430 East 29th Street, Suite 1040 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New York, NY 10016
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(646) <FONT STYLE="white-space:nowrap">440-9100</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DATE</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;25, 2018</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TIME</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8:30 a.m. Eastern Time</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PLACE</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offices of Gibson, Dunn&nbsp;&amp; Crutcher LLP, 200 Park Avenue, New York, NY
10166</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEMS OF BUSINESS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of an amendment to Rocket Pharmaceuticals, Inc.&#146;s (the &#147;Company&#148;) Seventh Amended and Restated Certificate of Incorporation to declassify the Board of Directors of the Company (the
&#147;Board&#148;);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of an amendment to the Company&#146;s Seventh Amended and Restated Certificate of Incorporation to eliminate the supermajority voting requirement with respect to the removal of directors and replace it with a majority
voting standard;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">If Proposal 1 to declassify the Board is approved by the stockholders, election of the seven (7)&nbsp;directors named in the proxy statement to hold office until the annual meeting of stockholders in 2019, or until their
respective successors have been duly elected and qualified;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">If Proposal 1 to declassify the Board is not approved by the stockholders, election of two (2)&nbsp;Class&nbsp;I directors named in the proxy statement to the Board for a term of three (3)&nbsp;years, or until their respective
successors have been duly elected and qualified;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ratification of the appointment of EisnerAmper LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of the Company&#146;s Second Amended and Restated 2014 Stock Option and Incentive Plan; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consideration of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RECORD DATE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The record
date for the Annual Meeting is April&nbsp;26, 2018. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment or postponement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROXY VOTING </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the
Annual Meeting in person. Whether or not you expect to attend the Annual Meeting, please submit the enclosed proxy or voting instructions by mail, telephone or Internet. A return envelope (which is postage prepaid if mailed in the United States) is
enclosed for your convenience. Submitting a proxy or voting instructions will not prevent you from attending the Annual Meeting and voting in person. Please note, however, that if your shares are held of record by a broker, bank or other nominee and
you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from that record holder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Gaurav Shah</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gaurav Shah, MD</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;&nbsp;&nbsp;&nbsp; , 2018</P></TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A><U>TABLE OF CONTENTS</U> </B></P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_1">EXPLANATORY NOTE</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_2">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_3">PROPOSAL&nbsp;1&nbsp;
DECLASSIFICATION AMENDMENT TO THE CERTIFICATE OF INCORPORATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_4">Background of the Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_5">Proposed Amendment to Article VI of the Certificate of
Incorporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_6">Removal of Directors Without Cause</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_7">Text of the Proposed Amendment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_8">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_9">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_10">PROPOSAL&nbsp;2&nbsp;
DIRECTOR REMOVAL AMENDMENT TO THE CERTIFICATE OF INCORPORATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_11">Background of the Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_12">Proposed Amendment to Article VI of the Certificate of
Incorporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_13">Text of the Proposed Amendment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_14">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_15">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_16">PROPOSAL 3&nbsp;ELECTION OF DIRECTORS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_17">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_18">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_19">PROPOSAL 4&nbsp;ELECTION OF CLASS I DIRECTORS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_20">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_21">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_22">DIRECTORS AND NOMINEES</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_23">Nominees for Election as Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_24">Information about Our Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_25">Information about the Board and Corporate Governance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_26">AUDIT COMMITTEE REPORT</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_27">PROPOSAL 5 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_28">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_29">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_30">Dismissal of RSM US LLP</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_31"><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_32">Audit Fees and Services</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_33">PROPOSAL 6 APPROVAL OF THE COMPANY&#146;S SECOND AMENDED AND RESTATED 2014
 STOCK OPTION AND INCENTIVE PLAN</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_34">Background of the Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_35">Summary of the Proposed 2014 Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_36">Plan Benefits</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_37">Tax Aspects under the Code</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_38">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_39">Our Recommendation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_40">EXECUTIVE COMPENSATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_41">Merger with Rocket Pharmaceuticals, Ltd.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_42">Summary Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_43">All Other Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_44">Executive Agreements; Termination and Change of Control
Benefits</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_45">Equity Incentive Awards </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_46">DIRECTOR COMPENSATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_47">Director Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_48">TRANSACTIONS WITH RELATED PERSONS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_49">Policies and Procedures for Related Person Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc535515_50">Certain Related-Person Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_51">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_52">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_53">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION
PLANS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_54">STOCKHOLDER PROPOSALS AND NOMINATIONS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_55">OTHER MATTERS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_56">AVAILABILITY OF CERTAIN DOCUMENTS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#toc535515_57">APPENDIX A</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE 2018 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON JUNE&nbsp;
25, 2018 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_1"></A>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;4, 2018, Inotek Pharmaceuticals Corporation (&#147;Inotek&#148;) and privately held Rocket Pharmaceuticals, Ltd. (&#147;Private Rocket&#148;)
completed a business combination in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the &#147;Merger Agreement&#148;), dated as of September&nbsp;12, 2017, by and among Inotek, Rome Merger Sub, a wholly owned
subsidiary of Inotek (&#147;Merger Sub&#148;), and Private Rocket, pursuant to which Merger Sub merged with and into Private Rocket, with Private Rocket surviving as a wholly owned subsidiary of Inotek. This transaction is referred to as the
&#147;Reverse Merger.&#148; Immediately following the Reverse Merger, Inotek changed its name to &#147;Rocket Pharmaceuticals, Inc.&#148; In connection with the closing of the Reverse Merger, our common stock began trading on The Nasdaq Global
Market under the ticker symbol &#147;RCKT&#148; on January&nbsp;5, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The former executive officers and a majority of the Board of Directors of Inotek
(the &#147;Inotek Board&#148;) resigned concurrent with the closing of the Reverse Merger. In addition, in March 2018, we dismissed Inotek&#146;s independent registered public accounting firm, RSM US LLP, and appointed the independent registered
public accounting firm of Private Rocket, EisnerAmper LLP, as auditor of the combined company. Throughout this proxy statement we discuss both the former executive officers and members of the Board or Directors of Inotek and the current executive
officers and members of the Board of Directors of Rocket Pharmaceuticals, Inc., the combined company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to the Reverse Merger, Inotek
completed a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-4</FONT></FONT> reverse stock split (the &#147;Stock Split&#148;). All share and per share amounts in this proxy statement reflect the Stock Split unless otherwise
noted. As a result of the Reverse Merger, and after giving effect to the Stock Split, each outstanding share of Private Rocket share capital (including shares of Private Rocket share capital to be issued upon exercise of outstanding share options)
automatically converted into the right to receive approximately 76.185 shares of the combined company&#146;s common stock (the &#147;Exchange Ratio&#148;), par value $0.001 per share. Immediately following the Reverse Merger, the former holders of
Private Rocket common stock owned approximately 81.357% of the fully-diluted common stock of the Company, with the holders of Inotek&#146;s common stock immediately prior to the Reverse Merger owning approximately 18.643% of the fully-diluted common
stock of the combined company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this proxy statement, the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to
Rocket Pharmaceuticals, Inc., the combined company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; under applicable federal securities laws and therefore
permitted to take advantage of certain reduced public company reporting requirements. As an emerging growth company, we provide in this proxy statement the scaled disclosure permitted under the Jumpstart Our Business Startups Act of 2012, including
the compensation disclosures required of a &#147;smaller reporting company,&#148; as that term is defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> promulgated under the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;). In addition, as an emerging growth company, we are not required to conduct votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be
conducted. We will remain an emerging growth company until the earliest of (i)&nbsp;the last day of the fiscal year in which we have total annual gross revenues of $1.07&nbsp;billion or more; (ii)&nbsp;December&nbsp;31, 2020;&nbsp;(iii)&nbsp;the
date on which we have issued more than $1&nbsp;billion in nonconvertible debt during the previous three&nbsp;years; or (iv)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange
Commission (the &#147;SEC&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_2"></A>QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When and where is our Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will hold our
Annual Meeting on June&nbsp;25, 2018 at 8:30&nbsp;a.m. local time, at the offices of Gibson, Dunn&nbsp;&amp; Crutcher LLP, located at 200 Park Avenue, New York, NY 10166. The term &#147;Annual Meeting,&#148; as used in this proxy statement, includes
any adjournment or postponement of such meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why am I receiving these materials? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have sent you this proxy statement and the enclosed proxy card because the Board is soliciting your proxy to vote at the 2018 Annual Meeting. This proxy
statement and proxy card is being mailed to stockholders on or about April&nbsp;&nbsp;&nbsp;&nbsp;, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of record as of the close of business on April&nbsp;26, 2018, will be entitled to vote at the Annual Meeting. On this date, there were
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock issued and outstanding and entitled to vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, on April&nbsp;26, 2018, your shares were registered directly in your name with our transfer agent, Continental Stock Transfer&nbsp;&amp; Trust, then you
are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to fill out and return the enclosed proxy card by mail or vote
by proxy over the telephone or the Internet as instructed below to ensure your vote is counted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares Registered in the Name of a
Broker or Bank </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, on April&nbsp;26, 2018, your shares were held not in your name with our transfer agent, but rather in an account at a brokerage
firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your account is
considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. Simply complete and mail the
proxy card and voting instructions to ensure that your vote is counted. Alternatively, you may vote by telephone or over the Internet as instructed by your broker or bank, if applicable. To vote in person at the Annual Meeting, you must obtain a
valid proxy from your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum of stockholders
is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of our outstanding shares entitled to vote at the Annual Meeting are present at the Annual Meeting in person or represented by proxy. Your
shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting or vote by proxy over the telephone or the Internet
as instructed below. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is no quorum, the chairperson of the Annual Meeting or the holders of a majority of shares present
at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on and how many votes are needed to approve each proposal? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposals 1 and 2: Amendment of Seventh Amended and Restated Certificate of Incorporation. </I>The amendments to the Seventh Amended and Restated
Certificate of Incorporation will require &#147;FOR&#148; votes from the holders of not less than 75% of the shares entitled to vote on the amendment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposals 3 and 4: Election of Directors</I>. The directors will be elected by a plurality of the votes cast at the Annual Meeting by the holders of shares
present in person or represented by proxy and entitled to vote on the election of the directors. Plurality means that the individuals who receive the largest number of &#147;FOR&#148; votes cast are elected as directors up to the maximum number of
directors to be chosen at the Annual Meeting. Accordingly, the seven nominees, if the stockholders approve Proposal 1, and the two nominees, if the stockholders do not approve Proposal 1, receiving the most &#147;FOR&#148; votes will be elected as
directors. If you &#147;withhold&#148; your vote with respect to one or more of the nominees, your shares will not be included in determining the number of votes cast and, as a result, will have no effect on this proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposals 5 and 6: Ratification of Appointment of Independent Registered Public Accounting Firm and Approval of Second Amended and Restated 2014 Stock
Option and Incentive Plan</I>. The ratification of the appointment of EisnerAmper LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018 and the approval of the Second Amended and
Restated 2014 Stock Option and Incentive Plan will require &#147;FOR&#148; votes from a majority of the votes cast at the Annual Meeting by the holders of shares present in person or represented by proxy and entitled to vote on this proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted as votes cast and will have no effect on the voting on the
proposals referenced above, with the exception of Proposals 1 and 2, where abstentions and broker non-votes will have the effect of being counted as a vote &#147;against&#148; these proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are broker <FONT STYLE="white-space:nowrap">non-votes?</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> occur when a beneficial owner of shares held in &#147;street name&#148; does not give instructions to
the broker or nominee holding the shares as to how to vote. If the beneficial owner does not provide voting instructions, the broker or nominee may vote the shares with respect to matters that are considered to be &#147;discretionary,&#148; but may
not vote the shares with respect to <FONT STYLE="white-space:nowrap">&#147;non-discretionary&#148;</FONT> matters. Where a broker does not have discretion to vote on a given proposal, the unvoted shares are considered &#147;broker non-votes.&#148;
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On each matter to be
voted upon, you have one vote for each share of common stock you owned as of April&nbsp;26, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one proxy
card? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may receive more than one proxy card if your shares are registered in more than one name or are registered in different accounts. Please
vote in the manner described below under &#147;How do I vote?&#148; for each proxy card to ensure that all of your shares are voted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How does the
Board recommend that I vote my shares? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless you give other instructions on your proxy card, the persons named as proxies on the card will vote in
accordance with the recommendations of the Board. The Board&#146;s recommendation is set forth together with the description of each item in this proxy statement. The Board recommends a vote: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;FOR&#148; the amendments to the Seventh Amended and Restated Certificate of Incorporation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;FOR&#148; the election of the nominees to the Board; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;FOR&#148; the ratification of the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;FOR&#148; the approval of the Second Amended and Restated 2014 Stock Option and Incentive Plan. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With
respect to any other matter that properly comes before the Annual Meeting, the proxies will vote as recommended by the Board or, if no recommendation is given, in their own discretion in the best interest of the Company and its stockholders. As of
the date of this proxy statement, the Board had no knowledge of any business other than that described herein that would be presented for consideration at the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the election of directors (Proposals
3 and 4), you may either vote &#147;FOR&#148; all or some of the nominees or you may &#147;WITHHOLD&#148; your vote for any nominee you specify. For the other matters to be voted on, you may vote &#147;FOR&#148; or &#147;AGAINST,&#148; or you may
&#147;ABSTAIN&#148; from voting. The procedures for voting are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, you may (a)&nbsp;vote in person at the Annual Meeting or (b)&nbsp;vote by proxy. Whether or not you plan to attend the
Annual Meeting, we urge you to fill out and return the enclosed proxy card by mail or vote by proxy over the telephone or the Internet as instructed below to ensure your vote is counted. You may still attend the Annual Meeting and vote in person
even if you have already voted by proxy, as described under &#147;May I change my vote after submitting my proxy card?&#148; below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote on the Internet, go to <I>www.proxyvote.com</I> to complete an electronic proxy card. Please have the enclosed proxy card available. Your vote must be received by 11:59&nbsp;P.M., Eastern Time, on June&nbsp;24,
2018, to be counted. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote over the telephone, dial toll-free <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> using a touch-tone phone and follow the
recorded instructions. Please have the enclosed proxy card available. Your vote must be received by 11:59&nbsp;P.M., Eastern Time, on June&nbsp;24, 2018, to be counted. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote by proxy, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, the designated proxy
holders will vote your shares as you direct. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote in person, come to the Annual Meeting, and we will give you a ballot when you arrive. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If you sign
the proxy card but do not make specific choices, your proxy will vote your shares &#147;FOR&#148; the amendments to the Seventh Amended and Restated Certificate of Incorporation, &#147;FOR&#148; all seven nominees to the Board, in the case of
Proposal 3, or for both nominees to the Board, in the case of Proposal 4, &#147;FOR&#148; the ratification of EisnerAmper LLP as our independent registered public accounting firm and &#147;FOR&#148; the approval of the Second Amended and Restated
2014 Stock Option and Incentive Plan. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any other matter is presented, the proxies will vote as recommended by the Board or, if no recommendation is
given, in their own discretion in the best interest of the Company and its stockholders. As of the date of this proxy statement, we know of no other matters that may be presented at the Annual Meeting, other than those listed in the Notice of Annual
Meeting of Stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a proxy card and voting
instructions with these proxy materials from that organization rather than from us. Simply complete and mail the proxy card and voting instructions to ensure that your vote is counted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Alternatively, you may vote by telephone or over the Internet as instructed by your broker, bank or other agent, if applicable. To vote in person at the Annual Meeting, you must obtain a valid
proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy form. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>May I change my vote after submitting my proxy card? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the stockholder of record of your shares, you may revoke
your proxy in any one of the following four ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">send a timely written revocation of the proxy to our Secretary; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">submit a signed proxy card bearing a later date; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">enter a new vote over the Internet or by telephone; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attend and vote in person at the Annual Meeting. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are not registered in your own name, you will
need the appropriate documentation from the stockholder of record to vote personally at the Annual Meeting. If your shares are held by your broker, bank or another party as a nominee or agent, you should follow the instructions provided by such
party. Your personal attendance at the Annual Meeting does not revoke your proxy. Your last vote, prior to or at the Annual Meeting, is the vote that will be counted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who will bear the expense of soliciting proxies? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will
bear the cost of the solicitation of proxies, including the preparation, assembly, printing and mailing of this proxy statement, the proxy card and any additional information furnished to stockholders. Copies of solicitation materials will be
furnished to banks, brokerage houses, fiduciaries and custodians holding in their names shares of our common stock beneficially owned by others to forward to such beneficial owners. We may reimburse persons representing beneficial owners of our
common stock for their costs of forwarding solicitation materials to such beneficial owners. Original solicitation of proxies by mail may be supplemented by solicitation by telephone, via the Internet or in person by our directors, officers or other
regular employees. No additional compensation will be paid to directors, officers or other regular employees for such services. In addition, we have engaged The Proxy Advisory Group, LLC to assist in the solicitation of proxies and provide related
advice and informational support, for a services fee and the reimbursement of customary disbursements, which are not expected to exceed $15,000 in total. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find the voting results from the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at our Annual Meeting. Final voting results will be published in a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> that we expect to file no later than four business days after the Annual Meeting. If final voting results are not available by the time we file the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> we will
disclose the preliminary results in the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> and, within four business days after the final voting results are known to us, file an amended <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to
disclose the final voting results. <B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_3"></A>PROPOSAL&nbsp;1 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DECLASSIFICATION AMENDMENT TO THE CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="font-size:20pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><A NAME="toc535515_4"></A>Background</B></TD>
<TD ALIGN="left" VALIGN="top"><B>of the Proposal </B></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s Seventh Amended and Restated Certificate of Incorporation (the
&#147;Certificate of Incorporation&#148;) currently provides for a classified Board divided into three classes, with each class being elected for a three-year term. On March&nbsp;29, 2018, the Board approved, and recommended that the stockholders
approve, an amendment (the &#147;Declassification Amendment&#148;) to the Certificate of Incorporation to declassify the Board and provide for the annual election of each of the Company&#146;s directors, effective at the 2018 Annual Meeting. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><A NAME="toc535515_5"></A>Proposed</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Amendment to Article VI of the Certificate of Incorporation </B></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After careful consideration, the Board has
determined that it is advisable and in the best interests of the Company and its stockholders to declassify the Board to allow the Company&#146;s stockholders to vote on the election of directors generally on an annual basis, rather than on a
staggered basis. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board carefully considered the advantages and disadvantages of the current classified structure. In reaching its determination to
propose the declassification of the Board, it concluded that the benefits of a classified structure, including maintaining continuity of experience and encouraging a person seeking control of the Company to initiate arm&#146;s length discussions
with management and the Board, were outweighed by the following considerations: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Board&#146;s belief that providing the Company&#146;s stockholders with the opportunity to annually register their views on the collective performance of the Board and on each director individually will further the
Company&#146;s goal of ensuring that its corporate governance policies conform to best practices and maximize accountability to the stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussions with certain of the Company&#146;s stockholders who prefer the annual election of directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the growing sentiment among the investment community in favor of the annual election of directors. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the
Declassification Amendment is adopted by the Company&#146;s stockholders, beginning at the 2018 Annual Meeting and at each annual meeting of stockholders thereafter, all directors scheduled to stand for election will be eligible to serve a <FONT
STYLE="white-space:nowrap">one-year</FONT> term expiring at the subsequent annual meeting of stockholders. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Declassification Amendment is not
adopted by the Company&#146;s stockholders, the Board will remain classified and the current Class&nbsp;I directors standing for election at the 2018 Annual Meeting will be eligible to serve a three-year term expiring at the Company&#146;s 2021
annual meeting of stockholders. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><A NAME="toc535515_6"></A>Removal</B></TD>
<TD ALIGN="left" VALIGN="top"><B>of Directors Without Cause</B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delaware corporate law provides that, unless a company&#146;s certificate of
incorporation provides otherwise, members of a classified board of directors may be removed only for cause. At present, because the Board is classified, our Certificate of Incorporation provides that directors are removable only for cause. If this
proposal is approved by our stockholders, our Certificate of Incorporation will be amended to remove this provision such that directors may be removed with or without cause after the Board is no longer classified. If the Declassification Amendment
is not adopted by the Company&#146;s stockholders, the Board will remain classified and our stockholders will be able to remove directors only for cause. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><A NAME="toc535515_7"></A>Text</B></TD>
<TD ALIGN="left" VALIGN="top"><B>of the Proposed Amendment </B></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The text of the proposed Declassification Amendment is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:10pt; font-family:Times New Roman">Article VI, Sections 3, 4 and 5. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">3. <U>Number of Directors; Term of Office</U>. The number of Directors of the Corporation shall be fixed solely and exclusively by resolution
duly adopted from time to time by the Board of Directors. <STRIKE>The Directors, other than those who may be elected by the holders of any series of Undesignated Preferred Stock, shall be classified, with respect to the term for which they severally
hold office, into three classes. The initial Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;I Directors of the Corporation shall be Devang Kantesaria and David P. Southwell; the initial Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;II Directors of the
Corporation shall be Martin Vogelbaum, Isai Peimer and Ittai Harel; and the initial Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;III Directors of the Corporation shall be Paul Howes and A.N. &#147;Jerry&#148; Karabelas. The initial
Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;I Directors shall serve for a term expiring at the annual meeting of stockholders to be held in 2015, the initial Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;II Directors shall serve for a term expiring
at the annual meeting of stockholders to be held in 2016, and the initial Class</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;III Directors shall serve for a term expiring at the annual meeting of stockholders to be held in 2017.</STRIKE> At each annual
meeting of stockholders, Directors elected to succeed those Directors whose terms expire shall be elected for a term of office to expire at the <STRIKE>third succeeding</STRIKE> <U>next </U>annual meeting of stockholders after their election.
Notwithstanding the foregoing, the Directors elected to each class shall hold office until their successors are duly elected and qualified or until their earlier resignation, death or removal. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, whenever, pursuant to the provisions of Article IV of this Certificate, the holders of any one or more series
of Undesignated Preferred Stock shall have the right, voting separately as a series or together with holders of other such series, to elect Directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies
and other features of such directorships shall be governed by the terms of this Certificate and any certificate of designations applicable to such series. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">4. <U>Vacancies</U>. Subject to the rights, if any, of the holders of any series of Undesignated Preferred Stock to elect Directors and to
fill vacancies in the Board of Directors relating thereto, any and all vacancies in the Board of Directors, however occurring, including, without limitation, by reason of an increase in the size of the Board of Directors, or the death, resignation,
disqualification or removal of a Director, shall be filled solely and exclusively by the affirmative vote of a majority of the remaining Directors then in office, even if less than a quorum of the Board of Directors, and not by the stockholders. Any
Director appointed in accordance with the preceding sentence shall <STRIKE>hold office for the remainder of the full term of the class of Directors in which the new directorship was created or the vacancy occurred and</STRIKE> <U>serve for a term
expiring at the next annual meeting of stockholders after his or her appointment and shall hold office</U> until such Director&#146;s successor shall have been duly elected and qualified or until his or her earlier resignation, death or removal.
<STRIKE>Subject to the rights, if any, of the holders of any series of Undesignated Preferred Stock to elect Directors, when the number of Directors is increased or decreased, the Board of Directors shall, subject to Article VI.3 hereof, determine
the class or classes to which the increased or decreased number of Directors shall be apportioned; provided, however, that no</STRIKE> <U>No</U> decrease in the number of Directors shall shorten the term of any incumbent Director. In the event of a
vacancy in the Board of Directors, the remaining Directors, except as otherwise provided by law, shall exercise the powers of the full Board of Directors until the vacancy is filled. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">5. <U>Removal</U>. Subject to the rights, if any, of any series of Undesignated Preferred Stock to elect Directors and to remove any Director
whom the holders of any such series have the right to elect, any Director (including persons elected by Directors to fill vacancies in the Board of Directors) may be removed from office <STRIKE>(i)</STRIKE><STRIKE></STRIKE><STRIKE>&nbsp;only with
cause and (ii)</STRIKE><U>&nbsp;with or without cause,</U> only by the affirmative vote of the holders of 75% or more of the outstanding shares of capital stock then entitled to vote <STRIKE>at an election of Directors</STRIKE> <U>thereon</U>,
voting together as a single class. At least forty-five (45)&nbsp;days prior to any annual or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
special meeting of stockholders at which it is proposed that any Director be removed from office, written notice of such proposed removal and the alleged grounds thereof shall be sent to the
Director whose removal will be considered at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective Date of Amendment. This amendment shall become effective on the date that the
Declassification Amendment is approved by the vote of the holders of not less than 75% of the shares entitled to vote on the amendment. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_8">
</A>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposal to amend the Certificate of Incorporation requires an affirmative vote of the holders of not less than 75% of the
shares entitled to vote on the amendment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_9"></A>Our Recommendation </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; THE DECLASSIFICATION AMENDMENT TO THE CERTIFICATE OF INCORPORATION. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_10"></A>PROPOSAL&nbsp;2 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTOR REMOVAL AMENDMENT TO THE CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_11"></A>Background of the Proposal </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s Certificate of Incorporation currently provides for a supermajority voting requirement with respect to the removal of directors. On
March&nbsp;29, 2018, the Board approved, and recommended that the stockholders approve, an amendment (the &#147;Director Removal Amendment&#148;) to the Certificate of Incorporation to eliminate the supermajority voting requirement with respect to
removal of directors and replace it with a majority voting standard. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_12"></A>Proposed Amendment to Article VI of the Certificate of
Incorporation </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After careful consideration, the Board has determined that it is advisable and in the best interests of the Company and its
stockholders to eliminate the supermajority voting requirement with respect to the removal of directors and replace it with a majority voting standard. The Certificate of Incorporation currently provides that our directors may only be removed for
cause by the vote of 75% of the shares then entitled to vote at a meeting of stockholders for the election of directors. This proposal eliminates the 75% requirement and replaces it with a majority voting standard. If the Director Removal Amendment
is adopted by the Company&#146;s stockholders, directors will be able to be removed with or without cause. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This change will make it easier for
stockholders to remove directors of the Company. This change further coincides with the declassification of our Board to ensure the accountability of directors to stockholders. Moreover, by eliminating the supermajority vote, we ensure that the will
of a majority of our stockholders is controlling with respect to director retention. The Board carefully considered the advantages and disadvantages of the current supermajority voting requirement. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_13"></A>Text of the Proposed Amendment </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The text of the proposed Director Removal Amendment is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:6%; font-size:10pt; font-family:Times New Roman">Article VI, Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">5.
<U>Removal</U>. Subject to the rights, if any, of any series of Undesignated Preferred Stock to elect Directors and to remove any Director whom the holders of any such series have the right to elect, any Director (including persons elected by
Directors to fill vacancies in the Board of Directors) may be removed from office (i)&nbsp;only with cause and (ii)&nbsp;only by the affirmative vote of the holders of <STRIKE>75% or more</STRIKE> <U>a majority</U> of the outstanding shares of
capital stock then entitled to vote at an election of Directors, voting together as a single class. At least forty-five (45)&nbsp;days prior to any annual or special meeting of stockholders at which it is proposed that any Director be removed from
office, written notice of such proposed removal and the alleged grounds thereof shall be sent to the Director whose removal will be considered at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective Date of Amendment. This amendment shall become effective on the date that the Director Removal Amendment is approved by the vote of the holders of
not less than 75% of shares entitled to vote on the amendment. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_14"></A>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposal to amend the Certificate of Incorporation requires an affirmative vote of the holders of not less than 75% of the shares entitled to vote on the
amendment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_15"></A>Our Recommendation </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; THE DIRECTOR REMOVAL AMENDMENT TO THE CERTIFICATE OF INCORPORATION. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_16"></A>PROPOSAL 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in
Proposal 1, on March&nbsp;29, 2018, the Board approved, and recommended that the stockholders approve, an amendment to the Certificate of Incorporation to declassify the Board, effective at the 2018 Annual Meeting. If the Company&#146;s stockholders
approve Proposal 1 at the Annual Meeting, the Company&#146;s stockholders will elect seven (7)&nbsp;directors to hold office until the annual meeting of stockholders in 2019, or until their respective successors have been duly elected and qualified.
If the Company&#146;s stockholders do not approve Proposal 1, this Proposal 3 will not be submitted to a vote of the stockholders at the Annual Meeting, and instead, Proposal 4 (Election of Class&nbsp;I Directors) will be submitted in its place.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the recommendation of the nominating and corporate governance committee of the Board (the &#147;Nominating and Governance Committee&#148;), the
Board has nominated Messrs. Roderick Wong, Carsten Boess, Pedro Granadillo, Gotham Makker, Gaurav Shah, David P. Southwell and Naveen Yalamanchi to serve as directors. Each of the foregoing persons currently serves as a director, and each has
indicated a willingness to continue to serve as a director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_17"></A>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes cast at the Annual Meeting by the holders of shares present in person or represented by proxy and entitled to
vote on the election of the directors. The seven nominees receiving the highest number of &#147;For&#148; votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the
seven nominees named above. If any of the nominees become unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by our Board. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_18"></A>Our Recommendation </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE
BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; EACH OF THE NOMINEES SET FORTH ABOVE. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_19"></A>PROPOSAL 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF CLASS I DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders will be asked to vote on this Proposal 4 solely in the event that, at the Annual Meeting, the Company&#146;s stockholders do not approve the
adoption of the amendment to the Certificate of Incorporation to declassify the Board, effective at the 2018 Annual Meeting, as described in Proposal 1. If the Company&#146;s stockholders approve Proposal 1, then the Company will amend its
Certificate of Incorporation to eliminate the classified Board and the stockholders will proceed to vote on Proposal 3, and not this Proposal 4. If, however, the stockholders do not approve Proposal 1, a vote will be taken on this Proposal 4. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the stockholders do not approve Proposal 1, the stockholders will elect two Class&nbsp;I directors to hold office until the annual meeting of stockholders
in 2021, or until their respective successors have been duly elected and qualified. If the stockholders do not approve Proposal 1, the Board will continue to be divided into three classes serving staggered three-year terms, the term of one class of
directors to expire each year. The current term of the Class&nbsp;I directors expires at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the recommendation of the Nominating
and Corporate Governance Committee, the Board has nominated Pedro Granadillo and David P. Southwell to serve as Class&nbsp;I directors. Pedro Granadillo and David P. Southwell serve presently as Class&nbsp;I directors, and each has indicated a
willingness to continue to serve as a director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_20"></A>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes cast at the Annual Meeting by the holders of shares present in person or represented by proxy and entitled to
vote on the election of the directors. The two nominees receiving the highest number of &#147;For&#148; votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the two
nominees named above. If any of the nominees become unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by our Board. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_21"></A>Our Recommendation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE
BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; EACH OF THE NOMINEES SET FORTH ABOVE. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_22"></A>DIRECTORS AND NOMINEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of the Board as of the date of this proxy statement, together with certain information about them, are set forth below. As described in the
biographical information below, a number of the members of our Board were associated with Private Rocket prior to the Reverse Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no
arrangements or understanding between any director, or nominee for directorship, pursuant to which such director or nominee was selected as a director or nominee. Additionally, there are no family relationships among our directors, officers, or
director-nominees. We know of no reason why any of the nominees may be unable to serve as a director. If any of the nominees are unable to serve, your proxy may vote for another nominee proposed by the Board. If for any reason any of the nominees
prove unable or unwilling to stand for election, the Board will nominate alternate(s) or reduce the size of the Board to eliminate the vacancy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_23">
</A>Nominees for Election as Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are the names, ages as of April&nbsp;26, 2018, principal occupations, and business experience,
as well as their prior service on the Board, of the directors. Unless otherwise indicated, principal occupations shown for each director have extended for five or more years. If the stockholders approve Proposal 1, then stockholders will be voting
on the election as directors of all of the individuals below. If the stockholders do not approve Proposal 1, then the stockholders will be voting on the election as directors of Messrs. Granadillo and Southwell as Class&nbsp;I directors. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Class&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Term&nbsp;Expires&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Position(s)&nbsp;Held&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Director&nbsp;&nbsp;&nbsp;&nbsp;<BR>Since</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Boess</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">51</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2016</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pedro Granadillo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">70</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gotham Makker, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gaurav Shah, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President,&nbsp;Chief&nbsp;Executive<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Officer and&nbsp;Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2018</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David P. Southwell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2014</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roderick Wong, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">41</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Naveen Yalamanchi, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">41</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2018</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Carsten Boess</I></B><B><I></I></B>&nbsp;has served as one of our directors since January 2016. He is
currently the Executive Vice President of Corporate Affairs at Kiniksa Pharmaceuticals, a privately held biotechnology company. He previously served as Senior Vice President and Chief Financial Officer at Synageva Biopharma Corporation from 2011
until the company&#146;s acquisition by Alexion Pharmaceuticals in 2015. Prior to his role at Synageva, Mr.&nbsp;Boess served in multiple roles with increasing responsibility for Insulet Corporation, including Chief Financial Officer from 2006 to
2009 and Vice President of International Operations from 2009 to 2011. Prior to that, Mr.&nbsp;Boess served as Executive Vice President of Finance for Serono Inc. from 2005 to 2006. In addition, he was a member of the Geneva based World Wide
Executive Finance Management Team while at Serono. Mr.&nbsp;Boess was also Chief Financial Officer at Alexion Pharmaceuticals and was a finance executive at Novozymes of North America and Novo Nordisk in France, Switzerland and China. Mr.&nbsp;Boess
received a Bachelor&#146;s degree and Master&#146;s degree in Economics and Finance, specializing in Accounting and Finance from the University of Odense, Denmark. We believe that Mr.&nbsp;Boess&#146; qualifications to sit on our Board include his
business and financial experience working at pharmaceutical companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Pedro Granadillo </I></B>has served as one of our directors
since January 2018, when he joined the Board in connection with the Reverse Merger. He has over 40 years of biopharmaceutical industry experience with expertise in human resources, manufacturing, quality and corporate governance. From 1970 until his
retirement in 2004, Mr.&nbsp;Granadillo held multiple leadership roles at Eli Lilly and Company, including Senior Vice President of Global Manufacturing and Human Resources and a member of the Executive Committee. He currently serves
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on the Board of Directors of Haemonetics Corporation, a position he has held since 2004. Mr.&nbsp;Granadillo has previously served on the Boards of Directors at Dendreon Corporation and Noven
Pharmaceuticals, as well as NPS Pharmaceuticals, which sold to Shire for $5.2&nbsp;billion in 2015. He graduated from Purdue University with a Bachelor of Science in Industrial Engineering. We believe that Mr.&nbsp;Granadillo&#146;s qualifications
to sit on our Board include his depth of knowledge of the pharmaceutical industry and his many years of experience serving on the boards of directors of healthcare companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Gotham Makker, MD</I></B> has served as one of our directors since January 2018, when he joined the Board in connection with the Reverse
Merger.<B><I> </I></B>Dr.&nbsp;Makker has over 17 years of healthcare industry experience. Since 2005, he has served as CEO of Simran Investment Group, LLC, a closely held equity investment fund. Prior to Simran, Dr.&nbsp;Makker was a healthcare
portfolio manager and principal at Citadel Investment Group LLC, a position he held from 2002 to 2005. Prior to joining Citadel, Dr.&nbsp;Makker served as an analyst at Oracle Partners LP covering biotechnology and medical device sectors from 2000
to 2001. From 1999 to 2000, Dr.&nbsp;Makker was a senior analyst on the life sciences investment banking team at Hambrecht&nbsp;&amp; Quist. Dr.&nbsp;Makker received an MD from the University of Nebraska Medical School, and he completed the Sarnoff
cardiovascular research fellowship at Columbia University, College of Physicians&nbsp;&amp; Surgeons and at Harvard Medical School, Brigham&nbsp;&amp; Women&#146;s Hospital. We believe that Dr.&nbsp;Makker&#146;s qualifications to sit on our Board
include his years of experience in, and extensive knowledge of, the healthcare industry.<B><I> </I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Gaurav Shah, MD</I></B> has
served as our President and Chief Executive Officer and as one of our directors since January 2018, when he joined the Board in connection with the Reverse Merger. Dr.&nbsp;Shah was appointed Chief Executive Officer of Private Rocket in September
2015. Prior to joining Private Rocket, from 2011-2015, Dr.&nbsp;Shah held various leadership positions at Novartis including Global Program Head for <FONT STYLE="white-space:nowrap">CART-19,</FONT> Global Clinical Program Head for <FONT
STYLE="white-space:nowrap">CTL-019</FONT> and Biosimilars, and Global Clinical Leader for Afinitor. Prior to Novartis, he spent three years at Eli Lilly and Company as Medical Director overseeing clinical development of numerous programs including
olaratumab. During his industry tenure, he has participated in several drug development programs resulting in successful regulatory approvals, such as <FONT STYLE="white-space:nowrap">CTL-019</FONT> in pediatric ALL, the first cell and gene therapy
approved in the U.S., and successful commercial launches. Prior to joining industry, Dr.&nbsp;Shah was Assistant Professor of Medicine/Oncology at Columbia University. He holds a B.A. in Behavioral Neuroscience from Harvard University and an MD from
Columbia University. Dr.&nbsp;Shah completed&nbsp;his internal medicine residency&nbsp;at Brigham and Women&#146;s Hospital/Harvard Medical School and completed his hematology/oncology fellowship training at the Memorial-Sloan Kettering Cancer
Center. We believe Dr.&nbsp;Shah is qualified to sit on our Board due to his role as Chief Executive Officer of the Company and his significant leadership and management experience in the biopharmaceutical industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>David P. </I></B><B><I>Southwell</I></B><B><I></I></B>&nbsp;has served as one of our directors since August 2014. He served as our
President and Chief Executive Officer from July 2014 to January 2018. From March 2010 to October 2012, Mr.&nbsp;Southwell served as Executive Vice President, Chief Financial Officer of Human Genome Sciences, Inc., or Human Genome Sciences, which is
owned by GlaxoSmithKline plc. Prior to his time at Human Genome Sciences, Mr.&nbsp;Southwell served as Executive Vice President and Chief Financial Officer of Sepracor Inc. from July 1994 to July 2008. Mr.&nbsp;Southwell has also served on the Board
of Directors of PTC Therapeutics Inc. since December 2005 and Spero Therapeutics, Inc. since February 2018. Mr.&nbsp;Southwell received a B.A. from Rice University and an M.B.A. from Dartmouth College. We believe that Mr.&nbsp;Southwell&#146;s
qualifications to sit on our Board include his broad experience serving on the boards of directors of public companies, his specific experience with public therapeutics companies and his executive leadership, managerial and business experience. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Roderick Wong, MD</I></B> has served as Chairman of our Board since January 2018, when he joined the Board in connection with the
Reverse Merger.<B><I> </I></B>Dr.&nbsp;Wong served as the Chairman of the Board for Private Rocket from July 2015 until January 2018. Dr.&nbsp;Wong has over 15 years of healthcare investment experience. Since 2010, he has served as Managing Partner
and Chief Investment Officer of RTW Investments, LP (&#147;RTW&#148;), a healthcare-centered investment firm. Prior to RTW, Dr.&nbsp;Wong was a Managing Director and the Portfolio Manager for the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Davidson Kempner Healthcare Funds. Prior to joining Davidson Kempner, Dr.&nbsp;Wong held various healthcare investment and healthcare research roles at SAC Capital Company and Cowen&nbsp;&amp;
Company. Dr.&nbsp;Wong served on the Board of Directors of Penwest Pharmaceuticals in 2010. He received an MD from the University of Pennsylvania Medical School, received an MBA from Harvard Business School, and graduated with a BS in Economics from
Duke University. We believe that Dr.&nbsp;Wong is qualified to sit on our Board due to his service prior to the closing of the Reverse Merger as Chairman of the Board of Directors of Private Rocket and his years of experience in, and extensive
knowledge of, the biopharmaceutical industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Naveen Yalamanchi, MD</I></B> has served as one of our directors since January 2018,
when he joined the Board in connection with the Reverse Merger.<B><I> </I></B>Dr.&nbsp;Yalamanchi joined Private Rocket as a Director in July 2015. Dr.&nbsp;Yalamanchi has over 15 years of healthcare investment and research experience. Since 2015,
Dr.&nbsp;Yalamanchi has served as Partner and Portfolio Manager at RTW Investments, LP, a healthcare-centered investment firm. Prior to RTW, Dr.&nbsp;Yalamanchi was Vice-President and <FONT STYLE="white-space:nowrap">co-portfolio</FONT> manager at
Calamos Arista Partners, a subsidiary of Calamos Investments, a position he held from 2012 to 2015. Prior to joining Calamos Arista Partners, Dr.&nbsp;Yalamanchi held various healthcare investment roles at Millennium Management and Davidson Kempner
Capital Management. Dr.&nbsp;Yalamanchi holds a BS in Biology from MIT and an MD from Stanford University. He completed his surgery internship at UCLA Medical Center. Dr.&nbsp;Yalamanchi currently serves as an observer of the Board of Directors of
Dermtech, Inc., a privately held diagnostic company. We believe that Dr.&nbsp;Yalamanchi is qualified to sit on our Board due to his service prior to the closing of the Reverse Merger as a member of the Board of Directors of Private Rocket and his
years of experience in, and extensive knowledge of, the healthcare industry. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_24"></A>Information about Our Executive Officers
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table identifies our executive officers and sets forth their current position(s) and their ages as of April&nbsp;26, 2018. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Age&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position(s) Held</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gaurav Shah, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jonathan Schwartz, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Medical Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Militello</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Controller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kinnari Patel, PharmD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">39</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Operating Officer and Head of Development</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should refer to &#147;Directors Continuing in Office&#148; above for information about our President and Chief Executive
Officer, Gaurav Shah, M.D. Biographical information for our other executive officers, as of April&nbsp;26, 2018, is set forth below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Jonathan Schwartz, MD</I></B> joined us as Chief Medical Officer in January 2018 in connection with the Reverse Merger.
Dr.&nbsp;Schwartz joined Private Rocket in January 2016 and served as Chief Medical Officer and Head of Clinical Development. Dr.&nbsp;Schwartz is responsible for leading our medical and program development. Dr.&nbsp;Schwartz has over 20 years of
combined clinical practice and drug development experience. Prior to Private Rocket, Dr.&nbsp;Schwartz was Vice-President of Clinical Development at Stemline Therapeutics, where he oversaw development efforts for anticancer, vaccine and
small-molecule platforms, a position he held since 2014. Prior to Stemline, he spent seven years at Eli Lilly and Company in several leadership positions, including Vice-President of Clinical Science, where he led development teams for numerous drug
programs including ramucirumab. Previously, Dr.&nbsp;Schwartz was Associate Professor of Medicine at the Mount Sinai Medical Center in New York, specializing in the treatment and translational research of hepatobiliary malignancies and also served
as Director for the Hematology-Oncology Fellowship training program. He has a BA in American Civilization from Brown University and an MD from Washington University (St. Louis). He completed post-graduate Internal Medicine and Hematology-Oncology
training at the Mount Sinai and New York Presbyterian Hospitals.<B><I> </I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>John Militello</I></B>&nbsp;joined us as Controller
in January 2018. From April 2015 to November 2017, Mr.&nbsp;Militello worked at Immune Pharmaceuticals, Inc., a publicly traded biotechnology company, where he most </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recently served as Vice President of Finance (principal financial officer), Controller and Chief Accounting Officer. Prior to that, Mr.&nbsp;Militello was an Assistant Controller with Retrophin,
Inc., a San Diego based biotech company, and the Manager, External Reporting&nbsp;&amp; Compliance at Volt Information Sciences, Inc., a publicly traded staffing company. Prior to Volt Information Sciences, Inc., Mr.&nbsp;Militello was a Senior
Manager with BDO USA, LLP serving multi-national SEC registrants. Mr.&nbsp;Militello is a Certified Public Accountant and earned his Bachelor of Science degree in Accounting from St. Joseph&#146;s College. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Kinnari Patel, PharmD</I></B><I> </I>joined us as Chief Operating Officer and Head of Development in January 2018 in connection with the
Reverse Merger. Dr.&nbsp;Patel joined Private Rocket in April 2016, serving as Vice President &#150; Head of Regulatory, Pharmacoviligence and Quality from April 2016 to July 2017 and as Senior Vice President, Global Program Head and Head of
Regulatory and Quality from August 2017 to December 2017. Prior to joining Private Rocket, Dr.&nbsp;Patel was the Global Regulatory Lead at AstraZeneca from January 2015 to April 2016. Prior to that, Dr.&nbsp;Patel was Head of U.S. Risk Management
at Bristol-Meyers Squibb from May 2014 through January 2015 and the U.S. Liaison for Global Regulatory Sciences at Bristol-Meyers Squibb from November 2010 to April 2014. Dr.&nbsp;Patel received the dual degrees of B.S. in Biology and Doctorate of
Pharmacy from the USciences in Philadelphia, PA. She also completed a <FONT STYLE="white-space:nowrap">two-year</FONT> Post-Doctoral Regulatory Affairs Fellowship through Rutgers University. Most recently, she received her Executive MBA from NYU
Stern School of Business with specialization in Corporate Finance, Leadership and Strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_25"></A>Information about the Board and
Corporate Governance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board oversees our business and monitors the performance of our management. In accordance with our corporate governance procedures, the Board does not
involve itself in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations of the Company. Our executive officers and management oversee the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations. Our directors fulfill their duties and responsibilities by attending meetings of the Board, which are held from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board held seven meetings during the year ended December&nbsp;31, 2017. During the year ended December&nbsp;31, 2017, each director then in office
attended at least 75% of the total of (i)&nbsp;the meetings of the Board held during the period for which he or she has been a director and (ii)&nbsp;the meetings of the committee(s) on which that director served during such period. Each of our
directors then in office attended our 2017 annual meeting of stockholders. It is our policy to encourage our directors to attend the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board of Directors Independence </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the listing
requirements and rules of the Nasdaq Global Market (&#147;Nasdaq&#148;), independent directors must compose a majority of a listed company&#146;s board of directors. In addition, applicable Nasdaq rules require that, subject to specified exceptions,
each member of a listed company&#146;s audit, compensation and nominating committees must be independent within the meaning of applicable Nasdaq rules. Audit committee members must also satisfy the independence criteria set forth in Rule <FONT
STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act. Our Board has undertaken a review of the independence of each director and considered whether any director has a material relationship with us that could compromise his or her ability
to exercise independent judgment in carrying out his or her responsibilities. In making this determination, our Board considered the current and prior relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with our
company and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. As a result of
this review, our Board determined that each of Mr.&nbsp;Boess, Mr.&nbsp;Granadillo, Dr.&nbsp;Makker and Dr.&nbsp;Yalamanchi qualify as &#147;independent&#148; directors within the meaning of the Nasdaq rules. Our Board also determined that our
former directors, Mr.&nbsp;Barberich, Mr.&nbsp;Howes, Mr.&nbsp;Machado, Dr.&nbsp;Phillips and Dr.&nbsp;Spivey, satisfied the independence requirements, as determined in accordance with the rules of Nasdaq. As required under applicable Nasdaq rules,
our independent directors meet in regularly scheduled executive sessions at which only independent directors are present. Dr.&nbsp;Wong is the current chairperson of our Board and is not considered an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independent director. Consistent with Nasdaq listing requirements, the independent directors regularly have the opportunity to meet in executive sessions without Dr.&nbsp;Wong, Dr.&nbsp;Shah and
Mr.&nbsp;Southwell in attendance. The purpose of these executive sessions is to promote open and candid discussion among the independent directors. We do not have a lead independent director. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Committees of the Board </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has three
committees: an audit committee (the &#147;Audit Committee&#148;), a compensation committee (the &#147;Compensation Committee&#148;), and the Nominating and Corporate Governance Committee. During the year ended December&nbsp;31, 2017, the Audit
Committee held six meetings, the Compensation Committee held two meetings, and the Nominating and Corporate Governance Committee held one meeting. Continuing directors and our nominees for election as director are required to attend the annual
meeting of stockholders, barring significant commitments or special circumstances, and are also required to participate in our committee meetings. The following table provides membership information for each committee: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Audit&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating&nbsp;and&nbsp;Corporate</B><br><B>Governance</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Boess**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pedro Granadillo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gotham Makker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Naveen Yalamanchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Committee Chairperson </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Financial Expert </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of the Audit Committee are Mr.&nbsp;Carsten Boess, Mr.&nbsp;Pedro Granadillo and Dr.&nbsp;Gotham Makker. Mr.&nbsp;Boess serves as chair of the
Audit Committee. The Audit Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq and which is available on our website at <I>www.rocketpharma.com/corporate-governance/</I>. The inclusion of our
website address here and elsewhere in this proxy statement does not include or incorporate by reference the information on our website into this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board has determined that Mr.&nbsp;Boess, Mr.&nbsp;Granadillo and Dr.&nbsp;Makker are independent as independence is currently defined in Rule 5605 of the
Nasdaq listing standards and Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act. In addition, our Board has determined that each member of the Audit Committee is financially literate and that Mr.&nbsp;Boess qualifies as an
&#147;audit committee financial expert&#148; as defined in applicable SEC rules. In making this determination, our Board has considered the formal education and nature and scope of their previous experience, coupled with past and present service on
various audit committees. The responsibilities of our Audit Committee include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">appointing, determining the compensation of, and assessing the independence of our independent registered public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered
public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing the overall audit plan with our independent registered public accounting firm and members of management responsible for preparing our financial statements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures as well as critical accounting policies and practices
used by us; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing major issues as to the adequacy of our internal control over financial reporting; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing procedures for the receipt, retention and treatment of complaints received regarding ethics-related issues or potential violations of our code of business conduct and ethics and accounting and
auditing-related complaints and concerns; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recommending, based upon the Audit Committee&#146;s review and discussions with management and the independent registered public accounting firm, whether our audited financial statements shall be included in our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regularly report to and review with the Board any issues that arise with respect to the integrity of our financial statements and our compliance with legal and regulatory requirements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">preparing the audit committee report required by SEC rules to be included in our annual proxy statement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing all related party transactions for potential conflict of interest situations and approving all such transactions; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussing quarterly earnings releases. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_26"></A>AUDIT COMMITTEE
REPORT<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has reviewed and discussed the audited financial statements for
the fiscal year ended December&nbsp;31, 2017, with management and our former independent registered public accounting firm, RSM US LLP. The Audit Committee has discussed with RSM US LLP the matters required by the applicable standards of the Public
Company Accounting Oversight Board (&#147;PCAOB&#148;). The Audit Committee has also received the written disclosures and the letter from RSM US LLP required by applicable requirements of the PCAOB regarding RSM US LLP&#146;s communication with the
Audit Committee concerning independence, and has discussed with RSM US LLP the firm&#146;s independence. Based on the foregoing, the Audit Committee recommended to the Board that the audited financial statements be included in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2017, for filing with the SEC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Rocket Pharmaceuticals, Inc.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audit Committee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Boess, Chairperson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pedro Granadillo</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gotham Makker</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and is not to be incorporated by reference in any filing we make under either the Securities Act of 1933,
as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of our Nominating and Corporate Governance Committee are Mr.&nbsp;Pedro Granadillo, Dr.&nbsp;Gotham Makker and Dr.&nbsp;Naveen Yalamanchi.
Dr.&nbsp;Yalamanchi serves as chairperson of the Nominating and Corporate Governance Committee. Our Board has determined that all members of our Nominating and Corporate Governance Committee are independent as independence is currently defined in
Section&nbsp;5605 of the Nasdaq listing standards. The Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable standards of Nasdaq and which is available on our website at
<I>www.rocketpharma.com/corporate-governance/</I>. The inclusion of our website address here and elsewhere in this proxy statement does not include or incorporate by reference the information on our website into this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The responsibilities of our Nominating and Corporate Governance Committee include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recommending to the Board criteria for Board and committee membership; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing a policy and procedures for identifying and evaluating Board candidates, including nominees recommended by stockholders; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">identifying individuals qualified to become members of the Board; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recommending to the Board the persons to be nominated for election as directors and to each of the Board&#146;s committees; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developing and recommending to the Board a set of corporate governance guidelines; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">overseeing the evaluation of the Board and management. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee
periodically determines the qualifications, qualities, skills and other expertise required to be a director and develops, subject to approval by the full Board, criteria to be considered in selecting nominees for director. Among other things, the
Nominating and Corporate Governance Committee considers whether the Board reflects the balance of knowledge, experience, skills, expertise, integrity, ability to make analytical inquiries, and diversity as a whole that the Nominating and Corporate
Governance Committee deems appropriate. The Nominating and Corporate Governance Committee has not adopted a policy regarding the consideration of diversity in identifying director nominees. The process followed by the Nominating and Corporate
Governance Committee to identify and evaluate director candidates includes requests to current directors and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to potential
candidates and interviews of selected candidates by members of the Nominating and Corporate Governance Committee and the Board. The Nominating and Corporate Governance Committee may use outside consultants to assist in identifying or evaluating
candidates. Final approval of director candidates is determined by the full Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider
qualified nominations for directors recommended by stockholders. In general, stockholder recommendations are evaluated on the same basis as any recommendation from members of the Board or management of the Company. Recommendations should be sent to
our Secretary, c/o Rocket Pharmaceuticals, Inc., 430 East 29<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1040, New York, NY 10016. For additional information about our director nomination requirements, please see
&#147;Stockholder Proposals and Nominations&#148; and our amended and restated bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of our Compensation Committee are Mr.&nbsp;Carsten Boess, Mr.&nbsp;Pedro Granadillo and Dr.&nbsp;Naveen Yalamanchi. Mr.&nbsp;Granadillo serves as
chairperson of the Compensation Committee. All members of the Compensation Committee are independent as independence is currently defined in Section&nbsp;5605 of the Nasdaq listing standards. The Compensation Committee operates under a written
charter that satisfies the applicable standards of Nasdaq and which is available on our website at <I>www.rocketpharma.com/corporate-governance/</I>. The inclusion of our website address here and elsewhere in this proxy statement does not include or
incorporate by reference the information on our website into this proxy statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The responsibilities of the Compensation Committee include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and determining and approving the compensation of our Chief Executive Officer; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">determining the compensation of our other executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">overseeing and administering our compensation and similar plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">appointing, compensating, and overseeing potential current compensation advisors in accordance with the independence standards identified in the applicable rules of Nasdaq; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our policies and procedures for the grant of equity-based awards; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and making recommendations to the Board with respect to director compensation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">preparing the Compensation Committee Report required by SEC rules to be included in our annual proxy statement or Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and discussing with management the compensation discussion and analysis to be included in our annual proxy statement or Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and discussing with the Board corporate succession plans for the Chief Executive Officer and other key officers. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of its process for approving or recommending to the Board the compensation for our senior executives other than our Chief Executive Officer, the
Compensation Committee reviews and considers the recommendations made by our Chief Executive Officer. In fulfilling its responsibilities, the Compensation Committee may delegate any or all of its responsibilities to a subcommittee of the
Compensation Committee, but only to the extent consistent with our amended and restated certificate of incorporation, amended and restated bylaws, Nasdaq rules, and other applicable law. In addition, pursuant to its charter, the Compensation
Committee has the sole authority to retain compensation consultants to assist in its evaluation of executive and director compensation. Beginning in October 2016, the Compensation Committee directly engaged Pearl Meyer&nbsp;&amp; Partners
(&#147;Pearl Meyer&#148;) as its compensation consultant to assist with matters relating to senior executive and director compensation. In January 2018, the Compensation Committee transitioned this work to F.W. Cook&nbsp;&amp; Co. (&#147;F.W.
Cook&#148;). The Compensation Committee requested that Pearl Meyer and F.W. Cook: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">develop a peer group of public companies to be used to benchmark pay levels of the senior leadership team and the board of directors; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">benchmark the total direct compensation of the senior leadership team; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">review the pay mix of the senior leadership team and compare it to the pay mix of the named executive officers of the peer group executive; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">review the amount of equity used to support the executive and Board pay programs and evaluate how this equity usage compared to peer practices and proxy advisory policies; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">conduct a detailed analysis of the design and amount of board of director pay at the peer companies and contrast this against the Company&#146;s current practices. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pearl Meyer and F.W. Cook ultimately developed recommendations that were presented to the Compensation Committee for its consideration. These recommendations
covered the executive and Board pay programs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee Interlocks and Insider Participation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2017, the Compensation Committee consisted of Mr.&nbsp;Timothy Barberich, Dr.&nbsp;Gary&nbsp;M. Phillips and Richard N.
Spivey, PharmD, PhD. No member of our Compensation Committee then in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
office had ever been an officer or employee of the Company. None of our executive officers then in office served as a member of the board of directors or compensation committee of any other
entity that had one or more of its officers serving on our Board or Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board Leadership </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roderick Wong currently serves as chairperson of our Board. Our Board has determined that its current structure, with separate Chairman and CEO roles, is in
the best interests of the Company and its stockholders at this time. The Board believes that this governance structure promotes balance between the Board&#146;s independent authority to oversee our business and the CEO and his management team who
manage the business on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> basis. Our Board believes that this leadership structure is appropriate for us, given Dr.&nbsp;Wong&#146;s extensive knowledge and
understanding of the biopharmaceutical industry and his ability to effectively identify strategic priorities for the Company. Furthermore, our Board believes that Dr.&nbsp;Wong&#146;s qualifications to be our chairperson include his significant
experience as a healthcare investor in all stages of the lifecycle of biopharmaceutical companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risk Oversight </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a culture that
incorporates risk management into the Company&#146;s corporate strategy and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business operations. Management discusses strategic and operational risks at
regular management meetings, and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing the Company. Throughout the year, senior management reviews these risks with
the Board at regular Board meetings as part of management presentations that focus on particular business functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board does not have a standing risk management committee, but rather administers this oversight function directly through our Board as a whole, as well as
through various standing committees of our Board that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, and our Audit Committee is responsible
for overseeing our significant financial and operational risk exposures and the steps our management has taken to monitor and control these exposures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee also monitors compliance with legal and regulatory requirements, including managing violations of our code of business conduct and ethics,
and considers and approves or disapproves any related-person transactions. Our Nominating and Corporate Governance Committee monitors the effectiveness of our corporate governance guidelines. Our Compensation Committee assesses and monitors whether
any of our compensation policies and programs has the potential to encourage excessive risk-taking. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Code of Business Conduct and Ethics
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers
responsible for financial reporting. The code of business conduct and ethics is available on our website at <I>www.rocketpharma.com/corporate-governance/</I>, under the corporate governance tab on our website. We intend to satisfy applicable
disclosure requirements regarding an amendment to, or a waiver from, a provision of our code of business conduct and ethics that applies to our principal executive officer, principal financial officer, principal accounting officer, or persons
performing similar functions, by posting such information on our website at the internet address set forth above. The inclusion of our website address here and elsewhere in this proxy statement does not include or incorporate by reference the
information on our website into this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Communications with Our Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders wishing to communicate directly with our Board may send correspondence to our Secretary, c/o Rocket Pharmaceuticals, Inc., 430 East 29<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1040, New York, NY 10016. Our Secretary will relay the information received to the Board. Stockholders may also visit our website at <I>www.rocketpharma.com</I> and select
&#147;Contact Us&#148; to communicate online with us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_27"></A>PROPOSAL 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF APPOINTMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s stockholders are being asked by the Audit Committee to ratify the appointment of EisnerAmper LLP to serve as the Company&#146;s independent
registered public accounting firm. EisnerAmper LLP has served as the independent registered public accounting firm for Private Rocket since August 2017 and was appointed to be the independent registered public accounting firm for the Company on
March&nbsp;16, 2018. The Audit Committee is solely responsible for selecting the Company&#146;s independent registered public accounting firm, and stockholder approval is not required to appoint EisnerAmper LLP as the Company&#146;s independent
registered public accounting firm for the fiscal year ending December&nbsp;31, 2018. However, the Board believes that submitting the appointment of EisnerAmper LLP to the stockholders for ratification is good corporate governance. If the
stockholders do not ratify this appointment, the Audit Committee will reconsider whether to retain EisnerAmper LLP. If the selection of EisnerAmper LLP is ratified, the Audit Committee, in its discretion, may direct the appointment of a different
independent registered public accounting firm at any time it decides that such a change would be in the best interest of the Company and its stockholders. Representatives of EisnerAmper LLP are expected to be present at the Annual Meeting. These
representatives will be provided an opportunity to make a statement at the Annual Meeting if they desire to do so and will be available to respond to appropriate questions from stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_28"></A>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposal to
ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018, requires an affirmative vote of a majority of the votes cast for or against the proposal at the Annual
Meeting by holders of shares present in person or represented by proxy and entitled to vote on the proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_29"></A>Our
Recommendation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BOARD RECOMMENDS A VOTE &#147;FOR&#148; THE RATIFICATION OF EISNERAMPER LLP AS THE COMPANY&#146;S INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_30"></A>Dismissal of RSM US LLP </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;21, 2018, RSM US LLP, an
independent registered public accounting firm, served as our independent auditors until March&nbsp;16, 2018, when the Audit Committee dismissed RSM US LLP in connection with the appointment of EisnerAmper LLP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The reports of RSM US LLP on the financial statements of Rocket Pharmaceuticals, Inc. (formerly known as Inotek Pharmaceuticals Corporation) for each of fiscal
years ended December&nbsp;31, 2017 and December&nbsp;31, 2016 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principle. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the fiscal years ended December&nbsp;31, 2017 and December&nbsp;31, 2016, and the subsequent interim period, there were no disagreements (as that term
is defined in Item 304(a)(1)(iv) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and related instructions) between the Company and RSM US LLP on any matter of accounting principles or practices, financial statement disclosure or auditing
scope or procedures which disagreements, if not resolved to the satisfaction of RSM US LLP would have caused RSM US LLP to make reference thereto in its reports on the financial statements for such years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As disclosed in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;21, 2018, the Company provided RSM US
LLP with a copy of the disclosures it made on its Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;21, 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(which are repeated above) and requested that RSM US LLP furnish the Company with a letter addressed to the SEC stating whether it agrees with the statements contained herein. A copy of RSM US
LLP&#146;s letter, dated March&nbsp;21, 2018, is filed as Exhibit 16.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;21, 2018. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the fiscal years ended December&nbsp;31, 2017 and December&nbsp;31, 2016, and the subsequent interim period through March&nbsp;16, 2018, neither the
Company, nor anyone acting on its behalf, consulted with EisnerAmper LLP regarding: (i)&nbsp;the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that may be rendered on the
Company&#146;s financial statements, and EisnerAmper LLP did not provide either a written report or oral advice to the Company that was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial
reporting issue, or (ii)&nbsp;any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and the related instructions) or a reportable event (as described in
Item 304(a)(1)(v) of Regulation <FONT STYLE="white-space:nowrap">S-K).</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_31"></A><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee <FONT STYLE="white-space:nowrap">pre-approves</FONT> all audit and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services
provided by its independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may be given as part of the Audit
Committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. All of the services
described below were approved by our Audit Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_32"></A>Audit Fees and Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2014, we retained RSM US LLP to provide audit services for the fiscal years ended December&nbsp;31, 2014, 2013, and 2012, and for services in connection
with our initial public offering which took place in February 2015 (the &#147;IPO&#148;). In the table below, Audit Fees reflects fees for audit services for the years ended December&nbsp;31, 2017 and December&nbsp;31, 2016. Audit-Related Fees for
2017 primarily reflect fees for services related to the Reverse Merger. Audit-Related Fees for 2016 primarily reflect fees for services related to our registration statement on Form <FONT STYLE="white-space:nowrap">S-3.</FONT> The Audit Committee <FONT
STYLE="white-space:nowrap">pre-approved</FONT> all services provided by our independent registered public accounting firm for the fiscal years ended December&nbsp;31, 2017 and 2016. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">139,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">162,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;190,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;266,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:20pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">&#147;Audit Fees&#148; include the aggregate fees billed for audit of annual financial statements, review of financial statements included in Form <FONT STYLE="white-space:nowrap">10-Qs,</FONT> and services normally
provided by the accountant for statutory and regulatory filings or engagements for those fiscal years. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">&#147;Audit-Related Fees&#148; include the aggregate fees billed for assurance and related services by the principal accountant that are reasonably related to the performance of the audit or review of the Company&#146;s
financial statements. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">&#147;Tax Fees&#148; include the aggregate fees billed for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">&#147;All Other Fees&#148; include the aggregate fees billed for any other products and services provided by the principal accountant. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_33"></A>PROPOSAL 6 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE COMPANY&#146;S SECOND AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_34"></A>Background of the Proposal </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
August 2014, the Board adopted the 2014 Stock Option and Incentive Plan (the &#147;Original Plan&#148;), which was subsequently approved by the stockholders in September 2014. The Board and stockholders subsequently approved amendments to the
Original Plan in November 2014 and the stockholders further ratified the Original Plan in June 2015. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2018, the Board approved the Second Amended
and Restated 2014 Stock Option and Incentive Plan (the &#147;Proposed 2014 Plan&#148;) which contains the following material features and changes from the Original Plan: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Shares Authorized for Issuance</I>. As of April&nbsp;2, 2018, [&nbsp;&nbsp;&nbsp;&nbsp;] shares were authorized for issuance under the Original Plan, of which [&nbsp;&nbsp;&nbsp;&nbsp;] shares remained available for
issuance, subject to automatic increase on each January&nbsp;1 for the term of the Original Plan by 4% of the number of shares of our common stock issued and outstanding on the immediately preceding December 31. On January&nbsp;4, 2018, in
connection with the Reverse Merger, the Company implemented the Stock Split, which adjusted the number of shares reserved and available for issuance under the Original Plan. Subsequently, the Company issued 26,272,107 shares of common stock on
January&nbsp;4, 2018 in connection with the Reverse Merger. The Proposed 2014 Plan nevertheless continues to provide for an aggregate maximum number of shares of common stock initially authorized for issuance of [&nbsp;&nbsp;&nbsp;&nbsp;] shares
(the &#147;Initial Limit&#148;). On January&nbsp;1, 2019, and each January&nbsp;1 thereafter for the term of the Proposed 2014 Plan, the number of shares reserved and available under the Proposed 2014 Plan will automatically increase by 4% of the
number of shares of our common stock issued and outstanding on the immediately preceding December&nbsp;31 (the &#147;Annual Increase&#148;); </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Increased Award Limits</I>. An increase in the number shares of stock underlying stock options or stock appreciation rights that may be granted to any one individual in any single calendar year of 750,000 shares, for
a maximum of 1,000,000 shares of common stock, and an increase in the number of shares of stock that may be issued in the form of incentive stock options. The Stock Split adjusted the foregoing limits in the Original Plan. These increases will bring
these limits back to the <FONT STYLE="white-space:nowrap">pre-Stock</FONT> Split amounts; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Section 162(m) Revisions</I>. In light of recent changes in the tax code, the Proposed 2014 Plan eliminates certain provisions relating to awards of &#147;performance-based compensation;&#148; and </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Term. </I>The term of the Proposed 2014 Plan will expire on June&nbsp;25, 2028. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board is submitting the
Proposed 2014 Plan to the stockholders for their approval at the Annual Meeting. The Board unanimously recommends that the Company&#146;s stockholders approve the Proposed 2014 Plan. The Company&#146;s ability to grant an appropriate number of
equity-based awards continues to be crucial in allowing the Company to effectively compete for talent and appropriately reward employees. It is in the long-term interest of the Company and its stockholders to strengthen the ability to attract,
motivate and retain employees, officers, directors and consultants, and to provide additional incentive for those persons through stock ownership and other incentives to improve operations, increase profits and strengthen the mutuality of interest
between those persons and the Company&#146;s stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Reverse Merger was not completed until January 2018, the Company currently does not have
an established grant practice and therefore it is difficult to predict how long the share reserve under the Original Plan is expected to last. Expectations regarding future share usage could be impacted by a number of factors, including award type
mix, hiring and promotion activity at the executive level, the future performance of our stock price, the consequences of acquiring other companies and other factors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the Stock Split, the number of shares authorized for issuance, and the limit on the number of incentive stock options that may be issued under
the Original Plan and the limit on the maximum number of shares of stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that could be granted to a single individual in a single calendar year pursuant to the award of stock options or stock appreciation rights were adjusted. Because the Company issued 26,272,107
shares of common stock on January&nbsp;4, 2018 in connection with the Reverse Merger, the <FONT STYLE="white-space:nowrap">as-adjusted</FONT> incentive stock option and per person stock option and stock appreciation right limits are not adequate to
accomplish the purposes of the Original Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Proposed 2014 Plan is not approved, the Original Plan as currently in effect will continue and we may
not be able to provide persons eligible for awards with compensation packages that are necessary to properly attract, retain and motivate these individuals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_35"></A>Summary of the Proposed 2014 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">The following description of certain features of the Second Amended and Restated 2014 Stock Option and Incentive Plan is intended to be a
summary only. The summary is qualified in its entirety by the full text of the Proposed 2014 Plan, which is attached hereto as <U>Appendix A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Purpose</I>. The Proposed 2014 Plan provides the Company with the flexibility to use various equity-based incentive and other awards as
compensation tools to motivate our workforce. These tools include stock options, stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, performance share awards, cash-based awards and dividend equivalent rights.
These tools provide meaningful performance incentives to our directors, officers, employees and other service providers, which, in turn, are expected to improve the Company&#146;s long-term performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Plan Administration</I>. The Proposed 2014 Plan is currently administered by the Compensation Committee (the &#147;Administrator&#148;).
The Administrator has full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific terms and conditions of each
award, subject to the provisions of the Proposed 2014 Plan. The Administrator may delegate to our Chief Executive Officer the authority to grant awards to employees who are not subject to the reporting and other provisions of Section&nbsp;16 of the
Exchange Act, subject to certain limitations and guidelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Eligibility</I>. Persons eligible to participate in the Proposed 2014
Plan are those full or part-time officers, employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and other key persons (including consultants) of the Company and its subsidiaries as selected from time to time by the Administrator
in its discretion. As of April&nbsp;2, 2018, individuals who are currently eligible to participate in the Proposed 2014 Plan include 4 officers, 14 employees who are not officers and 6 <FONT STYLE="white-space:nowrap">non-employee</FONT> directors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Plan Limits</I>. Subject to stockholder approval, [&#149;] shares will initially be reserved under the Proposed 2014 Plan. On
January&nbsp;1, 2019, and each January&nbsp;1 thereafter, the number of shares reserved and available under the Proposed 2014 Plan will automatically increase by 4% of the number of shares of our common stock issued and outstanding on the
immediately preceding December 31. The maximum award of stock options or stock appreciation rights granted to any one individual will not exceed 1,000,000 shares of common stock (subject to adjustment for stock splits and similar events) for any
calendar year period. The maximum aggregate number of shares of stock that may be issued under the Proposed 2014 Plan in the form of incentive stock options may not exceed the Initial Limit as cumulatively increased on each January&nbsp;1 by the
lesser of the Annual Increase for such year or 8,000,000 shares of common stock. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise of an option or settlement of an award to cover the exercise
price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of common stock or otherwise terminated (other than by exercise) shall be added back to the shares of common stock available for issuance under the
Proposed 2014 Plan. In the event the Company repurchases shares of common stock on the open market, such shares shall not be added to the shares of common stock available for issuance under the Proposed 2014 Plan. Stock may be issued under the
Proposed 2014 Plan in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c), NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not
reduce the number of shares of stock available for issuance under the Proposed 2014 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Stock Options</I>. The Proposed 2014 Plan permits the granting of (1)&nbsp;options to purchase
common stock intended to qualify as incentive stock options under Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) and (2)&nbsp;options that do not so qualify. Options granted under the Proposed 2014 Plan will
be <FONT STYLE="white-space:nowrap">non-qualified</FONT> options if they fail to qualify as incentive options or exceed the annual limit on incentive stock options. Incentive stock options may only be granted to employees of the Company and its
subsidiaries. <FONT STYLE="white-space:nowrap">Non-qualified</FONT> options may be granted to any persons eligible to receive incentive options and to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and key persons. The option
exercise price of each option will be determined by the Administrator but, subject to certain limited exceptions for awards assumed or substituted by the Company in connection with certain transactions, may not be less than 100% of the fair market
value of the common stock on the date of grant. Fair market value for this purpose will be the last reported sale price of the shares of common stock on The Nasdaq Global Select Market on the date of grant. The exercise price of an option may not be
reduced after the date of the option grant, other than to appropriately reflect changes in our capital structure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">The term of each option
will be fixed by the Administrator and may not exceed ten years from the date of grant, subject to certain limited exceptions as provided in the Proposed 2014 Plan. The Administrator will determine at what time or times each option may be exercised.
Options may be made exercisable in installments and the exercisability of options may be accelerated by the Administrator . In general, unless otherwise permitted by the Administrator, no option granted under the Proposed 2014 Plan is transferable
by the optionee other than by will or by the laws of descent and distribution, and options may be exercised during the optionee&#146;s lifetime only by the optionee, or by the optionee&#146;s legal representative or guardian in the case of the
optionee&#146;s incapacity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">Upon exercise of options, the option exercise price must be paid in full either in cash, by certified or bank
check or other instrument acceptable to the Administrator or by delivery (or attestation to the ownership) of shares of common stock that are not then subject to any restrictions under any Company plan. Subject to applicable law, the exercise price
may also be delivered to us by a broker pursuant to irrevocable instructions to the broker from the optionee. In addition, the Administrator may permit <FONT STYLE="white-space:nowrap">non-qualified</FONT> options to be exercised using a net
exercise feature, which reduces the number of shares issued to the optionee by the number of shares with a fair market value equal to the exercise price. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">To qualify as incentive stock options, options must meet additional federal tax requirements, including a $100,000 limit on the value of shares
subject to incentive stock options that first become exercisable by a participant in any one calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Stock Appreciation
Rights</I>. The Administrator may award stock appreciation rights subject to such conditions and restrictions as the Administrator may determine. Stock appreciation rights entitle the recipient to shares of common stock equal to the value of the
appreciation in the stock price over the exercise price. The exercise price may not be less than the fair market value of the common stock on the date of grant, subject to certain limited exceptions for awards assumed or substituted by the Company
in connection with certain transactions. The maximum term of a stock appreciation right is ten years, subject to certain limited exceptions as provided in the Proposed 2014 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Awards</I>. The Administrator may award shares of common stock to participants subject to such conditions and restrictions
as the Administrator may determine. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment with us through a specified restricted period. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Units</I>. The Administrator may award restricted stock units to any participants. Restricted stock units are ultimately
payable in the form of shares of common stock or, if determined by the Administrator, the cash equivalent, and may be subject to such conditions and restrictions as the Administrator may determine. These conditions and restrictions may include the
achievement of certain performance goals and/or continued employment with the Company through a specified vesting period or for board fees in lieu of cash compensation. In the Administrator&#146;s sole discretion, it may permit a participant to make
an advance election to receive a portion of his or her future cash compensation otherwise due in the form of restricted stock units, subject to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
participant&#146;s compliance with the procedures established by the Administrator and requirements of Section&nbsp;409A. During the deferral period, the restricted stock units may be credited
with dividend equivalent rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Unrestricted Stock Awards</I>. The Administrator may also grant shares of common stock that are free
from any restrictions under the Proposed 2014 Plan. Unrestricted stock may be granted to any participant in recognition of past services or other valid consideration and may be issued in lieu of cash compensation due to such participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Cash-Based Awards</I>. The Administrator may grant cash bonuses under the Proposed 2014 Plan to participants. The cash bonuses may be
subject to the achievement of certain performance goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Performance Share Awards</I>. The Administrator may grant performance share
awards to any participant that entitle the recipient to receive shares of common stock upon the achievement of certain performance goals and such other conditions as the Administrator shall determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Dividend Equivalent Rights</I>. The Administrator may grant dividend equivalent rights to participants, which entitle the recipient to
receive credits for dividends that would be paid if the recipient had held specified shares of common stock. Dividend equivalent rights may be granted as a component of another award (other than a stock option or stock appreciation right) or as a
freestanding award. Dividend equivalent rights may be settled in cash, shares of common stock or a combination thereof, in a single installment or installments, as specified in the award. Restrictions on dividend equivalent rights granted as part of
a restricted stock unit award or performance share award will only lapse when the restrictions on the corresponding award lapse. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Sale
Event Provisions</I>. The Proposed 2014 Plan provides that, upon the effectiveness of a &#147;sale event,&#148; as defined in the Proposed 2014 Plan, the Proposed 2014 Plan and all awards thereunder will terminate, unless the parties to the sale
event agree that such awards will be assumed or continued by the successor entity. Notwithstanding the foregoing and except as may be provided in the relevant award agreement, the Administrator may, in its discretion, accelerate the vesting of all
outstanding awards with time-based and/or performance-based vesting conditions or restrictions immediately prior to their termination and/or make or provide for a payment, in cash or in kind, to the grantees holding awards in an amount equal to
value of the awards as determined in the sole discretion of the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Adjustments for Stock Dividends, Stock Splits, etc</I>.
The Proposed 2014 Plan requires the Administrator to make appropriate adjustments to the number of shares of common stock that are subject to the Proposed 2014 Plan, to certain limits in the Proposed 2014 Plan, and to any outstanding awards to
reflect stock dividends, stock splits, extraordinary cash dividends and similar events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Tax Withholding</I>. Participants in the
Proposed 2014 Plan are responsible for the payment of any federal, state or local taxes that we are required by law to withhold upon the exercise of options or stock appreciation rights or vesting of other awards. Subject to approval by the
Administrator, participants may elect to have the tax withholding obligations satisfied by authorizing the Company to withhold shares of common stock to be issued pursuant to exercise or vesting. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Amendments and Termination</I>. The Board may at any time amend or discontinue the Proposed 2014 Plan and the Administrator may at any time
amend or cancel any outstanding award for the purpose of satisfying changes in the law or for any other lawful purpose. However, no such action may materially adversely affect any rights under any outstanding award without the holder&#146;s consent.
To the extent required under Nasdaq rules, any amendments that materially change the terms of the Proposed 2014 Plan will be subject to approval by our stockholders. Amendments shall also be subject to approval by our stockholders if and to the
extent determined by the Administrator to be required by the Code to preserve the qualified status of incentive options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Effective
Date of Proposed 2014 Plan</I>. The Board adopted the Proposed 2014 Plan on March&nbsp;29, 2018. It will become effective subject to stockholder approval at the Annual Meeting. No awards may be granted under the Proposed 2014 Plan after the date
that is ten years from the date of stockholder approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_36"></A>Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">Because the grant of awards under the Proposed 2014 Plan is within the discretion of the Administrator, we cannot determine the dollar value or
number of shares of common stock that will in the future be received by or allocated to any participant in the Proposed 2014 Plan. As of April&nbsp;11, 2018, the closing price of a share of the Company&#146;s common stock was $16.58. Following the
adoption of the Proposed 2014 Plan in March 2018, the Company made certain grants from the Proposed 2014 Plan which were contingent upon receipt of stockholder approval at the Annual Meeting. The grants made subject to stockholder approval are
summarized in the table below. If the Proposed 2014 Plan is not approved by the stockholders at the Annual Meeting, such grants will be forfeited. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>Exercise&nbsp;Price&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;(#)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gaurav Shah</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">145,000</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_37"></A>Tax Aspects under the Code </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal federal income tax consequences of certain transactions under the Proposed 2014 Plan as of the date
hereof. It does not describe all federal tax consequences under the Proposed 2014 Plan, nor does it describe state or local tax consequences or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Incentive Options</I>. No taxable income is generally realized by the optionee upon the grant or exercise of an incentive option. If shares
of common stock issued to an optionee pursuant to the exercise of an incentive option are sold or transferred after two years from the date of grant and after one year from the date of exercise, then (i)&nbsp;upon sale of such shares, any amount
realized in excess of the option price (the amount paid for the shares) will be taxed to the optionee as a long-term capital gain, and any loss sustained will be a long-term capital loss, and (ii)&nbsp;the Company will not be entitled to any
deduction for federal income tax purposes. The exercise of an incentive option will give rise to an item of tax preference that may result in alternative minimum tax liability for the optionee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">If shares of common stock acquired upon the exercise of an incentive option are disposed of prior to the expiration of the <FONT
STYLE="white-space:nowrap">two-year</FONT> and <FONT STYLE="white-space:nowrap">one-year</FONT> holding periods described above (a &#147;disqualifying disposition&#148;), generally (i)&nbsp;the optionee will realize ordinary income in the year of
disposition in an amount equal to the excess (if any) of the fair market value of the shares of common stock at exercise (or, if less, the amount realized on a sale of such shares of common stock) over the exercise price thereof and (ii)&nbsp;the
Company will be entitled to deduct such amount. Special rules apply where all or a portion of the exercise price of the incentive option is paid by tendering shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">If an incentive option is exercised at a time when it no longer qualifies for the tax treatment described above, the option is treated as a <FONT
STYLE="white-space:nowrap">non-qualified</FONT> option. Generally, an incentive option will not be eligible for the tax treatment described above if it is exercised more than three months following termination of employment (or one year in the case
of termination of employment by reason of disability). In the case of termination of employment by reason of death, the three-month rule does not apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options</I>. No income is realized by the optionee at the time the option is granted.
Generally, (i)&nbsp;at exercise, ordinary income is realized by the optionee in an amount equal to the difference between the option price and the fair market value of the shares of common stock on the date of exercise, and the Company receives a
tax deduction for the same amount, and (ii)&nbsp;at disposition, appreciation or depreciation after the date of exercise is treated as either short-term or long-term capital gain or loss depending on how long the shares of common stock have been
held. Special rules apply where all or a portion of the exercise price of the <FONT STYLE="white-space:nowrap">non-qualified</FONT> option is paid by tendering shares of common stock. Upon exercise, the optionee will also be subject to Social
Security taxes on the excess of the fair market value over the exercise price of the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Other Awards</I>. The Company generally
will be entitled to a tax deduction in connection with an award under the Proposed 2014 Plan in an amount equal to the ordinary income realized by the participant at the time the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
participant recognizes such income. Participants typically are subject to income tax and recognize such tax at the time that an award is exercised, vests or becomes
<FONT STYLE="white-space:nowrap">non-forfeitable,</FONT> unless the award provides for a further deferral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Parachute Payments</I>. The
vesting of any portion of an option or other award that is accelerated due to the occurrence of a change in control (such as a sale event) may cause a portion of the payments with respect to such accelerated awards to be treated as &#147;parachute
payments,&#148; as defined in the Code. Any such parachute payments may be <FONT STYLE="white-space:nowrap">non-deductible</FONT> to the Company, in whole or in part, and may subject the recipient to a
<FONT STYLE="white-space:nowrap">non-deductible</FONT> 20% federal excise tax on all or a portion of such payment (in addition to other taxes ordinarily payable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman"><I>Limitation on Deductions</I>. Section&nbsp;162(m) of the Code limits a publicly traded company&#146;s federal income tax deduction for
compensation in excess of $1&nbsp;million paid to its Chief Executive Officer, Chief Financial Officer and the next three highest-paid executive officers. Prior to the Tax Cuts and Jobs Act that was signed into law on December&nbsp;22, 2017,
compensation that satisfied conditions set forth under Section&nbsp;162(m) to qualify as &#147;performance-based compensation&#148; was not subject to the limitation, and the limitation did not apply to compensation paid to the Chief Financial
Officer. The Tax Cuts and Jobs Act eliminates the performance-based compensation exception beginning January&nbsp;1, 2018, but provides a transition rule with respect to remuneration which is provided pursuant to a written binding contract which was
in effect on November&nbsp;2, 2017 and which was not materially modified after that date. The Compensation Committee intends to administer any awards granted under the Original Plan prior to November&nbsp;2, 2017 which qualify as
&#147;performance-based compensation&#148; under Section&nbsp;162(m), as amended by the Tax Cuts and Jobs Act, including equity awards and other forms of compensation granted under the Original Plan that qualify as performance-based compensation, in
accordance with the transition rules applicable to binding contracts in effect on November&nbsp;2, 2017. With the elimination of the exemption for performance-based compensation, we expect that we will be unable to deduct all compensation in excess
of $1&nbsp;million paid to our Chief Executive Officer, Chief Financial Officer and the next three highest-paid executive officers, other than previously granted awards that are subject to the transition rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Times New Roman">The foregoing is only a summary of the effects of the U.S. federal income taxation upon participants and the Company with respect to awards
under the Proposed 2014 Plan. It does not purport to be complete, and does not discuss the impact of employment or other tax requirements, the tax consequences of a participant&#146;s death or the provisions of the income tax laws of any
municipality, state or foreign country in which the participant may reside. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_38"></A>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the majority of the votes cast for or against the proposal at the Annual Meeting by holders of shares present in person or represented
by proxy and entitled to vote on the proposal is required for the approval of the Second Amended and Restated 2014 Stock Option and Incentive Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_39">
</A>Our Recommendation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD RECOMMENDS A VOTE &#147;FOR&#148; THE APPROVAL OF THE SECOND AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE
PLAN. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_40"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_41"></A>Merger with Rocket Pharmaceuticals, Ltd. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Reverse Merger was not completed until January&nbsp;4, 2018, the following discussion of executive compensation relates to our <FONT
STYLE="white-space:nowrap">pre-Reverse</FONT> Merger named executive officers during the fiscal year ended December&nbsp;31, 2017&#151;David P. Southwell, Dr.&nbsp;Rudolf Baumgartner and Dale Ritter&#151;and the decisions and considerations of the
Inotek Compensation Committee. Unless the context otherwise requires, all references in this &#147;<I>Executive Compensation</I>&#148; section to the Compensation Committee refer to the Inotek Compensation Committee. Our current Board, including the
Compensation Committee thereof, is currently considering what changes, if any, will be made to the Company&#146;s executive compensation policies for the year ending December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_42"></A>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the compensation paid to the named executive officers (&#147;NEOs&#148;) that is attributable to services performed during the
fiscal years ended December&nbsp;31, 2017 and 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name and principal position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal</B><br><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards</B><br><B>$ (3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>Awards</B><br><B>$ (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>$ (6)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David P. Southwell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,862</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">533,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,267,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Former President and</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">465,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,231</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,093,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,275,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,060,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rudolf Baumgartner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">404,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,785</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Former Executive Vice</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President and<BR>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,538</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">839,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">780,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,761</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,166,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Ritter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,739</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">467,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Former Vice President-</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Finance</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,384</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">203,436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents bonus amounts accrued at December&nbsp;31, 2017 as annual bonuses, but paid in 2018 as retention bonuses upon consummation of the Reverse Merger. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents bonus amounts earned in 2016 and paid in 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Reflects the grant date fair value of option awards calculated in accordance with ASC Topic 718. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Reflects the grant date fair value of stock awards calculated in accordance with ASC Topic 718. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Represents restricted stock units (&#147;RSUs&#148;) granted in December 2016 and subsequently modified in January 2017. Amounts reflect the fair value of the modified RSUs as of the date of modification.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">The following table includes details regarding the values reported in the All Other Compensation column for 2017. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_43"></A>All Other Compensation Table </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Insurance<BR>&nbsp;&nbsp;&nbsp;&nbsp;Premiums&nbsp;&nbsp;&nbsp;&nbsp;</B><br><B>$(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Retirement&nbsp;Plan<BR>Contributions</B><br><B>$(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Disability</B><br><B>$(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David P. Southwell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rudolf Baumgartner, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Ritter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents premiums paid on behalf of our NEOs under our group term life insurance policy. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents Company matching contributions to the accounts of our NEOs in the Company&#146;s 401(k) plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Represents premiums paid on behalf of our NEOs under our disability insurance policy. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_44"></A>Executive Agreements; Termination and Change of Control Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the time of their employment, Mr.&nbsp;Southwell, Dr.&nbsp;Baumgartner and Mr.&nbsp;Ritter were each a party to an employment agreement with the Company.
Upon consummation of the Reverse Merger, the employment of Mr.&nbsp;Southwell and Dr.&nbsp;Baumgartner terminated. On March&nbsp;16, 2018, the employment of Mr.&nbsp;Ritter terminated. These employment agreements provided for &#147;at will&#148;
employment and contained the additional terms summarized below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>David P. </I></B><B><I>Southwell</I></B><I>. </I>On August&nbsp;11,
2014, we entered into an employment agreement with Mr.&nbsp;Southwell, as amended on September&nbsp;1, 2017, pursuant to which he served as our President and Chief Executive Officer. In 2017, Mr.&nbsp;Southwell received a base salary of $479,454. In
2017, Mr.&nbsp;Southwell was eligible for an annual performance bonus with a target amount of 50% of his base salary. For 2017, the Compensation Committee awarded Mr.&nbsp;Southwell a retention bonus of $239,862, representing 50% of his 2017 base
salary, in exchange for his continued active employment in a full-time capacity through the effective time of the Reverse Merger. While employed, Mr.&nbsp;Southwell was eligible to participate in our employee benefit plans in effect from time to
time, subject to the terms of those plans. Subject to the execution and effectiveness of a separation agreement, including, among other things, a general release of claims, Mr.&nbsp;Southwell would have been eligible to receive the following
payments and benefits in the event that his employment had been terminated by us without cause or by him for good reason as of the last day of the fiscal year, in either case not in connection with a change in control: base salary continuation for
12 months; if Mr.&nbsp;Southwell was participating in our group health plan immediately prior to the date of termination and elected COBRA health continuation, a monthly cash payment equal to the monthly employer contribution we would have made to
provide him health insurance if he had remained employed by us until twelve months following the date of termination; and the portion of the stock options and other time-based equity awards held by Mr.&nbsp;Southwell as of the date of termination
that would have vested in the 12 months following termination of his employment had he remained employed by us through such date would have immediately accelerated and become fully vested as of the date of termination. Subject to the execution and
effectiveness of a separation agreement, including, among other things, a general release of claims, Mr.&nbsp;Southwell would have been eligible to receive the following payments and benefits in the event that his employment had terminated by us
without cause or by him for good reason as of the last day of the fiscal year, in either case in connection with a change in control: a severance payment equal to 18 months of base salary and, if Mr.&nbsp;Southwell was participating in our group
health plan immediately prior to the date of termination and elected COBRA health continuation, a monthly cash payment equal to the monthly employer contribution we would have made to provide him health insurance if he had remained employed by us
until 18 months following the date of termination. In connection with the consummation of the Reverse Merger and his termination of employment, Mr.&nbsp;Southwell became entitled to the foregoing change in control severance benefits and all of his
outstanding equity awards were accelerated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Rudolf Baumgartner, M.D.</I></B>&nbsp;On May&nbsp;2, 2007, we entered into an
employment agreement with Dr.&nbsp;Baumgartner, our Executive Vice President and Chief Medical Officer, which we amended on December&nbsp;23, 2008, October&nbsp;9, 2009 and September&nbsp;12, 2017. In 2017, Dr.&nbsp;Baumgartner received a base
salary of $404,872. In 2017, Dr.&nbsp;Baumgartner was eligible for an annual performance bonus with a target amount of 35% of his base salary. For 2017, the Compensation Committee awarded Dr.&nbsp;Baumgartner a retention bonus of $141,785,
representing 35% of his 2017 base salary, in exchange for his continued active employment in a full-time capacity through the effective time of the Reverse Merger. Dr.&nbsp;Baumgartner was eligible to participate in our employee benefit plans in
effect from time to time, subject to the terms of those plans. Subject to the execution and effectiveness of a separation agreement, including, among other things, a general release of claims, Dr.&nbsp;Baumgartner would have been eligible to receive
the following payments and benefits in the event that his employment had been terminated by us without cause or by him for good reason as of the last day of the fiscal year: base salary continuation for twelve months; a monthly cash payment equal to
the monthly employer contribution to provide him health and dental insurance coverage if he had remained employed by us until 12 months following the date of termination; and accelerated vesting of all outstanding equity awards. In connection with
the consummation of the Reverse Merger and his termination of employment, Dr.&nbsp;Baumgartner became </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to the foregoing severance benefits and all of his outstanding equity awards were accelerated. The receipt of the severance payments and benefits set forth above are conditioned upon
Dr.&nbsp;Baumgartner not violating the terms of a restrictive covenant agreement between Dr.&nbsp;Baumgartner and Inotek. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Dale
Ritter.</I></B><I> </I>On August&nbsp;28, 2014, we entered into an employment agreement with Mr.&nbsp;Ritter, our Vice President-Finance, as amended on September&nbsp;1, 2017. In 2017, Mr.&nbsp;Ritter received an annual base salary of $282,304.
Mr.&nbsp;Ritter was eligible for an annual performance bonus with a target amount of 30% of his annualized base salary. In 2017, the Compensation Committee awarded Mr.&nbsp;Ritter a retention bonus of $84,739, representing 30% of his 2017 base
salary, in exchange for his continued active employment in a full-time capacity through the effective time of the Reverse Merger. Mr.&nbsp;Ritter was eligible to participate in our employee benefit plans in effect from time to time, subject to the
terms of those plans. Subject to the execution and effectiveness of a separation agreement, including, among other things, a general release of claims, Mr.&nbsp;Ritter would have been eligible to receive base salary continuation for six months,
payment of the employer contribution for group health coverage for up to six months and accelerated vesting of all outstanding equity awards in the event that his employment had been terminated by us without cause or by him for good reason as of the
last day of the fiscal year. In connection with the consummation of the Reverse Merger and his subsequent termination of employment, Mr.&nbsp;Ritter became entitled to the foregoing severance benefits and all of his outstanding equity awards were
accelerated. The receipt of the severance payments and benefits set forth above is conditioned upon Mr.&nbsp;Ritter not violating the terms of a restrictive covenant agreement between Mr.&nbsp;Ritter and Inotek. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">Effective as of January&nbsp;4, 2018, Gaurav Shah is the principal executive officer of the Company. We expect that the proxy statement for
the fiscal year ended December&nbsp;31, 2018 will include executive compensation disclosure regarding Dr.&nbsp;Shah and our next two most highly compensated executive officers as of fiscal year end, as well as executive compensation disclosure for
David P. Southwell, our former principal executive officer, since he served as Chief Executive Officer until January&nbsp;4, 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_45"></A>Equity Incentive Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information concerning outstanding equity awards for each of our named executive officers as of December&nbsp;31, 2017. All share
numbers and prices have been adjusted to reflect the Stock Split. All of the below unvested equity awards became fully vested upon consummation of the Reverse Merger. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities</B><br><B>underlying</B><br><B>unexercised</B><br><B>options</B><br><B>exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities</B><br><B>underlying</B><br><B>unexercised</B><br><B>options</B><br><B>unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;share</B><br><B>option</B><br><B>exercise&nbsp;price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>expiration</B><br><B>date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>securities</B><br><B>that have</B><br><B>not&nbsp;vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;value</B><br><B>of&nbsp;securities</B><br><B>that have</B><br><B>not&nbsp;vested</B><br><B>($) (5)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David P. Southwell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">08/28/24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/23/25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/21/26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">685,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">913,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rudolf Baumgartner,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162.312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/20/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/28/24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/23/25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/21/26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.20em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Ritter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/28/24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/23/25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/21/26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">These stock options were granted pursuant to our 2014 Stock Option and Incentive Plan (the &#147;2014 Plan&#148;) on August&nbsp;28, 2014, have a <FONT STYLE="white-space:nowrap">ten-year</FONT> term and vested 25% on
the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date and the remaining 75% were subject to equal monthly vesting over the following 36 monthly anniversaries. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">These stock options were granted pursuant to our 2014 Plan on June&nbsp;24, 2015, have a <FONT STYLE="white-space:nowrap">ten-year</FONT> term, and vested 25% on the <FONT STYLE="white-space:nowrap">one-year</FONT>
anniversary of our IPO and the remaining 75% were subject to equal monthly vesting over the following 36 monthly anniversaries. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">These stock options were granted pursuant to our 2014 Plan on March&nbsp;22, 2016, have a <FONT STYLE="white-space:nowrap">ten-year</FONT> term, and vested 25% on January&nbsp;1, 2017 and the remaining 75% were subject
to equal monthly vesting over the following 36 monthly anniversaries. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">These stock options were granted pursuant to our 2004 Stock Option and Incentive Plan (the &#147;2004 Plan&#148;) and are fully vested. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">These restricted stock units were granted pursuant to our 2014 Plan on December&nbsp;13, 2016, and were amended on January&nbsp;23, 2017 to modify their vesting schedule. In early January 2017, after Inotek&#146;s
failure to meet the primary endpoint in its first pivotal Phase 3 trial of <I>trabodenoson</I> monotherapy, the Inotek Board had determined that Inotek&#146;s new corporate strategy should be to identify and pursue a strategic merger that would
likely result in a change of control. As a result of this determination, the Inotek Board concluded that it would be in the best interest of Inotek to modify the vesting schedule of these restricted stock units to a time-based metric, in order to
enable Inotek to retain Mr.&nbsp;Southwell and Mr.&nbsp;Baumgartner during the execution of this new corporate strategy. The restricted stock units were modified such that, instead of vesting subject to the achievement of certain performance
criteria, the awards were subject to vesting in equal annual installments over four years from the date of grant, subject to the named executive officer&#146;s continued service through such each date. For Mr.&nbsp;Southwell and
Dr.&nbsp;Baumgartner, the awards that vested remained unsettled at December&nbsp;31, 2017, per the terms of the Restricted Stock Unit Agreements. The vested awards settled on March&nbsp;15, 2018, per the terms of the Restricted Stock Unit
Agreements. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">The value of the restricted stock units reflected in the table is based on a price per share of $10.44, which was the closing price of our common stock as of December&nbsp;30, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">These restricted stock units were granted pursuant to our 2014 Plan on January&nbsp;23, 2017. The awards were subject to vesting 25% per year over four years, on the anniversary of the grant date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">These restricted stock units were granted pursuant to our 2014 Plan on January&nbsp;17, 2017. The awards were subject to vesting 25% every six months over two years, on the
<FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the grant date. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_46"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_47"></A>Director Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the total compensation for each person who served as a member of our Board during 2017. Other than as set forth in the table, we
did not pay any compensation, make any equity awards or <FONT STYLE="white-space:nowrap">non-equity</FONT> awards to, or pay any other compensation to any of the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board in 2017.
David P. Southwell, our former President and Chief Executive Officer, received no compensation for his service as a director during 2017, and, consequently, is not included in this table. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All share numbers and prices have been adjusted to reflect the Stock Split. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">The Company adopted a <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy that became effective upon the
Company&#146;s IPO in February 2015. The purpose of this policy is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company.
During 2017, for service on the board of directors, annual cash retainers were paid as follows: for board members, $50,000, for the chairperson, $92,850. This policy was amended in March 2018 such that in 2018, for service on the Board, annual cash
retainers of $35,000 will be paid for Board members, excluding the chairperson. The chairperson will not receive an annual cash retainer for his service. In addition to cash retainers for service on the Board, cash retainers are paid for service on
committees of the board of directors. For service on the Audit Committee in 2017 and 2018, annual cash retainers are paid as follows: for committee members, $7,500, for the chairperson, $15,000. For service on the Compensation Committee in 2017 and
2018, annual cash retainers are paid as follows: for committee members, $5,000, for the chairperson, $10,000. For service on the Nominating and Corporate Governance Committee in 2017, annual cash retainers were paid as follows: for committee
members, $3,000, for the chairperson, $7,500. For service on the Nominating and Corporate Governance Committee in 2018, annual cash retainers will be paid as follows: for committee members, $4,000, for the chairperson, $8,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">In addition, each new <FONT STYLE="white-space:nowrap">non-employee</FONT> director upon his/her election to the Board will receive a <FONT
STYLE="white-space:nowrap">one-time</FONT> option grant to purchase shares of the Company&#146;s common stock in such amount and on such terms as authorized by the Board, or by a committee appointed by the Board, subject to periodic review.
Following completion of the Reverse Merger, based on a competitive market review of peer companies performed by F.W. Cook and our compensation philosophy, the Board authorized, to each <FONT STYLE="white-space:nowrap">non-employee</FONT> director
excluding the chairperson, a <FONT STYLE="white-space:nowrap">one-time</FONT> option grant to purchase 40,000 shares of the Company&#146;s common stock, and, to the chairperson, a <FONT STYLE="white-space:nowrap">one-time</FONT> option grant to
purchase 47,000 shares of the Company&#146;s common stock. Beginning in 2019, on the date of each annual meeting of stockholders of the Company, an annual option will be granted to each <FONT STYLE="white-space:nowrap">non-employee</FONT> director
serving on the Board immediately following the Company&#146;s annual meeting of stockholders to purchase shares of common stock in such amount and on such terms as authorized by the Board, or by a committee appointed by the Board, subject to
periodic review. Following the completion of the Reverse Merger, based on the competitive market review performed by F.W. Cook and our compensation philosophy, the Board authorized, to each <FONT STYLE="white-space:nowrap">non-employee</FONT>
director excluding the chairperson, an annual option grant to purchase 20,000 shares of the Company&#146;s common stock, and, to the chairperson, an annual option grant to purchase 27,000 shares of the Company&#146;s common stock. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the foregoing option grants will have an exercise price equal to the fair market value of a share of common stock on the date of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2017 Director Compensation Table </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Director name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>earned</B><br><B>$(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option awards</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All other<BR>compensation</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Barberich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Boess</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J. Martin Carroll</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul G. Howes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick Machado</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary Phillips, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard&nbsp;N.&nbsp;Spivey,&nbsp;PharmD, PhD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:20pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents fees earned in 2017, a portion of which were paid in 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents the grant date fair value of an option to purchase 11,250 shares of our common stock granted to each then-current <FONT STYLE="white-space:nowrap">non-employee</FONT> director on June&nbsp;20, 2017, with an
exercise price of $7.20 per share. </TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017, Board members held options to purchase the following
number of shares: 17,250 shares for Mr.&nbsp;Barberich and Mr.&nbsp;Machado; 20,250 shares for Mr.&nbsp;Boess, Dr.&nbsp;Phillips and Dr.&nbsp;Spivey; 33,000 shares for Mr.&nbsp;Carroll; and 19,714 shares for Mr.&nbsp;Howes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_48"></A>TRANSACTIONS WITH RELATED PERSONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_49"></A>Policies and Procedures for Related Person Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a written Related Person Transaction Policy, which requires that all related person transactions are reviewed and approved by our Audit
Committee. This review covers any material transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we were or are to be a participant, and a related person had or will have a direct or
indirect material interest, including, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. A
&#147;related person&#148; is any person who is or was one of our executive officers, directors or director nominees or is a holder of more than 5% of our common stock, or their immediate family members or any entity owned or controlled by any of
the foregoing persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc535515_50"></A>Certain Related-Person Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than compensation arrangements with directors and executive officers, which are described where required under &#147;Executive
Compensation&#151;Executive Agreements&#148; and &#147;Director Compensation,&#148; we have no other related-party transactions that are subject to disclosure in accordance with our policies and procedures for related party transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_51"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information known to us regarding beneficial ownership of our capital stock as of April&nbsp;2, 2018 for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each person, or group of affiliated persons, known by us to be the beneficial owner of more than 5% of our capital stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our named executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our other directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all executive officers and directors as a group. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the
rules of the SEC. A person is deemed to be a beneficial holder of our common stock if that person has or shares voting power, which includes the power to vote or direct the voting of our common stock, or investment power, which includes the power to
dispose of or to direct the disposition of such capital stock. Except as noted by footnote, and subject to community property laws where applicable, we believe based on the information provided to us that the persons and entities named in the table
below have sole voting and investment power with respect to all common stock shown as beneficially owned by them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table lists applicable percentage
ownership based on 39,435,148 shares of common stock outstanding as of April&nbsp;2, 2018. Shares of common stock that may be acquired by an individual or group within 60 days of April&nbsp;2, 2018, pursuant to the exercise of options, warrants or
other rights, are deemed to be beneficially owned by the persons holding these options for the purpose of computing percentage ownership of that person, but are not treated as outstanding for the purpose of computing any other person&#146;s
ownership percentage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise noted below, the address of each person listed on the table is c/o Rocket Pharmaceuticals, Inc., 430 East 29<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1040, New York, NY, 10016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name and address of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B><br><B>Beneficially</B><br><B>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B><br><B>of&nbsp;Class</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RTW Investments, LP (1)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">250 West 55th Street, 16th Floor, Suite A</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, NY 10019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,439,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tang Capital Partners, LP (2)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4747 Executive Drive, Suite 510</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,665,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.76</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named executive officers and directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David P. Southwell (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">382,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rudolf Baumgartner, M.D. (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Ritter (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Boess (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pedro Granadillo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gotham Makker, M.D. (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,331,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.38</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gaurav Shah, M.D.(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,098,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roderick Wong, M.D. (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,439,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Naveen Yalamanchi, M.D. (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All directors and executive officers as a group (10 persons) (10)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,799,477</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>47.67</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Based on Schedule 13D, jointly filed by RTW Investments, LP (&#147;RTW&#148;) and Roderick Wong with the SEC on January&nbsp;16, 2018. Roderick Wong is a control person of RTW and Chairman of the Board.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Based on Schedule 13G, jointly filed by Tang Capital Partners, LP, Tang Capital Management, LLC and Kevin C. Tang with the SEC on January&nbsp;16, 2018. Tang Capital Partners, LP shares voting and dispositive power over
such shares with Tang Capital Management, LLC and Kevin Tang. Mr.&nbsp;Tang disclaims beneficial ownership of all shares reported therein except to the extent of his pecuniary interest therein. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 16,660 shares of common stock, (ii) 190,874 shares of common stock issuable upon the exercise of options exercisable within 60 days after April&nbsp;2, 2018 and (iii) 175,000 restricted stock units that
are fully vested. Mr.&nbsp;Southwell ceased being an executive officer on January&nbsp;4, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 34,047 shares of common stock, (ii) 109,812 shares of common stock issuable upon the exercise of options exercisable within 60 days after April&nbsp;2, 2018 and (iii) 73,750 restricted stock units that
are fully vested. Dr.&nbsp;Baumgartner ceased being an executive officer on January&nbsp;4, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 4,956 shares of common stock, (ii) 27,223 shares of common stock issuable upon the exercise of options exercisable within 60 days after April&nbsp;2, 2018 and (iii) 9,375 restricted stock units that are
fully vested. Mr.&nbsp;Ritter ceased being an executive officer on January&nbsp;4, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 20,250 shares of common stock issuable upon the exercise of options exercisable within 60 days after April&nbsp;2, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 1,331,406 shares of common stock held by Simran Investment Group. Dr.&nbsp;Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be
the beneficial owner of securities owned or controlled by Simran Investment Group. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 761,850 shares of common stock and (ii) 337,042 shares of common stock issuable upon the exercise of options exercisable within 60 days after April&nbsp;2, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 114,278 shares owned by the Naveen Yalamanchi Revocable Living Trust, February&nbsp;9, 2016, of which Dr.&nbsp;Yalamanchi is the trustee. Dr.&nbsp;Yalamanchi has a pecuniary interest in RTW, but the
beneficial ownership of Dr.&nbsp;Yalamanchi in the table above does not reflect such ownership. Dr.&nbsp;Yalamanchi has no voting or dispositive power over the shares held by RTW. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Includes only current directors and executive officers serving in such capacity on the date of the table. Consists of the shares and stock options held by Mr.&nbsp;Southwell, Mr.&nbsp;Boess, Mr.&nbsp;Granadillo,
Dr.&nbsp;Makker, Dr.&nbsp;Shah, Dr.&nbsp;Wong, and Dr.&nbsp;Yalamanchi and shares and stock options held by current executive officers of the Company not referenced in the table. </TD></TR></TABLE>
<P STYLE="margin-top:42pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_52"></A>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of our common stock, to report to the
SEC their initial ownership of our common stock and any subsequent changes in that ownership. Specific due dates for these reports have been established by the SEC, and we are required to disclose in this proxy statement any late filings or failures
to file. Based solely on our review of the copies of such reports furnished to us and written representations that no other reports were required during the fiscal year ended December&nbsp;31, 2017, all Section&nbsp;16(a) filing requirements for our
most recent fiscal year were satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_53"></A>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">The following sets forth the aggregate information of the Company&#146;s equity compensation plans in effect as of December&nbsp;31,
2017. The Company&#146;s equity plans consist of the 2014 Plan, the 2004 Stock Option and Incentive Plan (the &#147;2004 Plan&#148;), and the 2014 Amended and Restated Employee Stock Purchase Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>securities&nbsp;to&nbsp;be</B><br><B>issued&nbsp;upon</B><br><B>exercise&nbsp;of</B><br><B>outstanding</B><br><B>options,&nbsp;
warrants</B><br><B>and&nbsp;rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-</B><br><B>average&nbsp;exercise</B><br><B>price&nbsp;of</B><br><B>outstanding</B><br><B>options,&nbsp;warrants</B><br><B>and rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number
of</B><br><B>securities&nbsp;remaining</B><br><B>available&nbsp;for&nbsp;future</B><br><B>issuance&nbsp;under&nbsp;equity</B><br><B>compensation&nbsp;plans</B><br><B>(excluding&nbsp;securities</B><br><B>reflected&nbsp;in&nbsp;
column</B><br><B>(a))</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security<BR>holders (1) (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269,073&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="12" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 795,239<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.40<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 269,073&nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="12" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">No additional awards will be made under the 2004 Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes 271,719 restricted stock units issued and outstanding pursuant to the 2014 Plan. There is no exercise price associated with these RSUs and therefore the weighted average price of outstanding options, warrants
and rights reflect only the weighted average exercise price of the 523,520 options outstanding at December&nbsp;31, 2017, issued pursuant to the 2004 Plan and 2014 Plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_54"></A>STOCKHOLDER PROPOSALS AND NOMINATIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder proposals and nominations should be addressed to our Secretary, c/o Rocket Pharmaceuticals, Inc., 430 East 29<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1040, New York, NY 10016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The required notice must be in writing and received by our
corporate secretary at our principal executive offices not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred twentieth (120th) day prior to the
<FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the preceding year&#146;s annual meeting. However, in the event the annual meeting is first convened more than thirty (30)&nbsp;days before or more than sixty (60)&nbsp;days after such
anniversary date, or if no annual meeting were held in the preceding year, a stockholder&#146;s notice must be received by our corporate secretary not later than the close of business on the later of the ninetieth (90th) day prior to the scheduled
date of such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made. Accordingly, for stockholder proposals or nominations to be brought before the 2019 annual meeting of
stockholders, the required notice must be received by our corporate secretary at the address set forth above no earlier than February&nbsp;25, 2019, and no later than March&nbsp;27, 2019. Proposals and nominations not received within this time frame
will be considered untimely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any stockholder proposal submitted pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act to be
included in the proxy statement for the next annual meeting of our stockholders must satisfy the SEC&#146;s regulations under Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act, and be received no later than December&nbsp;26,
2018. Under Rule <FONT STYLE="white-space:nowrap">14a-8,</FONT> we are not required to include such stockholder proposals in our proxy materials unless this condition is satisfied. Accordingly, any notice of such stockholder proposals received after
this date will be considered untimely. If the date of the annual meeting is moved by more than thirty (30)&nbsp;days from the date contemplated at the time of the previous year&#146;s proxy statement, then notice must be received within a reasonable
time before we begin to print and send proxy materials. In the event of such a change to the annual meeting date, we will publicly announce the deadline for submitting a proposal in a press release or in a document filed with the SEC. Nothing in
this paragraph shall be deemed to require us to include in our proxy statement and proxy card for such meeting any such stockholder proposal which does not meet the requirements of the SEC in effect at the time. Any such proposal will be subject to
Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_55"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the time of preparation of this proxy statement, neither the Board nor management intends to bring before the Annual Meeting any business other than the
matters referred to in the Notice of Annual Meeting and this proxy statement. If any other business should properly come before the Annual Meeting, or any adjournment thereof, the persons named in the proxy will vote on such matters according to
their best judgment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc535515_56"></A>AVAILABILITY OF CERTAIN DOCUMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accompanying this proxy statement and posted on the investor relations portion of our website at <I>www.rocketpharma.com</I> with this proxy statement, is our
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2017. The inclusion of our website address here and elsewhere in this proxy statement does not include or incorporate by reference the
information on our website into this proxy statement. <B>We will also mail without charge, upon written request, a copy of that Annual Report excluding exhibits</B>. Requests can be made by email by emailing info@rocketpharma.com, or by a written
request addressed to our Secretary, c/o Rocket Pharmaceuticals, Inc., 430 East 29<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1040, New York, NY 10016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders residing in the same household who hold their stock through a bank or broker may receive only one set of proxy materials in accordance with a
notice sent earlier by their bank or broker unless we have received contrary instructions from one or more of the stockholders. This practice will continue unless instructions to the contrary are received by your bank or broker from one or more of
the stockholders within the household. We will promptly deliver a separate copy of the proxy materials to such stockholders if you make a written or oral request to our corporate secretary at the address above, or by calling (646) <FONT
STYLE="white-space:nowrap">440-9100.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you hold your shares in &#147;street name&#148; and reside in a household that received only one copy of the
proxy materials, you can request to receive a separate copy in the future by following the instructions sent by your bank or broker. If your household is receiving multiple copies of the proxy materials, you may request that only a single set of
materials be sent by following the instructions sent by your bank or broker. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="toc535515_57"></A>Appendix A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ROCKET PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECOND AMENDED AND RESTATED 2014 STOCK OPTION AND INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 1. <U>GENERAL PURPOSE OF THE PLAN; DEFINITIONS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">The name of the plan is the Rocket Pharmaceuticals, Inc. 2014 Second Amended and Restated Stock Option and Incentive Plan (the
&#147;<U>Plan</U>&#148;). The purpose of the Plan is to encourage and enable the officers, employees, <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors and Consultants of Rocket Pharmaceuticals, Inc. (the &#147;<U>Company</U>&#148;) and
its Subsidiaries upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake
in the Company&#146;s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company&#146;s behalf and strengthening their desire to remain with the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">The following terms shall be defined as set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Act</U>&#148; means the Securities Act of 1933, as amended, and the rules and regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Administrator</U>&#148; means either the Board or the compensation committee of the Board or a similar committee performing the
functions of the compensation committee and which is comprised of not less than <FONT STYLE="white-space:nowrap">two&nbsp;Non-Employee&nbsp;Directors</FONT> who are independent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Award</U>&#148; or &#147;<U>Awards</U>,&#148; except where referring to a particular category of grant under the Plan, shall include
Incentive Stock Options, <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock Awards, Unrestricted Stock Awards, Cash-Based Awards, Performance Share Awards and
Dividend Equivalent Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Award Certificate</U>&#148; means a written or electronic document setting forth the terms and
provisions applicable to an Award granted under the Plan. Each Award Certificate is subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Cash-Based Award</U>&#148; means an Award entitling the recipient to receive a cash-denominated payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and
interpretations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Consultant</U>&#148; means any natural person that provides bona fide services to the Company, and such
services are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company&#146;s securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Dividend Equivalent Right</U>&#148; means an Award entitling the grantee to receive
credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; means the date on which the Plan is approved by stockholders as set forth in Section&nbsp;20. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; of the Stock on any given date means the fair market value of the Stock determined in good faith by the
Administrator; provided, however, that if the Stock is admitted to quotation on the National Association of Securities Dealers Automated Quotation System (&#147;<U>NASDAQ</U>&#148;), NASDAQ Global Market or another national securities exchange, the
determination shall be made by reference to market quotations. If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which there are market quotations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Incentive Stock Option</U>&#148; means any Stock Option designated and qualified as an &#147;incentive stock option&#148; as defined
in Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>&#148; means a member of the
Board who is not also an employee of the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock
Option</U>&#148; means any Stock Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Option</U>&#148; or &#147;<U>Stock
Option</U>&#148; means any option to purchase shares of Stock granted pursuant to Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Performance Criteria</U>&#148;
means the criteria that the Administrator selects for purposes of establishing the Performance Goal or Performance Goals for an individual for a Performance Cycle. The Performance Criteria (which may be applicable to the organizational level
specified by the Administrator, including, but not limited to, the Company or a unit, division, group, or Subsidiary of the Company) that may be used to establish Performance Goals shall include the following: total shareholder return, earnings
before interest, taxes, depreciation and amortization, net income (loss) (either before or after interest, taxes, depreciation and/or amortization), changes in the market price of the Stock, economic value-added, funds from operations or similar
measure, sales or revenue, developmental, clinical or regulatory milestones, acquisitions or strategic transactions, including licenses, collaborations, joint ventures, or promotion arrangements, operating income (loss), cash flow (including, but
not limited to, operating cash flow and free cash flow), return on capital, assets, equity, or investment, return on sales, gross or net profit levels, productivity, expense, margins, operating efficiency, customer satisfaction, working capital,
earnings (loss) per share of Stock, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
sales or market shares, number of customers and any other objective or subjective measure or metric the Administrator deems appropriate, any of which may be measured either in absolute terms or
as compared to any incremental increase or as compared to results of a peer group or on an individual basis. The Administrator may appropriately adjust any evaluation performance under a Performance Criterion to include or exclude any of the
following events that occurs during a Performance Cycle: (i)&nbsp;asset write-downs or impairments, (ii)&nbsp;litigation or claim judgments or settlements, (iii)&nbsp;the effect of changes in tax law, accounting principles or other such laws or
provisions affecting reporting results, (iv)&nbsp;accruals for reorganizations and restructuring programs, (v)&nbsp;any unusual, infrequently occurring or <FONT STYLE="white-space:nowrap">non-recurring</FONT> items, including those described in the
Financial Accounting Standards Board&#146;s authoritative guidance and/or in management&#146;s discussion and analysis of financial condition of operations appearing the Company&#146;s annual report to stockholders for the applicable year, and
(vi)&nbsp;any other inclusions or exclusions as the Administrator may determine with respect to an Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Performance
Cycle</U>&#148; means one or more periods of time, which may be of varying and overlapping durations, as the Administrator may select, over which the attainment of one or more Performance Criteria will be measured for the purpose of determining a
grantee&#146;s right to and the payment of an Award, the vesting and/or payment of which is subject to the attainment of one or more Performance Goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Performance Goals</U>&#148; means, for a Performance Cycle, the specific goals established in writing by the Administrator for a
Performance Cycle based upon the Performance Criteria. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Performance Share Award</U>&#148; means an Award entitling the recipient
to acquire shares of Stock upon the attainment of specified Performance Goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Restricted Shares</U><I>&#148;</I>&nbsp;means the
shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&#146;s right of repurchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Restricted Stock Award</U>&#148; means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator
may determine at the time of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Restricted Stock Units</U>&#148; means an Award of stock units subject to such restrictions
and conditions as the Administrator may determine at the time of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Sale Event</U>&#148; shall mean (i)&nbsp;the sale of all
or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (ii)&nbsp;a merger, reorganization or consolidation pursuant to which the holders of the Company&#146;s outstanding voting power and
outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately
upon completion of such transaction, (iii)&nbsp;the sale of all of the Stock of the Company to an unrelated person, entity or group thereof acting in concert, or (iv)&nbsp;any other transaction in which the owners of the Company&#146;s outstanding
voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Sale Price</U>&#148; means the value as determined by the Administrator of the consideration payable, or otherwise to be received by
stockholders, per share of Stock pursuant to a Sale Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148; means Section&nbsp;409A of
the Code and the regulations and other guidance promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Stock</U>&#148; means the common stock, par value $0.01
per share, of the Company, subject to adjustments pursuant to Section&nbsp;3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Stock Appreciation Right</U>&#148; means an Award
entitling the recipient to receive shares of Stock having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock
with respect to which the Stock Appreciation Right shall have been exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any corporation or
other entity (other than the Company) in which the Company has at least a 50&nbsp;percent interest, either directly or indirectly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Substitute Awards</U>&#148; shall mean Awards granted or Stock issued by the Company in assumption of, or in substitution or exchange
for, awards previously granted, in each case by a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Ten Percent Owner</U>&#148; means an employee who owns or is deemed to own (by reason of the attribution rules of Section&nbsp;424(d)
of the Code) more than 10&nbsp;percent of the combined voting power of all classes of stock of the Company or any parent or subsidiary corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">&#147;<U>Unrestricted Stock Award</U>&#148; means an Award of shares of Stock free of any restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 2. <U>ADMINISTRATION OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Administration of Plan</U>. The Plan shall be administered by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Powers of Administrator</U>. The Administrator shall have the power and authority to grant Awards consistent with the terms of the
Plan, including the power and authority: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(i) to select the individuals to whom Awards may from time to time be granted; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(ii) to determine the time or times of grant, and the extent, if any, of Incentive Stock Options,
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units, Unrestricted Stock Awards, Cash-Based Awards, Performance Share Awards and Dividend Equivalent Rights,
or any combination of the foregoing, granted to any one or more grantees; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(iii) to determine the number of shares of Stock to be covered by any Award; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(iv) to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan,
of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(v) to accelerate at any time the exercisability or vesting of all or any portion of any Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(vi) subject to the provisions of Section&nbsp;5(c), to extend at any time the period in which Stock Options may be exercised; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(vii) at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and
proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes
arising in connection with the Plan; and to otherwise supervise the administration of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">All decisions and interpretations of the
Administrator shall be binding on all persons, including the Company and Plan grantees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Delegation of Authority to Grant
Awards</U>. Subject to applicable law, the Administrator, in its discretion, may delegate to the Chief Executive Officer of the Company all or part of the Administrator&#146;s authority and duties with respect to the granting of Awards to
individuals who are&nbsp;not subject to the reporting and other provisions of Section&nbsp;16 of the Exchange Act. Any such delegation by the Administrator shall include a limitation as to the amount of Stock underlying Awards that may be granted
during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting criteria. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate
any prior actions of the Administrator&#146;s delegate or delegates that were consistent with the terms of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Award
Certificate</U>. Awards under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which may include, without limitation, the term of an Award and the provisions applicable in the
event employment or service terminates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(e) <U>Indemnification</U>. Neither the Board nor the Administrator, nor any member of either or
any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator (and any delegate thereof) shall be
entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#146; fees) arising or resulting
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
therefrom to the fullest extent permitted by law and/or under the Company&#146;s articles or bylaws or any directors&#146; and officers&#146; liability insurance coverage which may be in effect
from time to time and/or any indemnification agreement between such individual and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(f) <U>Foreign Award Recipients</U>.
Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, in its
sole discretion, shall have the power and authority to: (i)&nbsp;determine which Subsidiaries shall be covered by the Plan; (ii)&nbsp;determine which individuals outside the United States are eligible to participate in the Plan; (iii)&nbsp;modify
the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv)&nbsp;establish subplans and modify exercise procedures and other terms and procedures, to the extent the
Administrator determines such actions to be necessary or advisable (and such subplans and/or modifications shall be attached to the Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share
limitations contained in Section&nbsp;3(a) hereof; and (v)&nbsp;take any action, before or after an Award is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory
exemptions or approvals. Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any
other applicable United States governing statute or law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 3. <U>STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Stock Issuable</U>. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be [&#149;] shares
(the &#147;Initial Limit&#148;), subject to adjustment as provided in Section&nbsp;3(b), plus on January&nbsp;1, 2019 and each January&nbsp;1 thereafter, the number of shares of Stock reserved and available for issuance under the Plan shall be
cumulatively increased by 4&nbsp;percent of the number of shares of Stock issued and outstanding on the immediately preceding December&nbsp;31 (the &#147;Annual Increase&#148;). Subject to such overall limitation, the maximum aggregate number of
shares of Stock that may be issued in the form of Incentive Stock Options shall not exceed the Initial Limit cumulatively increased on January&nbsp;1, 2019 and on each January&nbsp;1 thereafter by the lesser of the Annual Increase for such year or
8,000,000 shares of Stock, subject in all cases to adjustment as provided in Section&nbsp;3(b). The shares of Stock underlying any Awards that are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the
exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the shares of Stock available for issuance under the Plan.
In the event the Company repurchases shares of Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject to such overall limitations, shares of Stock may be issued up to such
maximum number pursuant to any type or types of Award; provided, however, that Stock Options or Stock Appreciation Rights with respect to no more than 1,000,000 shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Stock may be granted to any one individual grantee during any one calendar year period. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares
of Stock reacquired by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Changes in Stock</U>. Subject to Section&nbsp;3(c) hereof, if, as a result of any
reorganization, recapitalization, reclassification, extraordinary cash dividend, stock dividend, spinoff, stock split, reverse stock split or other similar change in the Company&#146;s capital stock, the outstanding shares of Stock are increased or
decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other securities of the Company or other <FONT STYLE="white-space:nowrap">non-cash</FONT>
assets are distributed with respect to such shares of Stock or other securities, or, if, as a result of any merger or consolidation, sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or
exchanged for securities of the Company or any successor entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i)&nbsp;the maximum number of shares reserved for issuance under the
Plan, including the maximum number of shares that may be issued in the form of Incentive Stock Options, (ii)&nbsp;the maximum number of Stock Options or Stock Appreciation Rights that can be granted to any one individual grantee in a single calendar
year,&nbsp;(iii) the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, (iv)&nbsp;the repurchase price, if any, per share subject to each outstanding Restricted Stock Award, (v)&nbsp;the exercise
price for each share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Stock Options and Stock Appreciation
Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable, and (vi)&nbsp;any Performance Goals applicable to outstanding Awards. The Administrator shall also make equitable or proportionate adjustments in the number of
shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to take into consideration any other extraordinary corporate event. The adjustment by the Administrator shall be final, binding and conclusive. No
fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator in its discretion may make a cash payment in lieu of fractional shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Mergers and Other Transactions</U>. In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the
assumption or continuation of Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if
appropriate, the per share exercise prices, as such parties shall agree. To the extent the parties to such Sale Event do not provide for the assumption, continuation or substitution of Awards or except as may be otherwise provided in the relevant
Award Certificate, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall terminate. Notwithstanding the foregoing and except as may be otherwise provided in the relevant Award Certificate, the
Administrator, in its discretion, may (i)&nbsp;determine to accelerate the vesting of all outstanding Awards with time-based vesting, conditions or restrictions immediately prior to their termination as of the effective time of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Sale Event; (ii)&nbsp;determine to accelerate the vesting of all Awards with conditions and restrictions relating to the attainment of performance goals immediately prior to their termination
upon the effective time of the Sale Event or to the extent specified in the relevant Award Certificate; and/or (iii)&nbsp;make or provide for a payment, in cash or in kind, to the grantees holding Awards in an amount equal to value of the Awards (as
determined in the sole discretion of the Administrator). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Acquisitions by the Company</U>. Stock may be issued under the terms of
the Plan in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c), NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the
number of shares of Stock available for issuance under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">SECTION 4. <U>ELIGIBILITY</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">Grantees under the Plan will be such full or part-time officers and other employees, <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Directors and Consultants of the Company and its Subsidiaries as are selected from time to time by the Administrator in its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 5. <U>STOCK OPTIONS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Award of Stock Options</U>. The Administrator may grant Stock Options under the Plan. Any Stock Option granted under the Plan shall be
in such form as the Administrator may from time to time approve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">Stock Options granted under the Plan may be either Incentive Stock
Options or <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a &#147;subsidiary corporation&#148; within the meaning of
Section&nbsp;424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">Stock Options granted pursuant to this Section&nbsp;5 shall be subject to the following terms and conditions and shall contain such additional
terms and conditions, not inconsistent with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options may be granted in lieu of cash compensation at the optionee&#146;s election, subject to
such terms and conditions as the Administrator may establish. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Exercise Price</U>. Other than in connection with Substitute Awards,
the exercise price per share for the Stock covered by a Stock Option granted pursuant to this Section&nbsp;5 shall be determined by the Administrator at the time of grant but shall not be less than 100&nbsp;percent of the Fair Market Value on the
date of grant. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the option price of such Incentive Stock Option shall be not less than 110&nbsp;percent of the Fair Market Value on the grant date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Option Term</U>. The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than
ten years after the date the Stock Option is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
granted; provided, however, that, an Award Certificate may provide that, in the event that on the last business day of the term of a Stock Option (other than an Incentive Stock Option)&nbsp;(i)
the exercise of the Stock Option is prohibited by applicable law or (ii)&nbsp;shares of Stock may not be purchased or sold by certain employees or directors of the Company due to the <FONT STYLE="white-space:nowrap">&#147;black-out</FONT>
period&#148; of a Company policy or a <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement undertaken in connection with an issuance of securities by the Company, the term of the Stock Option shall be extended for a period of thirty
(30)&nbsp;days following the end of the legal prohibition, <FONT STYLE="white-space:nowrap">black-out</FONT> period or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, as applicable. In the case of an Incentive Stock Option that is granted
to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Exercisability;
Rights of a Stockholder</U>. Stock Options shall become exercisable at such time or times, whether or not in installments and/or subject to the achievement of Performance Goals, as shall be determined by the Administrator at or after the grant date.
The Administrator may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised
Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(e) <U>Method of Exercise</U>. Stock Options may be exercised in whole or in part, by giving written or electronic notice
of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the following methods except to the extent otherwise provided in the Option Award Certificate: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">(i) in cash, by certified or bank check or other instrument acceptable to the Administrator; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(ii) through the delivery (or attestation to the ownership following such procedures as the Company may prescribe) of shares of Stock that are
not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(iii) by the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to
promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with
such procedures and enter into such agreements of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(iv) with respect to Stock Options that are not Incentive Stock Options, by a &#147;net exercise&#148; arrangement pursuant to which the
Company will reduce the number of shares of Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">Payment instruments will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer
agent of the shares of Stock to be purchased </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the
Company of the full purchase price for such shares and the fulfillment of any other requirements contained in the Option Award Certificate or applicable provisions of laws (including the satisfaction of any withholding taxes that the Company is
obligated to withhold with respect to the optionee). In the event an optionee chooses to pay the purchase price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee upon the
exercise of the Stock Option shall be net of the number of attested shares. In the event that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Stock Options, such as a system using
an internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted through the use of such an automated system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(f) <U>Annual Limit on Incentive Stock Options</U>. To the extent required for &#147;incentive stock option&#148; treatment under
Section&nbsp;422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under the Plan and any other plan of the Company or its parent and
subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall constitute a
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 6. <U>STOCK APPRECIATION RIGHTS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Award of Stock Appreciation Rights</U>. The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation
Right is an Award entitling the recipient to receive shares of Stock having a value equal to the excess of the Fair Market Value of a share of Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the
number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Exercise Price of Stock
Appreciation Rights</U>. Other than in connection with Substitute Awards, the exercise price of a Stock Appreciation Right shall not be less than 100&nbsp;percent of the Fair Market Value of the Stock on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Grant and Exercise of Stock Appreciation Rights</U>. Stock Appreciation Rights may be granted by the Administrator independently of any
Stock Option granted pursuant to Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Terms and Conditions of Stock Appreciation Rights</U>. Stock Appreciation Rights
shall be subject to such terms and conditions as shall be determined from time to time by the Administrator. The term of a Stock Appreciation Right may not exceed ten years; provided, however, that, an Award Certificate may provide that, in the
event that on the last business day of the term of a Stock Appreciation Right (i)&nbsp;the exercise of the Stock Appreciation Right is prohibited by applicable law or (ii)&nbsp;shares of Stock may not be purchased or sold by certain employees or
directors of the Company due to the <FONT STYLE="white-space:nowrap">&#147;black-out</FONT> period&#148; of a Company policy or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
a <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement undertaken in connection with an issuance of securities by the Company, the term shall be extended for a period of thirty
(30)&nbsp;days following the end of the legal prohibition, <FONT STYLE="white-space:nowrap">black-out</FONT> period or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 7. <U>RESTRICTED STOCK AWARDS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Nature of Restricted Stock Awards</U>. The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award is
any Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant. Conditions may be based on continuing employment (or other service relationship) and/or achievement of <FONT
STYLE="white-space:nowrap">pre-established</FONT> Performance Goals and objectives. The terms and conditions of each such Award Certificate shall be determined by the Administrator, and such terms and conditions may differ among individual Awards
and grantees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Rights as a Stockholder</U>. Upon the grant of the Restricted Stock Award and payment of any applicable purchase
price, a grantee shall have the rights of a stockholder with respect to the voting of the Restricted Shares and receipt of dividends; provided that, if the lapse of restrictions with respect to the Restricted Stock Award is tied to the attainment of
Performance Goals, any dividends paid by the Company during the performance period shall accrue and shall not be paid to the grantee until and to the extent the Performance Goals are met with respect to the Restricted Stock Award. Unless the
Administrator shall otherwise determine, (i)&nbsp;uncertificated Restricted Shares shall be accompanied by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such Restricted Shares
are vested as provided in Section&nbsp;7(d) below, and (ii)&nbsp;certificated Restricted Shares shall remain in the possession of the Company until such Restricted Shares are vested as provided in Section&nbsp;7(d) below, and the grantee shall be
required, as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c)
<U>Restrictions</U>. Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Stock Award Certificate. Except as may otherwise be provided by
the Administrator either in the Award Certificate or, subject to Section&nbsp;17 below, in writing after the Award is issued, if a grantee&#146;s employment (or other service relationship) with the Company and its Subsidiaries terminates for any
reason, any Restricted Shares that have not vested at the time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company be deemed to have been reacquired by the
Company at its original purchase price (if any) from such grantee or such grantee&#146;s legal representative simultaneously with such termination of employment (or other service relationship), and thereafter shall cease to represent any ownership
of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company upon request
without consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Vesting of Restricted Shares</U>. The Administrator at the time of grant shall specify the
date or dates and/or the attainment of <FONT STYLE="white-space:nowrap">pre-established</FONT> Performance Goals, objectives and other conditions on which the <FONT STYLE="white-space:nowrap">non-transferability</FONT> of the Restricted Shares and
the Company&#146;s right of repurchase or forfeiture shall lapse. Subsequent to such date or dates and/or the attainment of such <FONT STYLE="white-space:nowrap">pre-established</FONT> Performance Goals, objectives and other conditions, the shares
on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed &#147;vested.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 8.
<U>RESTRICTED STOCK UNITS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Nature of Restricted Stock Units</U>. The Administrator may grant Restricted Stock Units under the
Plan. A Restricted Stock Unit is an Award of stock units that may be settled in shares of Stock (or, if determined by the Administrator, the cash equivalent based on the Fair Market Value of such Stock) upon the satisfaction of such restrictions and
conditions at the time of grant. Conditions may be based on continuing employment (or other service relationship) and/or achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> Performance Goals and objectives. The terms and
conditions of each such Award Certificate shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees. Except in the case of Restricted Stock Units with a deferred settlement date that
complies with Section&nbsp;409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled in the form of shares of Stock (or, if determined by the Administrator, the cash equivalent based on the Fair
Market Value of such Stock). Restricted Stock Units with deferred settlement dates are subject to Section&nbsp;409A and shall contain such additional terms and conditions as the Administrator shall determine in its sole discretion in order to comply
with the requirements of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Election to Receive Restricted Stock Units in Lieu of Compensation</U>. The
Administrator may, in its sole discretion, permit a grantee to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of an award of Restricted Stock Units. Any such election shall be made in writing and
shall be delivered to the Company no later than the date specified by the Administrator and in accordance with Section&nbsp;409A and such other rules and procedures established by the Administrator. Any such future cash compensation that the grantee
elects to defer shall be converted to a fixed number of Restricted Stock Units based on the Fair Market Value of Stock on the date the compensation would otherwise have been paid to the grantee if such payment had not been deferred as provided
herein. The Administrator shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and other terms and conditions thereon as the Administrator deems appropriate. Any
Restricted Stock Units that are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Rights as a Stockholder</U>. A grantee shall have the rights as a stockholder only as to shares of Stock acquired by the grantee upon
settlement of Restricted Stock Units; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units underlying his Restricted Stock Units, subject to the provisions of Section&nbsp;12 and such
terms and conditions as the Administrator may determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Termination</U>. Except as may otherwise be provided by the Administrator either in the
Award Certificate or, subject to Section&nbsp;17 below, in writing after the Award is issued, a grantee&#146;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&#146;s termination of employment
(or cessation of service relationship) with the Company and its Subsidiaries for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 9.&nbsp;<U>UNRESTRICTED STOCK
AWARDS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman"><U>Grant or Sale of Unrestricted Stock</U>. The Administrator may grant (or sell at par value or such higher purchase price
determined by the Administrator) an Unrestricted Stock Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the grantee may receive shares of Stock free of any restrictions under the Plan. Unrestricted Stock Awards may be
granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 10.
<U>CASH-BASED AWARDS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman"><U>Grant of Cash-Based Awards</U>. The Administrator may grant Cash-Based Awards under the Plan. A Cash-Based
Award is an Award that entitles the grantee to a payment in cash upon the attainment of specified Performance Goals. The Administrator shall determine the maximum duration of the Cash-Based Award, the amount of cash to which the Cash-Based Award
pertains, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Administrator shall determine. Each Cash-Based Award shall specify a cash-denominated payment amount, formula or payment ranges
as determined by the Administrator. Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and may be made in cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 11. <U>PERFORMANCE SHARE AWARDS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Nature of Performance Share Awards</U>. The Administrator may grant Performance Share Awards under the Plan. A Performance Share Award
is an Award entitling the grantee to receive shares of Stock upon the attainment of Performance Goals. The Administrator shall determine whether and to whom Performance Share Awards shall be granted, the Performance Goals, the periods during which
performance is to be measured, which may not be less than one year except in the case of a Sale Event, and such other limitations and conditions as the Administrator shall determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Rights as a Stockholder</U>. A grantee receiving a Performance Share Award shall have the rights of a stockholder only as to shares of
Stock actually received by the grantee under the Plan and not with respect to shares subject to the Award but not actually received by the grantee. A grantee shall be entitled to receive shares of Stock under a Performance Share Award only upon
satisfaction of all conditions specified in the Performance Share Award Certificate (or in a performance plan adopted by the Administrator). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">(c) <U>Termination</U>. Except as may otherwise be provided by the Administrator either in the
Award agreement or, subject to Section&nbsp;17 below, in writing after the Award is issued, a grantee&#146;s rights in all Performance Share Awards shall automatically terminate upon the grantee&#146;s termination of employment (or cessation of
service relationship) with the Company and its Subsidiaries for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">SECTION 12. <U>DIVIDEND EQUIVALENT RIGHTS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Dividend Equivalent Rights</U>. The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent Right is
an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other Award to which it relates) if such shares had been issued to the grantee.
A Dividend Equivalent Right may be granted hereunder to any grantee as a component of an award of Restricted Stock Units, Restricted Stock Award or Performance Share Award or as a freestanding award. The terms and conditions of Dividend Equivalent
Rights shall be specified in the Award Certificate. Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue
additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent Rights may be
settled in cash or shares of Stock or a combination thereof, in a single installment or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted Stock Units or Performance Share Award shall provide that such
Dividend Equivalent Right shall be settled only upon settlement or payment of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions as such other
Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Termination</U>. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to
Section&nbsp;17 below, in writing after the Award is issued, a grantee&#146;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&#146;s termination of employment (or cessation of service relationship) with the
Company and its Subsidiaries for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 13. <U>TRANSFERABILITY OF AWARDS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Transferability</U>. Except as provided in Section&nbsp;13(b) below, during a grantee&#146;s lifetime, his or her Awards shall be
exercisable only by the grantee, or by the grantee&#146;s legal representative or guardian in the event of the grantee&#146;s incapacity. No Awards shall be sold, assigned, transferred or otherwise encumbered or disposed of by a grantee other than
by will or by the laws of descent and distribution or pursuant to a domestic relations order. No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation hereof shall be
null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Administrator Action</U>. Notwithstanding Section&nbsp;13(a), the Administrator, in its discretion, may provide
either in the Award Certificate regarding a given Award or by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
subsequent written approval that the grantee (who is an employee or director) may transfer his or her <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options to his or her immediate family
members, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of the
Plan and the applicable Award. In no event may an Award be transferred by a grantee for value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">(c) <U>Family Member</U>. For purposes of
Section&nbsp;13(b), &#147;family member&#148; shall mean a grantee&#146;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">son-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law,</FONT></FONT> or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including adoptive relationships, any person sharing the grantee&#146;s household (other than a tenant of the grantee), a trust in which these persons (or the
grantee) have more than 50&nbsp;percent of the beneficial interest, a foundation in which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own more than 50&nbsp;percent of
the voting interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Designation of Beneficiary</U>. To the extent permitted by the Company, each grantee to whom an Award has
been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&#146;s death. Any such designation shall be on a form provided for that purpose by the
Administrator and shall not be effective until received by the Administrator. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, or if the beneficiary designation is deemed
ambiguous, incomplete or invalid by the Administrator, the beneficiary shall be the grantee&#146;s estate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 14. <U>TAX
WITHHOLDING</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Payment by Grantee</U>. Each grantee shall, no later than the date as of which the value of an Award or of any
Stock or other amounts received thereunder first becomes includable in the gross income of the grantee for Federal income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator regarding payment of, any Federal,
state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind
otherwise due to the grantee. The Company&#146;s obligation to deliver evidence of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Payment in Stock</U>. Subject to approval by the Administrator, a grantee may elect to have the Company&#146;s minimum required tax
withholding obligation satisfied (or, if and when the Company adopts any applicable accounting standard allowing for greater share withholding, up to such withholding rate that will not cause an adverse accounting consequence or cost and is
permitted under applicable tax rules), in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued pursuant to any Award a number of shares with an aggregate Fair Market Value (as of the date the withholding is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
effected) that would satisfy the withholding amount due. The Administrator may also require Awards to be subject to mandatory share withholding up to the required withholding amount. For purposes
of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value of Stock includible in income of the grantees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 15. <U>SECTION 409A AWARDS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">To the extent that any Award is determined to constitute &#147;nonqualified deferred compensation&#148; within the meaning of
Section&nbsp;409A (a &#147;<U>409A Award</U>&#148;), the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to comply with Section&nbsp;409A. In this regard, if any amount
under a 409A Award is payable upon a &#147;separation from service&#148; (within the meaning of Section&nbsp;409A) to a grantee who is then considered a &#147;specified employee&#148; (within the meaning of Section&nbsp;409A), then no such payment
shall be made prior to the date that is the earlier of (i)&nbsp;six months and one day after the grantee&#146;s separation from service, or (ii)&nbsp;the grantee&#146;s death, but only to the extent such delay is necessary to prevent such payment
from being subject to interest, penalties and/or additional tax imposed pursuant to Section&nbsp;409A. Further, the settlement of any such Award may not be accelerated except to the extent permitted by Section&nbsp;409A. For the avoidance of doubt,
the Company is not required to indemnify or reimburse a grantee for any taxes or penalties that may be imposed on an Award due to <FONT STYLE="white-space:nowrap">non-compliance</FONT> with the requirements of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 16. <U>TERMINATION OF EMPLOYMENT, TRANSFER, LEAVE OF ABSENCE, ETC.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>Termination of Employment</U>. If the grantee&#146;s employer ceases to be a Subsidiary, the grantee shall be deemed to have terminated
employment for purposes of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) For purposes of the Plan, the following events shall not be deemed a termination of employment:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(i) a transfer to the employment of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another;
or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(ii) an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the
employee&#146;s right to <FONT STYLE="white-space:nowrap">re-employment</FONT> is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise so provides in
writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 17. <U>AMENDMENTS AND TERMINATION</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">The Board may, at any time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for
the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall materially adversely affect rights under any outstanding Award without the holder&#146;s consent. Except as provided in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Section&nbsp;3(b) or 3(c), without prior stockholder approval, in no event may the Administrator (a)&nbsp;lower the exercise price of a Stock Option or Stock Appreciation Right, (b)&nbsp;cancel a
Stock Option or Stock Appreciation Right when the exercise price exceeds the Fair Market Value in exchange for cash or another Award, or (c)&nbsp;take any other action with respect to a Stock Option or Stock Appreciation Right that would be treated
as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the shares of Stock are listed. To the extent required under the rules of any securities exchange or market system on which the Stock is
listed or to the extent determined by the Administrator to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section&nbsp;422 of the Code, any amendments to the Plan shall be subject to
approval by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section&nbsp;17 shall limit the Administrator&#146;s authority to take any action permitted pursuant to Section&nbsp;3(b) or 3(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 18. <U>STATUS OF PLAN</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a
grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine in connection with any Award or Awards. In its sole discretion, the Administrator may
authorize the creation of trusts or other arrangements to meet the Company&#146;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the
foregoing sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 19. <U>GENERAL PROVISIONS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(a) <U>No Distribution</U>. The Administrator may require each person acquiring Stock pursuant to an Award to represent to and agree with the
Company in writing that such person is acquiring the shares without a view to distribution thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(b) <U>Delivery of Stock
Certificates</U>. Stock certificates to grantees under the Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the
grantee, at the grantee&#146;s last known address on file with the Company. Uncertificated Stock shall be deemed delivered for all purposes when the Company or a Stock transfer agent of the Company shall have given to the grantee by electronic mail
(with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#146;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#147;book
entry&#148; records). Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any certificates evidencing shares of Stock pursuant to the exercise of any Award, unless and until the Administrator has
determined, with advice of counsel (to the extent the Administrator deems such advice necessary or advisable), that the issuance and delivery of such certificates is in compliance with all applicable laws, regulations of governmental authorities
and, if applicable, the requirements of any exchange </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
on which the shares of Stock are listed, quoted or traded. All Stock certificates delivered pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions as the
Administrator deems necessary or advisable to comply with federal, state or foreign jurisdiction, securities or other laws, rules and quotation system on which the Stock is listed, quoted or traded. The Administrator may place legends on any Stock
certificate to reference restrictions applicable to the Stock. In addition to the terms and conditions provided herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the
Administrator, in its discretion, deems necessary or advisable in order to comply with any such laws, regulations, or requirements. The Administrator shall have the right to require any individual to comply with any timing or other restrictions with
respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(c) <U>Stockholder Rights</U>. Until Stock is deemed delivered in accordance with Section&nbsp;19(b), no right to vote or receive dividends or
any other rights of a stockholder will exist with respect to shares of Stock to be issued in connection with an Award, notwithstanding the exercise of a Stock Option or any other action by the grantee with respect to an Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(d) <U>Other Compensation Arrangements; No Employment Rights</U>. Nothing contained in the Plan shall prevent the Board from adopting other or
additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases. The adoption of the Plan and the grant of Awards do not confer upon any employee any right to
continued employment with the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">(e) <U>Trading Policy Restrictions</U>. Option exercises and other Awards under
the Plan shall be subject to the Company&#146;s insider trading policies and procedures, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">(f) <U>Clawback
Policy</U>. Awards under the Plan shall be subject to the Company&#146;s clawback policy, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 20.
<U>EFFECTIVE DATE OF PLAN</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">The Plan shall become effective upon stockholder approval in accordance with applicable state law, the
Company&#146;s bylaws and articles of incorporation, and applicable stock exchange rules or pursuant to written consent. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Effective Date and no
grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the date the Plan is approved by the Board. For the avoidance of doubt, this second amendment and restatement is not intended, and shall not be interpreted to,
modify any Awards granted prior to June [25], 2018 to the extent such modification would result in a loss of deductibility under Section&nbsp;162(m) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">SECTION 21. <U>GOVERNING LAW</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">The Plan and all Awards and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware
applied without regard to conflict of law principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">DATE APPROVED BY BOARD OF DIRECTORS: March&nbsp;29, 2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman">DATE APPROVED BY STOCKHOLDERS: June [25], 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g535515i1.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ROCKET PHARMACEUTICALS, INC. 430 EAST 29TH STREET, SUITE 1040 NEW YORK, NY 10016&nbsp;&nbsp;&nbsp;&nbsp;VOTE BY
INTERNET&#151;www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting
date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the
costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via <FONT STYLE="white-space:nowrap">e-mail</FONT> or the Internet. To sign up for
electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT> Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting
date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51
Mercedes Way, Edgewood, NY 11717.&nbsp;&nbsp;&nbsp;&nbsp;TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:&nbsp;&nbsp;&nbsp;&nbsp;E45393-P08686 KEEP THIS PORTION FOR YOUR RECORDS&nbsp;&nbsp;&nbsp;&nbsp;DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.&nbsp;&nbsp;&nbsp;&nbsp;ROCKET PHARMACEUTICALS, INC. The Board of Directors recommends a vote FOR all the nominees for Directors listed in proposal 3 or 4, as applicable, For Against Abstain and
FOR proposals 1, 2, 5 and 6. 1. Approval of the amendment to the Company&#146;s Amended&nbsp;&nbsp;&nbsp;&nbsp;and Restated Certificate of Incorporation to declassify the Board.&nbsp;&nbsp;&nbsp;&nbsp;4. If Proposal 1 is not approved by the
stockholders of the 2. Approval of the amendment to the Company&#146;s Amended&nbsp;&nbsp;&nbsp;&nbsp;Company, election of each of Messrs.: For&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Withhold
and Restated Certificate of Incorporation to eliminate&nbsp;&nbsp;&nbsp;&nbsp;Nominees: the supermajority voting requirement with respect to the removal of directors and replace it with a
majority&nbsp;&nbsp;&nbsp;&nbsp;4a.&nbsp;&nbsp;&nbsp;&nbsp;Pedro Granadillo* voting standard.&nbsp;&nbsp;&nbsp;&nbsp;3. If Proposal 1 is approved by the stockholders of the 4b.&nbsp;&nbsp;&nbsp;&nbsp;David P. Southwell* Company, election of each of
Messrs.: *as Class&nbsp;I Directors for a term of three years. For&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Withhold Nominees: 3a.&nbsp;&nbsp;&nbsp;&nbsp;Roderick Wong For Against Abstain 5.
Ratification of the appointment of EisnerAmper LLP as 3b.&nbsp;&nbsp;&nbsp;&nbsp;Carsten Boess&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company&#146;s independent registered public accounting
firm for the fiscal year ending December&nbsp;31, 2018. 3c.&nbsp;&nbsp;&nbsp;&nbsp;Pedro Granadillo&nbsp;&nbsp;&nbsp;&nbsp;3d.&nbsp;&nbsp;&nbsp;&nbsp;Gotham Makker&nbsp;&nbsp;&nbsp;&nbsp;6. Approval of the Second Amended and Restated 2014 Stock
Option and Incentive Plan. 3e.&nbsp;&nbsp;&nbsp;&nbsp;Gaurav Shah&nbsp;&nbsp;&nbsp;&nbsp;NOTE: To transact such other business as may properly come 3f.&nbsp;&nbsp;&nbsp;&nbsp;David P. Southwell&nbsp;&nbsp;&nbsp;&nbsp;before the meeting or any
adjournment thereof. 3g.&nbsp;&nbsp;&nbsp;&nbsp;Naveen Yalamanchi For address changes and/or comments, please check this box and write them on the back where indicated. Please indicate if you plan to attend this meeting.&nbsp;&nbsp;&nbsp;&nbsp;Yes
No NOTE: Please sign as name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g535515i2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com.&nbsp;&nbsp;&nbsp;&nbsp;ROCKET PHARMACEUTICALS, INC. Annual Meeting of Stockholders June&nbsp;25, 2018 8:30 a.m., Eastern Time This proxy is solicited by the Board of
Directors The undersigned appoints Gaurav Shah and John Militello, or either of them, as Proxy holders, with full power of substitution, to represent the undersigned at the Annual Meeting of Stockholders of Rocket Pharmaceuticals, Inc. (the
&#147;Company&#148;), to be held on June&nbsp;25, 2018, at 8:30 a.m., Eastern Time, at the offices of Gibson, Dunn&nbsp;&amp; Crutcher LLP, located at 200 Park Avenue, New York, NY 10166, and at any adjournments or postponements of the Annual
Meeting, and to vote on behalf of the undersigned as specified in this Proxy all the shares of common stock of the Company that the undersigned would be entitled to vote if personally present, upon the matters referred to on the reverse side hereof,
and, in their sole discretion, upon any other business as may properly come before the Annual Meeting. The undersigned acknowledges receipt of the Notice of the Annual Meeting of Stockholders and of the accompanying Proxy Statement and revokes any
proxy heretofore given with respect to such Annual Meeting. This Proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this Proxy will be voted in accordance with the Board of Directors&#146;
recommendations, which are set forth on the reverse side hereof. The votes entitled to be cast by the undersigned will be cast in the discretion of the Proxy holders on any other matter that may properly come before the Annual Meeting and any
adjournment or postponement thereof. Address Changes/Comments:&nbsp;&nbsp;&nbsp;&nbsp;(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.) Continued and to be signed on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g535515g79v64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g535515g79v64.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1I(4&AO=&]S:&]P(#,N,  X0DE-! 0
M     &0< 5H  QLE1QP!6@ #&R5'' (   )  !P"4  (<G(Q,3<U-#<< @4
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M:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M    "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O
M9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN
M=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M    4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L
M<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M     $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M     $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
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M8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M.$))30/M       0 \     !  (#P     $  CA"24T$)@      #@
M       _@   .$))30/R       *  #_______\  #A"24T$#0      !
M '@X0DE-!!D       0    >.$))30/S       )           ! #A"24TG
M$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F  8
M  $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $
M+0    8       $X0DE- _@      '   /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M.$))300(       0     0   D    )      #A"24T$'@      !      X
M0DE-!!H      S4    &              "8   !<          !
M                  $              7    "8
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   "8     %)G:'1L;VYG   !
M<     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG    F     !29VAT;&]N9P   7     #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     ,X0DE-! P     #Z
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V
M 0 X0DE-!"(      49-30 J    "  ( 1(  P    $  0   1H !0    $
M  !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @
M !0   "< 3L  @    D   "PAVD !     $   "\    Z  ;=T   "<0 !MW
M0   )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X.C T.C$R
M(#$P.C4X.C0X ')R,3$W-30W       #H $  P    '__P  H ( !     $
M  %PH , !     $   "8          8! P #     0 &   !&@ %     0
M 38!&P %     0   3X!*  #     0 "   " 0 $     0   48" @ $
M 0              2     $   !(     3A"24T#_0      "
M_^$!2$U- "H    (  @!$@ #     0     !&@ %     0   &X!&P %
M 0   '8!*  #     0 "   !,0 "    '@   'X!,@ "    %    )P!.P "
M    "0   +"':0 $     0   +P   #H   #P     $   /      4%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#0Z,3(@,3 Z-3@Z-#@
M<G(Q,3<U-#<       .@ 0 #     ?__  "@ @ $     0   7"@ P $
M 0   )@         !@$#  ,    !  8   $:  4    !   !-@$;  4    !
M   !/@$H  ,    !  (   (!  0    !   !1@("  0    !
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M 0$! 0'_P  1" !1 ,0# 1$  A$! Q$!_\0 'P   00" P$!
M  <("0H&"P(#! 4!_\0 2!    8! P$& @4&"0T!     0(#! 4&!P ($1()
M$Q05(3$*02)187'P%A<C@9'!,C@Y0G>AL;;1&"DS-SI2<G1V>+*UX?'_Q  =
M 0$  00# 0               0(#! <%!@@)_\0 3Q$  0(% 00&!@0("0T!
M     0(#  0%$2$Q!A)!40<3(F%QD10R@:&Q\ @CP>$5)#,U0E)TT18V-T-B
M<K.U\24F-$558W-U=H*2HK2R_]H # ,!  (1 Q$ /P"_QI"#2$(]FC/N(=O-
M/=WK,E\@*)7&O61-Q,/ *]E'12B8L=!1*)592=E%0#]%&Q#1X\/ZF!+H*8X8
M,_4Y&EL*F9^9:EVAH5J[2CR0V+K<5W(2HZD@ 7CLFRVR&TNVE3;I&S%'G*O/
M+L5(EF_JF&S8=?-S*RF7E)<7LI^9=::!QO7(!@%O'Q!<4RRVS0H&#UYS"C)5
M=M+2L]-&B,@SQ#'*5*5@8XA%H:&01(!E4HN85=.7Y3 #EU#J<@36DQTG-IGP
MB6IRG)!!(<<6M2)EP7]9I('5IQV@A9-Q@J23CV#2?H:3#VSCKE9VL;E-J7D!
MR48E)83-$E%6%I:<F5;K\TI=U!<S*[C3*DA*$S.]>)KML&\_;WNVKA9G#=Y8
MRDFU;IJSM*E!")O%;.H!>LLM6W9@>^&*H?NDI5D#R'=F ?!R"_KQW^D5^F5M
MH.2$PE:K76PLA$PU_7:)N4C]=!4@\#'EO;SHOVTZ.)ST;::D/,2RUJ1*5:7O
M-4B> )MZ//M@M=84C?,L\6II"2%+92""7!W&[U''M=D[=>K)!U"KPK8[N6L%
MCE6</$1[<GNHZ?OU4&R8&'Z) %3J4.)2$*8YRE'E'YEB5:6],/-L,M@E;CJT
MMH2 +DE2B!IP%R= "8Z93:94JS.L4VDR$W4I^:6&Y>3DF')F8>63:S;3*5K-
MOTC;=2.THA()BO\ ;F.WOI-3M36O;:,?(Y1B8V4;A8;Q<'$I7(*8CD5!\:TJ
M$8FV),'.L4!(A8)9%NU3$.^;Q4B@8JHZTJW23+,/I:I,L)U"%CK9AXK:;<2-
MX*# MOX5V0M0R;@-D6)]C;"?0_JM2I[D]MY65;/3#[*A)TFF"6GIR5=4 4/5
M)]2E2NZFV9.46ZXJ_:?:*2(D6V=]ICMMW>M6,-7[ G0\JK-RG>XKNCMLPG5%
MB$ZEQK#\PIQMP:D^DIUPZAY!%'A20C6)N4P[10=K:574AMIWT><L-Z2?4$O%
M7Z74DX?2/Z': RI*>&D^DKH)VYZ-G'IJ<DE5C9Y*CU6T%*;6]*(1>R34&4[[
MU,<-TI(F?J"LA#4PXJ)%>>==IC2\&D(-(0:0@TA!I"#2$&D(-(0:0@TA!I"#
M2$&D(-(0:0@TA!I".M4!$OH/ \_C[?QZ\Z'_ !\(@_88UX6['*^1\NY]RG.9
M*NE@N4A%7^[0$,I-R"SI"$@HVSR;1A#0K$3>"B(ULW;I$(SCD6Z!C$!94BBY
MCJ&\NUN=FYZIS;DW,.S"DS,PVCK%$I;;;=(0VVGU4)3BP -^.@C[3='&SM#V
M<V/V?E:'2Y*ELOT>E3DRF480VJ:FIFGL.O3,TZ ')F8<6M14\Z5*(L!NI"4(
M;AS_ (:XG_&.]]_'G&15.X6N@V",M]'LDY4;7"+^*A[%7)-Y#3$:X .!.UD6
M"R+E(#EY(J0#BFJF(IJD.F8Q1O2[[\L\V_+O.,/-J24.M+4A:;']%22"/#0\
M1:..J=,IU8DGZ=5I"3J=.F4[DQ)3TNU-2SZ#8;KC+J5(-CH;73@I(($/B[0S
M/F9,LY2K4'D/(=CLL!$8BP)/1M>=/C(P#2=M6$Z%:;%-IPK0K>-&7E9R<DWC
MB1.V.[ K@&J*J31)) G8]JJG/SLVRU,S3SK2)&ENI:*MUKK)B18><<+:=U)6
MIQ:E%2MXW-[Z :FZ%=CMF=G*!/3=%HTC(SC^TVV<D_/-M%4Z[)TW:NJT^2E%
M3+JG'?1I>4EVFFV4J2V A*BDN%;BX^]=5L-+"W*-U::<[^WGXQWMG#AHX;NF
MBZS5VU62<-73951!RU<HJ%50<-UTC$51715*51)5,Y3IJ 4Y#%,4!U4E124E
M)*2@A22DD%)&A21ZI' C(BR^TA]MQIUMMUIQ"D.M.H2XVXA0(4A:%A2%I4DD
M*"DD$8-P;1>5[(G)M_RSL>QW:\E6V:NUF2L%]KXS]A>'D9AQ%U^W2D;$(/9!
M;J=/U&;!%%J5V\46=K)I$%PNJ<.L?1.Q$W,SVSLF_-O.3#V_,-EUT[SA0T\I
M#84K&]NH 3<BYU.;Q\F?I'4*C;.]+%=I]!ILK2:>96D38DI)L,RK;\W39=^9
M6RRGZME+KRE.%IH);2I1W$I3B)--=NC1<&D(-(0:0@TA!I"#2$&D(-(0:0@T
MA!I"#2$&D(-(0:0@TA'6H( 7U^O]P_@ ]]03:WC]WQ/A[H@Y!','X1K@,U>F
M9\PE^895R)S]X7&: 0^\/F'N'SUY4J/YPG?VR<R+$?ECQ%^7MQ:XS'W V3(_
M@QLWF_\ F]0],_ZLEL7T![C8C0V.(3+6''88XF$ *//H'2(\B(   'N(B/R^
ML?8/GJ1J/$<0/B0(I5H1]POP%]+DX'>0(=5O( 0S-& /H(8+VQFX$!]C;<L6
MB _KZ1_'/',[0?Z>@<J;1!KQ%,EKBVNN-+7XQKOHO4E6S,R4D*!VOZ0"%)RD
M@[;5LW"M%#(RDF&KZX6-C1^A[A]GK^/\1]/8/<0Y1"M+<\#Y[HNP]B+_ "?V
M/_MO.5Q#[@ODP4?V" @/V@.O071[_%>3_P"--_\ T+TM@^.AX8CY5?2H%NF6
MN ZBF;/W%B+?Y(EN8'CX$'C$MVN[1YU@TA!I"#2$&D(-(0:0AK=*WM;3,C9U
MMNV6C9_QI:,]49-^>TXPB+(S=6:,/$'(G--/#E-W+V0@E%"$G8U@NZ?PIS=,
MHV:"!@+ 4DZ$&W(WBHI4 "00#D0Z34Q3!I"#2$&D(-(0"/ "/U>ND(X]1?K_
M !Z_K^6D(Y:0A"\];D<+;:*<K><SWZ%I4*'>$8(O53K34\[(4#>7UR!:%6EY
MU_TB!C-HQFX,D0>]<"DB4R@<=4JK3Z0P9FH3+<NV ;;ZNVX1;LMM@[RU'06!
ML3D@1VK9'8C:G;JIII6RU'FJI,]GKEM(W923;5>ST]..;LO*,X-EON("CV$!
M:RE)J_;R.V]R[ED92D;:VC_#5"4,LT5NJZJ:F49UOR8@KLG+<QV5+;K%X$A(
MX[R:*'!O-F9A.@&H*]TA3TYUDM2 N1EO5](-C.N:74C.XP#;@5+ OG/9]\]&
M7T4-G=GA+U7;IUG::L)LXFEH2109-S@EYMQ/6552#KUZ6I51-E2S@ )C>#-^
M.\U=+#<]7'1;:L4$6^XK&\='M<B"OT])'>4:GRQ@<MI<]/BY8ZL#?#IEZQL,
MF<I6YNJ?A*4GQN5AI0=.!5)4#TH'/:FV>RW.IN=Y3EVIF]R77#A6\/X)5O9,
MA[8*=9_!J5%2]BJW,/*H@2#<,[/U#=>G-G%$=E,L!.4@#(E)8%3B.#C9ODIZ
M0+-2+!CV^8:/WBQ\[Q]MBH/&\ U3Z143OSBPKQ\QCRPE(8.FGV:+;6-^J((U
M]C-B=(ZE)H$VH!Z7=E9B0.\34T3"4RC:4GU7R\0J6>R"&EHZQRQ#:%8 E'2A
M0F5>@U:4K=(VG[*4[(/4N9FZ[.+5HNCHDDO2=:DU$G=J,D^N190-^;=E2,>
M;=A+"8BEC2+CLZ9'0]#92O\ 7CEQA7W(%]5,?8KFD 5LKMJJ'+6T9+1,T,8
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MSB6AU#LGB<L5,RAKE Z/)!KJIVIO"H%20XPTA*VY=32K*;6\%=M:E(*26C9
M)*2%9,<=TH_2MVDFW)S9_8RF*V65+N/2=2J<RZQ.U03;*E,S+4@MI/HDNVTX
M%MHF]UY]S=#S2I<D)38&@*S7ZI#1U=J\+%UV AFB3&)A(2/:1<3&,FY>E!HP
MCV2*+5HW2 ."(MTDR '/!?4=;-::;8;0TRA#33:0E#;:4H0A(%@E*4@)2!R
M CQQ.3DW49I^>J$U,3T[-.*=F9N;><F9F8=6;J<>?>4MUU:CE2EJ43Q,:ZC:
MI6;$7XE)6+-!RI92*WY[B)V28&8.0=,(4DKD^6\V>(=WWK>--%N6D@1\J4K8
M[1TV<$4,DX1,>W_.?]Y)\K>7QX16JW4VN+;H\P#\_)ML<]9$8<4C/B)NR:R]
M^>>3[0G;%4I^UPUE:P;_ #G7:.S=O+?2[G56C2.CLJ1,9%D&3=PDA$1D.6=<
MQ*"SZ!F8I2P/!!K(N73+'<00=X"XN+VOO YR/;GAFWLRF7!;<5P!MG!OFWR+
M8\TSV\?%;9HQSBJ)I&>]N<'FG(=9BT(='),1D!7'[FR"P;E;(/[I7UJM8VY)
MM3NP-+OX9RR;OW0JKI1+$ZAD] [9.3<BP[R-,Y];B=/ 1)EP3A5QDV&<7Q;S
M\HCMDPW\?$,;T(R>3JHLX-@FSK 2<-'2J6%]NV-"R"K]YXJ:>F,G(SRXN7$B
MNDHZ/9[E,=P@V9-8QHV;Q5)NX<7UXZ#F!GB!H>'+$7 6V4FU[]_'.MONC8(Q
M.RG#$7LG:;$@BUG.&$,)EPDN@L"/F+R'/"#&.[ LH5,$@L+R2.K95GA" 'GJ
MIGA2@/'&3NBV[PL![!&#O'>WKYO>_?&OU>US?W\//O.D;5&0:SVKO!?5R,ML
MK$2;O"NX;&2T@#QBTD'\>J1&*L2/AT'YXD9!M9Z=-D5.B1W$.NN6QNVA>GEC
M>'#/SIGG&<-R83G!M[0>? XQQ((B2O+/Q:.6K'CEQ!X8VKU+'.4)!H5H6[6O
M(+G(,!"NE2@FJ]AJ@WJ]:5DG1#B(LD)B5\(B?H!TU?E*9%2HNJ&" #P&OA\^
MZ+0EP#=2KC4:B_')MR[Q[(L2=BKN!WO[EMH1LG[Y:@%<N<G>Y1/&DXZJ:5#F
M;UBXT/!NXNT2M/03;)1Q5)QS/,(F0)'Q1)R(9,Y!)B9%5*2D+J"LCM^SA?Q'
MW"++H2%63[>5SRP(IJ]FYAN.R!V]K.A9&QV2U1E=W+;E[39ZG98$\@SBU:JO
MDJ:@YB?B7B!TD4(BRE@'S-602%L22&*.7K55; :PG\IGF01W "WO]D9"UGJ=
M;$I2,=UK_&+/_;^=E$EO;PJ7<!A>O)J[H\&P+DS-E'-DBOLMXS9G<R,G0'!B
M]V=U.P:J[V?HISF.?QBLM ID,$^0[:ZZC>%QJ.'=W??B+++FXJQ]4Z]QP0?,
M"_=##/A:]]&8;REDO8ID!C-6>E8AIZV1L:6UZ#Q1QCJ,4L<; RV*Y=5QU A%
MN)&34FJ:Q5%)S&J,[3'$3.P29(1T-$V"3RN/,8[M1[XK?1:RQ;."!SSFW?;Y
MTCG\1GV2F5\K7=GOWVOU*9NMA:5N)@\[T&H,EW=O.2J%4)6<J5B,8 :3G'C"
M,%M V9A&)N)9JPAX*79-UV[.3.A#J3?>S; 4!KKC$0RX "D^S7'SGSAO^T#X
MI^VXEQG!8PW=X"L&5KG28]"N$R72++&5VR6%&)029-SWJK69JFW)9BE2,27E
MV$FV)(.@%=6%:.3K">$O$7!3IWY]_P!D5*8N>R0.XX\.6OVB%/IOQ(>]'=QN
MGQ!B_9GL\A%Z9*7&%87&J37GV1;S-UE])MFLU*R%FKQH"MXUC86*4=2)Y9VT
MEV;1= JKY^HUZV2L]:2JR1<&WB+VO>U^8]N(@L)2DE2KFQM8BQ/+(O%SM=(S
MEBX1X[H[ALLE]+Z0$,JB)!]N ,!3&]R^@\>FK\8T:LO#>;<J=D-VGMAR%<,9
M^?7##&0LJ5JS4"?<N:V%HJMN"=B/,868,R>BU1E(N0862MS:3*18/$ ; 9-9
MLY4$N*"I)O;0JUY9[QQN(SU#K6[).3NDYQ<#AXB_?C,7A]@W;2T_>QA67RPX
MV]91H;J%R'.T%S#5Y-;),2NI$0M9G4Y%M9(^)A$^I=M9D&[A@M'IKM7#54>M
M5%5$XW0Z"+[JO=]I$8JFBDVN#IS'F,Z1-SJ[%J.M7_1G_P"$=0=#X'X1(U'B
M/C#&^S6_B28$_P"G9W^^EDUP.R_YAI_]1[_Z7HVETV_RI[7?M-/_ +ID(?1K
MGXU9#;=X_P#%,W+?T%Y2_N9,:XRM?FBJ?L$W_8+CNW1K_*'L+_U=L[_>TI"@
M8._U*XA_HQH?]UHK5ZF_F^1_9)?^R1'%;7?QJVE_Y_6/[PF(5+6;'7HP9KC'
M'#&[2&2F-"I;/(TM'I1,K?FM6@V]TDXI'H!*-D+2DQ)./6"0)) FS<OE&Z8)
M)@1, (0"Q87O;/.%S:U\<N$9SJ81Q,7J#C2$-=N>Q[9ED:P+6O(&T[;;=K.Y
M7%TZL5IPAC6=G';D1Y%=W*2=;=/7:HCZB=PLH8?F.HL.0\HJWE#12L:9.(7N
MG4>F8\@6=6H-2K-(K,<42L*[48&+K<&R*( !@:Q,.U9L&X&X#GN6Y.> ZN>-
M2 !I$$DY))/?F,ITB(QNUTZI7R$>UF\5BO7&MR2?=2->M,+&V"$?IA[$>14L
MV=L'1 Y'Z*Z"@!R/ !H0#K$@D9!(/=B&]U/8SLMH=A2MM'VD[::A:&ZX.FUB
MK6#<:0LVT<A[.&<G'5IN\:+!\E&ZR9P'UZN=18<AY1.\K]97F?#X8ATI" 0.
M ]O0 ]. ] X#T^[]VIBF,*C,9XZA;?.9!AJ'3(B^V=N@SLEVC*O",+;/LVH$
M!LUF[&U9)3$LW;@DGW"+]XX22[LG=D+T%Z8L+WL+\[9_?"_#@(S80Y#CGC\?
M_NIA&$U+&>.:"^L4G1J%2Z;(W"1-,6Q_5:M!UY[9Y8W5S*6%U$,6B\U(CUGY
M>R1W+CZ9_P!)](W*T+GG\C3RC-Q#D./;2$-KR'LSVBY<G#V?*>U[;WD>RJJ
MJM8;QAO'EIG%SE$1 R\M-5YY(+\&,(_I7!P$1$?<>=18<AY15O*_65YF%2QY
MB/%>(HLT'BG&U"QG"G$ACP^/Z?7J=&',0."B=A78Z.:G$H>A1,D(E^7IP
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M\9($3/ A8MI&@Z,B!C@B9P#;OA2 YP3$XE QN.H>S2S/H\NQ+[V_U#+3.^0
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M'=-Q>]JN/GB!YV&4SG7$LS257$69I"W0>-6D2_*5DS1=F>-XB7G6,T]9M%7
MMFG>-R'0^?GW_OAV67,CIXPP_?\ *B,:,XG2J3-W%*)%R+ 90L3&+22;,70H
M.1:^)!(J8K"W6%+JZNZ,(=.D(\F'[C?KY5AM%]Q^TQP:4<(NZQ!IVAM:I1:L
MNX]DZ8O[ =C'LXZ)EUEEW)%HAB[F$&J*:!S22BJJB22$-%L6\_)L- 7K(K#
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FY:0@TA!I"#2$<3>W[?\ Q'2$<M(0:0@TA!I"#2$&D(-(0:0C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g535515i1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g535515i1.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0.F:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R
M9R]D8R]E;&5M96YT<R\Q+C$O(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM<#I#<F5A
M=&]R5&]O;#TB36EC<F]S;V9TPJX@5V]R9" R,#$P(B!X;7!-33I);G-T86YC
M94E$/2)X;7 N:6ED.D%!0S!%,3,S,T4R,C$Q13@X,48U14(X.3A$03,Q0S9&
M(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.D%!0S!%,3,T,T4R,C$Q13@X
M,48U14(X.3A$03,Q0S9&(CX@/&1C.F-R96%T;W(^(#QR9&8Z4V5Q/B \<F1F
M.FQI/E1A;6EL87)A<V%N($MA=&AI<G9E;#PO<F1F.FQI/B \+W)D9CI397$^
M(#PO9&,Z8W)E871O<CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A
M;F-E240](GAM<"YI:60Z04%#,$4Q,S$S13(R,3%%.#@Q1C5%0C@Y.$1!,S%#
M-D8B('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z04%#,$4Q,S(S13(R,3%%
M.#@Q1C5%0C@Y.$1!,S%#-D8B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F
M.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[0!(4&AO
M=&]S:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
M       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_VP"$  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @("
M @(" @(" @,# P,# P,# P,! 0$! 0$! @$! @(" 0(" P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __  !$(!"4#
M- ,!$0 "$0$#$0'_Q "S  $  @(# 0$!            !@<%" 0)"@," 0$!
M 0$                   $"$  !! ,!   % 0,'"04  "<% @,$!@ !!P@1
M$A,4"1466!DATU87EW@*,2(CE-2UU3B80:2T&#E1)#*2,R4V-W>W87&!LG:1
MH4)28G,T-74FEK;6)U?7*-AY\+'!T801 0$!  $#!0$! 0$!       1 2$Q
M46%!@0(2(G&1L:'1_]H # ,!  (1 Q$ /P#W\8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U/
M,^X?+E<"/6*P]6&@Q$.[]MYX5E%@]D@J!VGSH'M5@[+&/1GPZ)04?2PU.F2'
M)LE#<.4A<7[9U[<V)I\LU7!#\E?E4-3[7=#Q7KE?@4,O3!5Y#&?.G?(5SIK/
M2&'7^<6.STA?.=VL)3>@+95'#F9$1 V;/UN&A[[M*F$B:N?E'JSDO:KO:.?4
M%GI\FP4C;,:Y/6#B/8:97:L=>KU6M?[''[=;Z.#JXN]L5ZZ#93P-V6DJRW(W
M\["=MN:0(JZK?D;\@W"9N"+Z84AK_:VJ4YF39.;=/J(R9,O-YMO+ZD='&+13
MA HE1CO2Z,3KS5@8><#),L)B+DH>>92X)JP'?9?G1CGO+^J2+X]'HG9P]XL/
M,SC]3N3.K2!YYSVX]6LQJ+ 6 23C#&N=T,F6B/2&6DD(K3>XOUE/L)<$U5Y;
M\EOCD5SD3UEKI)^P\^+\ZHO64V*F<IZS=6!7/>CV&XU&IV2RQ:M22T^K1Y=M
MH145(:(M1I$ E'U&E(9>=:0L364F?D+\SC873B14AUD.,XP*$D>I$S'G;OHL
M=2)YT5338>G')L[F[$>/T8@+Z '=:KFE*-JU-3K[7XI7I(FN<,_(-Y)*%.<@
MD]2<&V#JLOM8JHUVQ4CH%8L&['YU1I79:?8PEAJPPG3;K2M_%+@<NU"(RE)W
MJ*R]OX?$37$8_(/YI(1K>1KY#K-O"T*H52\V^Q4GSQWRXUH" NM"J'4J]N=8
M:WS<D'06D\\O8PPZ/T]N=%@OJ<?:;TT]\@FMB.,=CI'?.<UWJW.%69^DVV(V
M2K9"U4BY<_G&1$AMN0/.00-Z!5TZZ",0WD2(,S[;[:;&<2ZRM;:M*V1,W[95
MHK\B-)LH"/)B294.5'?,CF7XTR"'389L60TY)2XS)A@%ZG.MJUI3</>GE:TW
MOYL#AHOE'<BZG-W.J.0519DU,Q%B$*BJACB$<20EZD)F;9W%@E9;49YSX_(U
M(=0VK>EJUK8?=FXU"3J,J/:JW(3-T&5#VR<&.ZEIL3DIFOJC;1*5I_1UZ"^B
M'M/Q^Z4RO3?S;0KX!P%]'YXV6+ %WRF(.@!SA@Z%7: :2P42U,2.=*%ANYVI
M@T<V07IA3[R$-:>WI&U?-OX8&.@]?Y,3?E11O4.=D),$(*LLV/!NU:EOPZX=
M>9CA#\IF.3<<CA#$B0VB+*7K3$A;B4MJ5M6M;$UDW^B<_BLDY,F]4Z/'"D/T
M@R^_9@K+(DK\TE/Z83=<FI1 (?-">U]%W:'/BTO_ #?\U7P 6Z+SX#+'CSEZ
MIP:>6L$6IBH1:SA!TLG:IL.,1A5D?&F3F7IE@ECYC+[4)M*I+C+J%I1M*D[V
M$*K?HK@UNADB%=[!SDC"$]*,\;GR4VT+&:8ZK7R,@26Y^E4R7'^O:HQ"(XVF
M&W\[KWR[4WI:?AO!-6,6MM5 $Z^%.V:OA3-MF21U5$EC(X:3LQ"'&W,EP:_
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M='_8:5.TX7CQDZ'JT\YMO27-)+$T/>ON& RX,,R<L=E?.];K7$8\^G4.ZV<
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MCS(T9R*VY+C2X[S7S-/-K4)Z*JJ'N7AEHM<FM$"9:E1WJ;1+W7CUU GZ\),
M;SSJS=1CI)S2(E@?32H^I4XG*W"+2(LJ4Q D.QT.MM+5H35U4CO').BTBQ]&
MJET@R:;3G"3=N,%X1>K;JVQ .#9YZ[&.M0\*6!LM5@G%))<E,-(='269+>U,
M.MN*)/13U4]N\-L_[5SGB=@K]9K_ $RL\N'V<Y2KT/@EC5JHW-KH-GE(LNK1
MB%#"NJZ>/A-S#S8^(^ZI+C;JFG6U;+-7S2NM<XZ-(U%I%L&V.1^S0FX+9'IE
M;6S73ANSUL41DZ>CM?:?=GJ66B:9=^1]+X]]*D)VVK"-<:'[W\\6^@LW8M9)
M].EI^P1-IY.MVTC9]O%#5R!#OV:&B*[*EW^&_-Y^9TN4!:(Q8^Q<O3KB-QGO
MD+-<0'[VX@2-=0V0*J&T2@V&O5FO76$+NUF=Z/*(\F%=IL%@JU?KU(G+FT*J
MT,Y'FR3<65-BM1DNR96H<3<5^6A-3^P^SO,M7<-(,=5&MM5XIL.7GP =L-AX
MLUBKQ;N3V@V$ $1$J#7:80BER\ME]R*&&3(TJ<Y'8DL+<$U-.F]\HG*C_,*N
M?189YKL,ZTC*(FO5TL>&RIM3IY&[$/UDP+BRH%>@O"!J_I2I2D,;5OYMJTVA
MUQ!(IZJ>]O-5@Y96NIE[PJHP3HNNSR $U7K=NPU]T]SR'U%UR:*8KJB,NKB*
M9*40D6)AA=?3":7(^\TRG:M%FM@[OUWGO/$U+]J#ZFG[V3V*I\ *&/6TM89"
M![I:5)&AZD+.%7A P4PJ5-G_ $=08,;6G9#S3>]*V15EH]@\$J^J%\;9.LBN
MD66FUFM-4NM6*V2%/7PY;JU7"\^,&&R9$&ORC]%*152E)VE#L56MZ^&];V(G
MM[[WR3FEF T^[7".&L-C0.>@PTBSI1F%$,V*%4 A&RD@XL@+IPD[;2+(N#,+
MOP8LTBYJ,PXX]\4:$:Y^8_;XGT]>IM2KG/#E;@0>?N=)=,V!%P'R/T$IT:X4
M&FQDP3// 8MPN8:HTV=/:;)+;@:<98CN3UIFJA%W(L&;[$X]'ZJ3Y9"F'CDN
MN5/I%EMAL#4KB:'B)O-+GS>B&:R(9%5R;(O1Q%BZ,B+): _J*ALJ"_'EZ:>U
M\FA&(5[0\R6?5O 2+.3) (='YA89935%NI"N7$%WA1872 51>' 9<JVV<ZL<
M^RX&ALN$T*TXCZ&U1Y6F!-6O$ZUQ2G\>I%^"6 /&Y&4%4L3S=VHBB1E@U!L"
M8 BBURCU6LC2!\U/()>8C0AD"$]+_D^33.OD5I(FWR^O//0?'NL&E5_G%TC6
M\FU40=XEI$"C[L(97;*IU %XR6<%-"0A4HN,^EH;+?8);5$DZW'UN-(TV2+E
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M.W#\L%F&>U+%YDHO*^7="!57U'QORZ1#C>RRX_I(O.Z+2:[<+[UVM<8CT<E
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MH4&CN]ZGA:Z+EV(!'Z]79T%\HJ*+<'//)2IN(E6MIO"\-D//A7TS \S]//\
M1)%VZ%UJ,(/E:-5CU1$\RNK=BB\V#2'*9%(F(\ZNDTS>DMSOT\J[ 6-8U)TR
MC4N'';<<B<5KW45_D#*U03-FE^CP7:Q,Z$?"QY8#GHXG>XT;KW'%<^!7J+8
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M.S^D6%@%9^CLL0T*0<K-FNITU$W#VVA$TL]_D3_E+]MY\I#PK\>?5O._)"?
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MF#I98Q(?7&&,16/BM*-)TVVTA!$"I7DO@O/BS1NL4R7'(Q#\"QBG)]NN9B.
MF"?ZS?TF%7H!:P3!X("*5V6SJ8'16FH2%F'E?2VI+6VRW4K.<"Y<>YK3N3/
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M$8K$K2ONVUOZD:=^Y:9>;%U,S_"N<7#CQGA%W'&[USBQA9P"PP;E<;?8CYJ
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MHN#\W](HG$J6RLUU 85Z'U'JA;@U9H*SEQD<C=XW4ZF[9>XM()M,6(G8H,*
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M+4,R_P!2+A'N*T=@L'LU$NCU$37O+UJZU504. 4Z,]:K4YRTU81:"=@G&N:
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M(78K';%VN$XLBJ2[.58K:1E?(\MUCYY2M?3^724I+=4OO\>WBP0Y5BNN,A1
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M+/'(P$Z@R8-7C1&(<=# EAW4EQT;&JM"\@>@ZC'H1,&Y=ZW;>6A+C7AA2=W
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M D#&\H2)XQ\7N.H?)4ZEN4P_/:C261<4_-\\^W[[2NP@[HPM#%V<O.Q%0/\
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M&="J=Q:KZV6H;:'X,;;,W4EA6T;&;&O;OXY^M.RP<3^M6D1Q-5X1?>.UHH/
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M%5XMUJ^CV9Y*)#^M&6L9'?2IM3JV6QN\-NL(8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M]O.#A,>G=2]DUP4<,1)=\@0C-_\ 2<*FJJW V[J2',<X4^/\TU&97X8(P7<
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MJ#O'0KH@]SVZWNNN3-#V-[GBY$N,:#NJ0W/AQEN-Z4-R-HL(8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M_F4I?S+439Z-U\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MF&B3*CCY<ER(MY45IMQOYC*?X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M]MQA$EQKY)2RST2>U^]W:5%L@X_P6Z-WVA;Z5.Z%4(5RH,J'6ZURSEW-NT6
MY#M+A>*.L+LSGW4ARH<2.WIU9-+L9[;#"=3%$BW./^KP_:>KW7GM7YQT9FK5
M21;Q<3J\^M&HU&,6"@F  *T EE) F.,'SW"1Y6AC>I<A^:T.FK<:C?10EX;D
M4^"_)-QLV?EUE=7O8PR($+*V"+-BA=J#JK54Z=;.OC%:C%WES2G$XW--13[3
M*5;3-."VF-N[E?%(F]64E^Q;19/)W9._5?DESHECH-?:-50#TBO%(,&XQBE;
MKMK $03Y=FIH,PID&PH@R%H<:BQBK#[29+K#:9+@G+DS?=M>#R:*+.<Z/#K
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MWV.,)W--0F5J,LWV+&@+?4PWM]"MOJ9;VA:B1G17JJ0]V('Q^P<GL5?ES+&
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M>;:F[3"8!B6_MXVF-H3&CH0PW\B4IT7E5Q AXFM=L42GQ./6"XT URZUJD;
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MR P/E:7O?W$)EMASYFT)3H.21XAQ\O=!_12G,Z40O L-^ST"S3*\-D%(X5,
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M>C(&V.Q_<+*F%EA-7A#R$MYQ4Z; :TRX]M*4_*+K8/"& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@4W:> <GN$2RQC%8<;?M=^"]3)F
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M6_2F]Z3O?^36][P<-D(XKUOKS_(&2;OY\7ZBVEW[6XL<XZ$WPM"MV?3S&WZ
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M??:7 =W)AI6UK:5*2M(X8/K7*O<4^\EOZD+/X3KW)8X^M!Z77^I>=NGVVZ"
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MLUTPG^/.90[B;03[)'Y;Y?Z33^AWUN,F9-A2'+.:[-8A4PU&.NM2$R2<&?\
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M91>G=0?U#>AUMFP/R&=;?BZ?;^&]E^NK1NGY)N/4F_6VO2>>=J,\PYMV&E\
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M  S'!^/)^F_XGC^D'XY?]5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO\
MB>/Z0?CE_P!5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\ #,<'X\GZ;_B>/Z0?CE_U
M6V?\,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_P")X_I!^.7_ %6V?\,QP?CR
M?IO^)X_I!^.7_5;9_P ,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_XGC^D'XY
M?]5MG_#,<'X\GZ;_ (GC^D'XY?\ 5;9_PS'!^/)^F_XGC^D'XY?]5MG_  S'
M!^/)^F_XGC^D'XY?]5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO\ B>/Z
M0?CE_P!5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\ #,<'X\GZ;_B>/Z0?CE_U6V?\
M,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_P")X_I!^.7_ %6V?\,QP?CR?IO^
M)X_I!^.7_5;9_P ,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_XGC^D'XY?]5M
MG_#,<'X\GZ;_ (GC^D'XY?\ 5;9_PS'!^/)^F_XGC^D'XY?]5MG_  S'!^/)
M^F_XGC^D'XY?]5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO\ B>/Z0?CE
M_P!5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\ #,<'X\GZ;_B>/Z0?CE_U6V?\,QP?
MCR?IO^)X_I!^.7_5;9_PS'!^/)^F_P")X_I!^.7_ %6V?\,QP?CR?IO^)X_I
M!^.7_5;9_P ,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_XGC^D'XY?]5MG_#,
M<'X\GZ;_ (GC^D'XY?\ 5;9_PS'!^/)^F_XGC^D'XY?]5MG_  S'!^/)^F_X
MGC^D'XY?]5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO\ B>/Z0?CE_P!5
MMG_#,<'X\GZ;_B>/Z0?CE_U6V?\ #,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?I
MO^)X_I!^.7_5;9_PS'!^/)^F_P")X_I!^.7_ %6V?\,QP?CR?IO^)X_I!^.7
M_5;9_P ,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_XGC^D'XY?]5MG_#,<'X\
MGZ;_ (GC^D'XY?\ 5;9_PS'!^/)^F_XGC^D'XY?]5MG_  S'!^/)^F_XGC^D
M'XY?]5MG_#,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO\ B>/Z0?CE_P!5MG_#
M,<'X\GZ;_B>/Z0?CE_U6V?\ #,<'X\GZ;_B>/Z0?CE_U6V?\,QP?CR?IO^)X
M_I!^.7_5;9_PS'!^/)^F_P")X_I!^.7_ %6V?\,QP?CR?IO^)X_I!^.7_5;9
M_P ,QP?CR?IO^)X_I!^.7_5;9_PS'!^/)^F_XGC^D'XY?]5MG_#,<'X\GZ;_
M (GC^D'XY?\ 5;9_PS'!^/)^F_XGC^D'XY?]5MG_  S'!^/)^F_XGC^D/XY/
M_DQ;;_\ X%[QP?CRV^_$Y[S[CZ\@>GN1>I:%2Z-Z6\==AUR/J6^<2)CE'L;D
MM!AL<8#QI\\K(A2$$*T08>TB4]'>0VT^W]/3NV6HGRR<YT=O.&3 8# 8# \[
M7^&=_P"1ON']^+OW^Y^<Y=:^77V37TIZ;]G<_P#R!6H!S@U:9?%JN4X[4Q=5
ME!J<3YH<M_0?/O=KJ%YP6%LT=73W+-UKIU,"#!5BB6.(*"S5HB2V%[FM)5"9
M*UXA>T_1\+FSUBY=ZDOG:P=@\R^>K_ZFZ20H-"-2?%_5.B>A.64?K3U;!USG
M8J)6"=3Y-8[B2=IIZ,6EUMNKLD);>V=2/NJLQ?<?U/UL5Z_Y7R?GWI:X]7\6
M$H'GW]?]*.#^=WLD[>+3>/40^N\]DW"I\^#UMVJ=FN5'#U8G9VV7_P!,;'0X
MB%,2BZBC9)<\J@XCW7T[V;R1YRZ0Y["ZW$ZQ=O5'F_DG78=!LOGZ[3 %9[18
MJT M[!ZI[\Q"WN/V(1%=EO0Q,Y95X4YOZDF7*0I+:(NYE;R^AK3[2D>].0<7
M\[W*UII->XOQGI%[<,(Y:QSF4,WZ)F5KKA7J2C=.D7:SE;+R$+,AAQ]1E"GX
MIQUB4ZIB-I2MDXEUH\"_(#[@!T2IGK@#,D)5N\P>KT<E_0((NV6GK_>GO67)
MN'<$)&:1"YM7/V-,5"/>-Z9$LS9D8M V\^_O2FOG35F5 NF^U_>#7(N2BZK<
MNRBNJ\, ^SQ7HT^3YKSZI'R#G KSY[7S7NO5.:F^;6[1BLR.)]5:LQFI578H
MB41*EH'R6UQ$ZT)GJY79O<'O\ ,]<T2D72S3"MKOOIGKOG+K8SE]:G#N4<(\
MC7/HX?JE"C;=K4L,9DV9-9I$>O.%&B,^6S=Y3K;[FXB%)$Q<5V_(+ZZ%];]8
MG:!7.DV/G%BX_P"FJ=Y %%>-(>H;_>?*%+'$]6"J6B# 9-]"F]7*";])V(?4
MIE2*G C0]?/+7M<)PS=G],D0UT\*5WE?Y K/U;C_ %.S]6>[#UVS]"X-1T/V
M<*+\[$ ]$=N*?/-CK[+T=%S*2F:>U"'F7WY[L+]2B:BMMLDG?$GYWZ?[OVXU
MS+A\7N-S!=.K@S\C,CU!&H];H\7H?+5<P[0P)\TO6R!8*+8A5,V1K:V8X;4B
M#\MA'O.2$?=?+N0@3.JAX_JGU]3N1\?G6+OW4) GIWC[PAV3M/6K'1.=RC7#
MVO0_HI54]!]+K\0/S$2&'QN?<\WMJ*T2@SV0,9>R$Q#^HZU[+,718_;G1ZCZ
M7\^B.,]3ZKZ"\A\K*\PYWWSL/[#U&[4_HA?TS;K94@Y^X]BJ%7!BAB^![<J$
MIB0&CLQRD4T_N:IY3?U=DG'E54SWYU*;Q'R/=W_22#EPJ?6>DUGU#P_G)SFM
M2].= */=J8IG,Q=&J5FYQ: ESETP,]IPO28S 0L=$3$36)J51-_5JQVJ^D_0
MQ%L5P,GP6\,D8Q#WCS7SYU*37H$4XTF /M5DJ_5Z,5W+'3-#7AA@1N'-?9^D
M]%>94E+R-_'(SF?\=)=7][_D##<RKU5Z';K8BS-^2Z7WJP]QA\I R6?ZG>_>
MA_,(A_M&@D2I+"HZ/YAY[;.@B9XW47[+3(B,6F07T*5AJ97H&\R]4Y):0":!
MSOT:1]*D:T&;M#U^,D*[82Q6K6&UVT&$FNVVD56K4BR0XQBJ$AS#\-I;RD#_
M (OJ6K?U7#.MI,(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8'G6_#U_F?D@_.VVG^1'_FKH;OR_P#9]1R7V-2U?_'5O>&OETQZ
M*<,F P& P&!YVO\ #._\C?</[\7?O]S\YR[U:^77V>B7(R_"6VT?/I#:$Z<4
MI;FDH2GZBU:UI2U_#6OF4K6OY=[_ )=X']0A#:4H;2E"$)TE"$)TE*4ZU\-)
M2G6M:2G6O\FM8'ZP& P& P&!^4(0VGY6T);3\5*^5"=)3\RU;4K?P3K6OBI6
M][W_ .QWO :0A*EK2A"5N?+]1>DZTI?R:^"?G5K7Q5\NOY-?'_)@?W>M*UM*
MM:WK>MZWK>OCK>M_R;UO6_Y-ZWK )2E"4H0E*4)3I*4IUI*4I3KX)2E.OAK2
M=:U_)K _BD(7M&U(2K;:OG;VI.M[0KY=I^9&]ZWM*OE5O7QU_+\-X&%KE8KM
M/$M :J#%5P*S+*3VA06!&&P$3CA2:<-3=18C;3/W98T1D2Y+OP^=^2^XZO:E
MK4K89S>OC_)O^76_Y-ZW_P!N!^4(0VE*&TI0A&M)0A"=)2E.OY-)2E.M:3K6
MO^S6!^L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@>=;\/G_J1_G;_ +T] _\ $]BPUO3'HIPR8# 8# 8'G:_PSO\ R-]P_OQ=
M^_W/SG+O5KY=?9Z)<C)@="M]\]^AP]X]'?U6'O4(:2Y[^\5"N062P=![IU:K
M5KA\]/GRZ=>M-?IUTO9"LGZ( O$VPN%WEZW&899DCW7406UQM&LG_B54GTG^
M2(EU+QW4;E0T52OVFIU-WL)LQP_IZ!]ULK7;.A43IH\DY5*)=H/)C4#DM<"6
M8/HH4K8G[DRIQ<F;$1N,R)C<7\EK'59/E8DSQY/056A76_/>R_\ 5DQU:79M
M<_1W&@JZ6IR)PZ:-Z[+KJ:)HALLU7I#)1P;IY+"TKWK>B9U=<_GOMWY(:B_Y
M>YE:*EUMR(S-Y8&E(Z#QF]W>1VZD6CT-UBM=HO\ T7LAU+9GS\OD'"1%>/UP
M-;'6[/+1-98)**3''$HK6YB8\K]%?DSZ>4-U[]E+?S\+8_2'%*X"O-^\W$6[
M#SGDMN"^@7^OPBX1<2IU.=,H1;G=9CMDFI!H; >/M:<)%$O-:U$X6CXQN7K;
MI?M?HUP[X,Z8#K0KCG4J9JID>47'G7*N?V</Z?+0Z;6:S:2SFZSV4L7Y ,%F
MDV*%]?ZD<@XA+^D;5%BTV3A9/L?N/L?G_H7F5/X/5#9&D$ 7,B@R(-XO8.A@
M.NW2P=S&U'JO/[WTX;M8?@@3G7$G'++%+3UP43)#B_E>D:B*@OQ,DY67^/OG
M/4Z)4_1I3L96TF[E?/9/IJR0REO!DP!*;0X'33-5YM,'02!,@QJJ$*37X4D-
M]HW&AH%OL-LH4A"75C77Z5B>I$^HNLOTL;Z_D6]'K;L4LQ^O/=LUYA*>+4^5
MV$@!()HS/C\I?L4WM&F&ZVFG_3M+953ZGG&XGU587B!#N'Y-:7R&.9$5 X"
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M^7YM)WHN;N=&C7\!3\1O[EM)_P#QWZ__ /M$POV^1_ 4_$;^Y;2?_P =^O\
M_P"T3!]OD?P%/Q&_N6TG_P#'?K__ .T3!]OD_O\  4_$;^Y;2?\ \=^O_P#[
M1,'V^31[_#AU&N44=^3*H5,4R%K=2][7RG5T6PY(=:&5JJP-"*^+;=E//R7F
MAHUA#25NK6ZO6OBM2E?RY5^7I_'I;R,&!YUOP^?^I'^=O^]/0/\ Q/8L-;TQ
MZ*<,F P& P&!YVO\,[_R-]P_OQ=^_P!S\YR[U:^77V>B7(R8&H9_Q!Y-LPPF
M,)<R'Z:^E<&GIHVWW0.9!2[QVB!Z3L98.=%6B&7J]B5VL;&LT0C#>C3ALUE'
MVCK#.M-X6ZB<[S9XAXFOEHLM30]?G6FZ<OH'.WR)^_FS%HO]+ZE<?4'/4D"S
MIHH0,V7?6$&K1)*E77'2<];WW\A]*TM*%U4SPK\7W)^BVL'+D<_J%[\RB =V
MN:YYV_M0^6P*_%Z-::[*/FIA!VM1YZ8WJD_(BP7I#DN7JT)2AEW:8B61^E02
M4?AU!T!RXS+/6JUS"V5]?E>Q529=.YURK%V>9<D:#:J73>12BT'6KGS[BK;#
MJ#-B$(,C K<:=J8VAJ-(07]-[:WY2\Y/,<1M<--JO(_E!970.0%[;W#J_3 ^
MK'989)(V^?4MU]L(VXGM"[-):%$IOWKT2'+^G%6AK3:4DNLOUOR7YU[,?*6O
MH=0><NI37.6%7:OWF\4.["I',Y5]>YY(K-JI5HKQVIE!.^H6%A,@:_%D3(Q:
M1'?6\RK3>AFQ,>2\ XEP511GDE'"T/1.L\^K1.*)ED=L+K'*ZZJH4*%J'/(2
MV(D:O $JCI<;0A;^_F6^IUW>UX12*/Q^^,5S[N1?Y) *2>K1NBI.MF+YT0]"
M5$ZQ:6+YU']AQA>YSAW/F;[:6VYY?=;:&:G.)3];YD:2G"W7 L7GWQ>0Z%S+
MG$B"_7>DUR+W/OO/F:7T3JM'/ZK]XZ=6[#WXL_;J9: RR%.M/3K>+D%@LZ<X
M/?D.,[1$^DQKZ0NL!>?/O@[D-EY]&O+\.@GNJ^E1]]X_6Y_8>E"HY+T$9=N,
MJ='Y34&;JD97XMR<Z*<W8 X>)%!F4FGTDX[R'TIV,K@G_/OX_O#]/A=;MU>A
M\ZJU&NM)L=?M%CM/5;S(J9FE5F]5'G5>J<:6;M9D=2Z)4[_861-<@L_H(F+.
ME/-Q&M)4Z@7=6&'J'CKCOG3KG3&BPO7 .Y@Y75.N=/L-\N=]:Z/6[U2@=49L
MY6]FSMAM1<<3H+ X? 5'E;^2$AE$?2=_#>QSN^6)YWY@\7W:M\YZ?S^I//4@
M+?!G7Z<PY:NIA:A(Z+4 M<YO7;L<H5D.P!A2Q503SX?"'/%!ZW(FXOU&=:6Z
MXMP76=I7@KROSDO1B--I5@!3.?U)%(!0&.M=:=%D>>CR]B+@Z/<@$N]/B>A4
M:G3;B1;"BSK!$>&C3%1HC3,?Y6M"ZB_$*WX:\CT_O=KY44&4*I\Q+UKG?=++
M9+KT6SMUB=S>G@I%%HSA3H9H_*2/J=*Z",A!!PE2XJ(\R-!BH4M"&4#G4@XI
MY<\<O5GG5_Y!S"+# C2'/;I09TA?1PTX<4Y55+CSF@SW@5QGPC<*96*M=#$#
M48A%0I6I2E2&UNH;6@;N^KB$O!'$[5Z4Z+Z8Z$R8O5CNC//= ZJ1-V093J;.
MH7/[KSALVW6P]@AURTV&6!OQ+40@3@/S@RI#FX#S"G%*P7B)(_X4\NKLW.[A
M&YIJ ;Y55N;T^E-0[9>&:XR*XS%*1>./6>FHLNJG?S'*-&I:Z^0/0R4\6\^I
MQAY#GP5H75$<M_$[Y'Y]R"G<R-5VUW:P5D%3@\[K+_2NJ5GHQ/=0I5DH#<8+
M8ZY?(AF@TPK6+L<B2:P#E0J\XP8EH5$5]56]B[5SV'P!Y1M)-)@QS6:X1@ >
M=5:J2(=_Z,+_ *MJYR<V LE!!\F;&6R(URH6!/UB#,2S7TCFWGX^E.Z7\R_F
M%U:G'O,W#> B3 /C]!AT@6?!4ZM%XP\O8IFY86@5=JF4^%]P6,$)3'Z'664Q
M6W&EH=7K7SN*6Y_GX2N%R[RUQ#D$'I4*I50B0=[&Y$WU0UT&YW?J]IO\4=74
MU$0)M%MZ?8[=92P$)54?IT& [*W#B1-J;:;3I:_F%0_E?ASS!QF;6"E"YN_$
M,TRSP[;5CQZ[]!NA\(2$\T-\;KT*(;N5J/%%5BI\ML<T&'#..K$B84A>HD=E
M>_GPMU8/4?-O#^QG:C<.@<SIM@O?/;"%M] O4\ .?M53M-8_4G*P6@EE,ZDR
MV0,TJ])8@RE/C]R%:<6PI24[T2HA,\@\:L'#N6\#O,:WWZK<C?J):K6.QWVX
MM]%W;:?#E0X=VF7X&:#V=5F(H)3-2W6I#33S<UYGZ:6%_2T6[U93EGDW@W%[
M<,N_.J;-#6 !RL)P^JNSKC=[+ IG)0'Z$N#0J8(L]C,BJI7W9-8'R)+4%EC<
MN5%0\]M;NU+4+K62W?BJ\J&ETY%2"6KFT0!U0!T8\W4NA=,ADCXJLBNWM!:
M!L+%XBGN85@98^]&RT?5;D#E,/O+:3KZ3JDZ'VURJ7^+/R;5K5U \2ICUE W
MN&Y6JQSZ2=MPJA\QH$WSE3_,1>K5>JBK0P =*E.;UJ5$58G8NK$U%+28S<Q+
M6_\ .%U:Y7P%Y++E7C,CE6XTR>UT2)8$"+QT8'!N0CJ[D.3?:W?!H>W08%ZJ
M1R>/8E:$%FY@V++;^M'8:<4M2A=0Z1^,7Q/,$#PLWDA.;%@R#3TA^7U;L4@E
M8(UE%\X!V<)<"CE^W/N=7LH+D5;@D!)1R6-EPQ+++C&T;6E8NK*1XG\YP+Z,
MZC6Z65IO011ZW69NQTZ_=$K'ZN7NU_(]5.HN0@);((2^@%])*R#+ <U'G"8L
MI]Q+,9MEUQI0NKFY!S(5QKF-)Y<%-6BR#J4!BA6K%=CDNRVT^\U\[LTW83<U
M6WIQ4K.><?=VG3;*%.?(RVVTE#:2+(P.D[N+_M6D>E/='<>7U>[W.L<TY7Q:
M'PP$8LW>"E<T<L-27!Z*:YKP2L&1G)^R[J[,N06)QGD.'%DH+,6&M#KVM;-9
M)F+)\M]B]R]6ZKRX)>%O">)0!_HVR&>G6+SG9>?V'N59H_3*=2^(;F [(6$J
MXB<O%=M1$L[#D#U32,4"F3'BQ8\E>D#<S/ZSGY0W/6=JIG-.0>00/8/VXLY*
M\=$/WOE-B$T558A<GJ$@C0JX<NME)@J\T-O'9#U<00#[E_>&JY +,-,NHT[K
M0R==:22_R7>G[7U[I8P$+,4@6 XY-F5OAR^($3G6S786?.?$>GG:%6HY-V*]
M,Z+R.Q]).$;4*FKTZS714'[0=)D+D:=$R.=1.X?D]NMKYSIRF':58[O7'N>V
M_JY#A_4B]2%!ZMT?VTL+?(O.; 7I5,#';16J%19&YCX<=(?0?C;>9U'D0H;(
MGQ]G'M?IS\C]TYS;7YD3H7*[.'"^%NK3"'-O,5Z/0N>@;-<N.PO1_-K!7;0#
MA7.V=%$:.GC$X=7W+%!>JD%4=#L&:W(TY5F8[BO65WZ?1/,'6;+Q:K6&^=E>
MI+@#E@&MBGG2LSHMT=AU&GE783B=Z&B05@.L$23\E3<> /BOO2'&VFEK3&<Z
MNA%OH?Y'^*.<U L5KU,[T#SZ!]3<U!2.C\]N'I*'Z-U;.C>9^@>:JYTB^4 W
M/H#%DLE/,F*[*NSDYY@"L+/2X]'<4_O#7&MJ$^@/=YGHO,IYV;T@-5J+[7Z5
M1NBO<\\TVPQ0.E<M,\5Z"?Y56ZW"L0NJ=":"CK>+'5LH8+1F!L"V$&I7ZS('
MMM[T3A2-?]1_D]N ZI7!/(;S)L0N[6@35#QOAW6@D:)3K_6/+<GY^@<X$3:%
M6+$3H!FY6^ IQ^+)CQWP;Z(<YW[:1/E%GQ=VODZR]ILO))/]?T=6^CUCJ7;:
M ^<W3Y%"1=ZKS_KMTI] Z&S5'Y,UH8Q?*,&'E$;CO.0W]2OK1]_1<1K1G9Z-
MEL(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7_\ F.=<_P#EW,K7RZ9_'HWR,F!YUOP^?^I'^=O^]/0/_$]BPUO3'HIPR8#
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M2);&FXZ"7$<G>!38_E_ENCUL;S)PSQ'S?WGA!$M((6"!% &^S\V#@57>H;T
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M5/LE1L0!KIM0-2>H?+8GR[D\Y67+N(='NM$8?T1KZVFI3FOEWIX3&?YMZO\
M373@X(?76>:S25LLW,!;O1H_)^C[J?/B%SXEUWIO0><&*I*O42>7N'(;+0!
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M/0I:HKCR8DUI<=[:'D[1H19> P&!&)MRK(ZVU^B3"S+-MM06RV( $^E)<DD
ME0DUZ'9"27&F%QH\87+M@YM>W5M[6N6C2-*W\WP#Y'[Y2JH:IM;LUK  3_1#
M,VO40,6*PX!*WG1H,E99XBNPY+K;Y8A#KX>5,<:9TM:(["U[U\-8$LP&!'IM
MLK@ZR@*=.+Q(UGM VP&*^%<4K4TJ,JK@1JQ3(J=(VA3(ERQP=.[WO6];DH^'
MQ^._@'\LEMK=08%2;,8B!F#EB U(2[,4I*9]DLY%D2 #L?(A>]RRI*0AEK6_
MAK:U:^.]8$BP& P&!J-VKWOXM\Y737..Y>G>,\PO^A$$\[3+7=Q$&SQ I1<A
ML63GA=/N$!T(HJ([]LM]MO4C32]M_-I*MZ"5<$]@>6_4C]EB>=^^<M['.IK8
MU^UC*';A1PM7HIE4M B:7$QW_P!1@CRCD!]$>0MK3+SC#B$*VIM>M!L?@,#0
M>S?E,_'13K(?J-D]G^?!MCJQDE7;$+WT0++>$'@TMT>8#S'(+TF.V1$D&'(\
MEGY]K8D-K;7I*T*3H-J>/=KY%Z"HH[IO#^DTOJ_/BLHC @V^AV =9 3Q 1+<
M'EQBYPQ]]N.4%3F5,R8SOR/QW4[2XA*OY,"S\".7"X5/GM5L5ZOEF TRE5 ,
M1L5JMMI+00-<K8 1%<FE#1PT3?C#A8L=#96Z\^\XAMMM.U*WK6L#0S^+E^,K
MY?J+]P^=66?A\ZI,CH8F-$::^'QV^_,D+:BQXJ$?YRG5K2VA&MJ4K2=;W@=@
MXLH,.#!QL(1@& QB!$*"2PN7'(#"@PA';EP"(Z?$<>BSH$Z*\AUEYI:FW6U:
M4G>];UO Y^ P& P-20WD2J4KK=F[+S:[=!IEFM@:4)*CI-H-W:K_ %C_ %S^
MMF[E8=;NQ0V('S[;*D2A^],--M#XTI:XB&7-)WHM;;80P-4N4>3ZSR:G7&G"
MK;8BL6X\IH7*)4T@P*;E01M!J!JGP2\5,6*TRHC/BFEO/)6E36G4)TE.D_'6
MRU&!?A+BH2H<\HP2([7Z_1N5=*Y=/;KH\,&GW!/5*!3^<6:YFR,> J0FY*KM
M-CH;EH^.]:5IO>MM-MH2+K7VT?CRNYD\!D,]JCNJ.TR^\ZZC<ET*O0B#U!*\
M>K/%ZO7ZK34_>!(AK]FX,Z5,+JDIVDF\A28JQZ4#6RU99CP""GSS:8U^2_5D
M$>B6.@5"TTF'8HE1M?5W:H]<2QDU$/U^R6R/">J_UP*42ADX+,DZDIF//1!Z
MHA*X#/X]8LRS2++<N^=0Z!/_ &.&5"$5MVH1:SH88G<(+%79YN6_(B28T\SP
M>+*98CP8:FWS)!R2Y,><:=:%;.WGC)RX=PX[V")T)T$/Y(.N8]-)15AQ&/9M
M7N+#@G7II^1-:(#E(B"HFHVF&_@TMM:E_4TY\J!>$"LGE&.8ZG"ZB&OY2L%/
MZYXW7RL@:'819G66J7R*E%.>!K5#)#GA]#N@WC\-%@@38Q2.49D*UIME^/#D
MQQ6&Z]XFI'8-WU1>VV00[?;Y8^A2GQ<0(IX<8.^> 7GN.Q&5,@OIEP!(VO1R
MJ6Y&G$R)7S,/:7&5MO!67YEY9F\]ZE"[')Z9(L-U,2.L2^H?&HCA &Y/=.C\
MHCQ]5X5&*2'J0U5&N,!&V?C()N3&_N=R%K>?T\V*H:[^#+>]=C'3*;V"62O=
MA[!S2WH*WH4V69JU.I?;CW9=C_H2),[=HEA'; L.,C,J"Q&0L:,TC3,MM<YP
M5P OX\9\:S/@R'3I2>0Q*;Q**N)%"!5W&ZW[F)SN-NDV(D1W"8CT\4FZ=6;G
M(@0DR&7V&?M$?:M:<5(%6JYX2JBSE63^VY-WGPX+Y^'W&@S*V"EZN<[S1!)0
M^;/M'E:;=K869N>C9H:Q&>9GHC);97$0],U)%0F'^-J@CP?*ABKI.N)#G<CH
M<0X4ZE6H-U8Z)5NAD^>N.A[*(@$JM#42JE8Y+6P8J8K;["1@SY)<66ISYDEJ
MZ.!>38?"K88L3/0C-M@;I"N9T\&0!!1>JS1V^AW3HT*,1+P-*)6FPL$KO(C.
M3WE,(>C1V5;83(W(?D$W6L9W\;;ZZ73*FSTXE;98(EYYYWNPSA@*DS1/FCD,
M6_5NXT);-=%36;*<Z;SGJMF!%9*M06Y+)5EQ"&%0TJ=%;8=F\N"NQVLA8)=O
M( !A_EC/*[(!B!ATY$T:*Z $Z)72@R=*<1^E3!Y,;(C2&G&93$N)+^&DM.-)
M<V*K-'@JC1^T0>R,GVBLURX$K:? V^KQK$/>D*[19NZ5MRK*CE@K%9-5BY6V
M7]*<_')_.A$=W33<IA$C!4HZEY(E=%Z#=[\-ZA+HSMJ&\_<8#5^JL+%S+ES*
M]<WOU.NG1(<@[H;T,C79_-FH$!>XPV?'$$ID-4QUK[3447B("=\$,&3<<VCL
M!J*]2;U<NF<4853P<EKG]TZ+W>I>BKK)LZ_O&9'2@L^_4]AB)$D+@N0Q3KC?
MUW9B6)S(K,+\(5R7:.K7,GTBS2[#W5_GT_K2V@U?CB[(5Y>1Y>5IL\:+<CRM
M5S0N709Z%,L.*;DQK#(1(T\Y%@O,"DSPH#=MYTW"Z788=:OMY#7KIU4= @Y;
MUEF4WT=?/3M#@ +%O3$VFQ ]]Z#*CSMM-2EDAS36M;CR?GDK%1>-^.FKMQ(M
M5E=6N$GFVJ\W!*55L'68QHI9'?)$SQH2L>KIJ(Z0'1)?,'FIC8]AA#<<RTIW
M3BH[GVJ!4JH/A6ITH600\6JA<X3Y7U'E)5_?,1K-7M WID3DHZ28N]7(6 U)
MM!&,)X\.A26U$6(LR$M3"&X[+4=#0J</^8CZ>7\5J<#L]E<Z'PJYSKU4>G6D
M0B[*DE2H+H%2FBC5=L!EZ64K@^H=(FCA:'RKA&$U%AK<FR7&G52!60Y-Y,I/
M(N;WWEH2P64C7+[4*I2YCQ%8[1,>,JO&ZOQEN1#D1H34?<X@)K"9SFU-?1;E
MOK2TVAA*&TBJJG> ZC9JENLWGH%C-OD //*]8BH02)K3I6%S[C'1>(1G(3/_
M +N'0\@M6^C293VTO.I;G-:VTE#*ULX*V!\Z<)'^?J/,J426 *SB9ELR8/ J
MG^R"SDJ)7:_58,XU#6>L;Q RV$K45ER2J3I&T-(:9988::90-VK]PA@,!@,!
M@,!@,!@,!@,!@,!@>=;\/G_J1_G;_O3T#_Q/8L-;TQZ*<,F P& P&!YVO\,[
M_P C?</[\7?O]S\YR[U:^77V>B7(R8&G_/>:=V#=@Z]UJZ#^2%+#>#U/J53+
M#KA;WM5SSY4+>6DC*8W79'/!R1]L9#6,H:ES/U.<R5L4_P"@K[4?&B_3+O9N
M!A&'L.CR@!Q-64+19U!R>JXLW]SH*D]N$_H0HON$V[,T+20^GN1])*G?I?-\
MNMJ^&L#IW)^$^R<PA\\J8 B!]'4NR]/Y!:.CU'H*VZ%6I]LJ''.SU'HEGO+U
M(IY".0I]]<E5IQYR6-,37S4-E4II]#FW&C5Q'@G@GT,;3T&HD;&$$$0==C\_
M&]^)VN^MWWH(J9X8Y_Q:=5!8^+'DNC.3ZZK+DG5S?U5)']6!I<W"5+5J<FEQ
M?-V\&6FR=#MRZZ3IU%I1">9GTZ]U@Q9!/3*G47//K'+*CPH?6QP6* @\VI_5
M8K%[:=:+*;=)1T:V.3*6[.5"HU+\.^B3=IY59K)T7G,TP(!6<]TRQ#5%1\TC
MTGI\#N6NJ@0C<VFEK,1Y9/F]-"Q@D+]>#Q1PP#M$H?.><8<CBXL.R^-NC&K;
MR&2LK1"HBET#S%3W+.1+66':>7N\/N!*P=31R\'' RQ9D=Z)K$QJNF?NYPI:
M!S.DRDD&/IQ6ZE1^=X"(0N7^8*-6QO)TEN'^<^[<*G%WV"@MD&7[-S@. >O5
M'W&KY&7*VQ:0BU28C^X#CL4F\^E_3K7T7H5$+5^.>X.%JS JMD%PN6 [(^4A
M\VKEV(\X16B!'F?GJLO=$KAU_F73EPKJ,M_*;!.;^RC#)SO[3/2FRL64[,U(
M+4WZKXO[3TWN?8.@+NU("U.^5&921C8F43!FB5:F%^!E88NV1P51@FI$X#OF
ME@:1.?L9-IQDTTB+#&IU*^L2\(K;_P =]Q2)-PN;V6IUN&8.7"8>J\.>2#B;
MO3M^J1/9.;\R-/DZG>@8ZJU/D[,RM,,N@R@\?I_[5F"Z.<>;V+W?>?\ CVOR
MZW+16.B,U&[IKT6HU>XS[?;+G:Z=3=^4KWQB94(]O0%J#Q 8KIUD'F=[BCQ+
M3L88P]IAF7%B):+6%_AT6XT"OD:3&Y-S9NQR.I6&D47GU@ODRJ<PN5Q%>41%
M7L (O^AU*8HQ76>$GG$D(\"$_$4=2F*E&ER5;I4DWX'O\/K=+LT.VCU\XIUM
MN)FDU"OW&91&N1PR?<K/U<*NHP?ZLKFZ0B$P)V*$+"!Q"K,N01J86Y3\"0ME
MF)7-H'@,W0+3P"R*9YI;4<EM/%+:6@%IMD86[<*WP#H''NM=,"3YH0\X]=['
M83P,VVX^AIXLH*A,R4P]IMY(J/WGP1T(@CI4"J"N+/![KUCTQ?&!Q<W:P$22
M9]!! R:EV4NP$IA#;75^!&H\]D.PVM[4F//<EQB8J7\NDBK+NOAR;;^IVBSE
MFN>VD->&_'$BZ6BSL3-W6V.>:;W*-VH#8A3 24.*B+V#U%=2M9'36Y4?[:1%
M6QO3NA4=XOX>Z5SCN'->@VR\(MP#GU7" ZXX-O1$-(I0^O +_5V:/!KT[FQH
MK;J,5@6B+*<C;M 2(F:UIQZ'+7!AN*+NLQ%\O=TA<&YGP":-XQ;*=PZWU*:.
M@EKA;AX7T92*O.L+#-:Z[7T\X+0Z<])@$X!:8E"[5"(6 9KZK.HSV_D)>:@H
M+\<1Q\57F.BV>JWDL,:$B)LXI,N,]M5*A>9+MR[5!C_J#KCLJKB^M&PYJ.S(
M^;4E@#$F2-;(L,?(*@(/QKZ8,G.GDE/T0/8A\FP56/T.Z&+">-]K!%. \%H$
MZKF0Q:K6,'"Y@]:JT<,P9DS]9TP>0U(=!.JW,5++<6?1OQ_6\6(H[5QM-<+E
MJ2GEPL$^DS99;E9J('T=V_HW1ZN (0@]5BQ&[9Q/IP^H?5A#A;4AD>IA4>-!
M2PR@FZS?(_+W0S?E#I=:ZNU,L?8>ERI]9;G6&R2:*>3S+G)4+0^2C"5EW6^G
M;#N6'G_.QMA.07A!4:3.%IS4Z(]'D/(V*Y]]\==RZ(QR$^0ZS1:U=.#\EY9
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MS\BZSF9FG"[\5<<>]-4M46-':VEO1A;6 P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P&!YUOP^?^I'^=O^]/0/_$]BPUO3'HIPR8#
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M6YQ&XI%GJU[K/2Z;681*4FPU E2AE#!RY2/N8D*R6><RM>EP-MI+,0ZE=O\
M7LZ4=.W@/8'+2^=Y%<8'(V.=74 /Y^$/>*[9;S3;1(239DVNODN[@G!CXXFY
M,4.)IW'>UJ4J+MLLQ%.@>O/7?/9%7J-GFU:O%"#Z;F=Z47XS9X50KE"10_.M
MBL\ZW"6S924 Y]0;)U8\-F&D.NO-2H(^,^M#J9CCHF-F/976O0%0L)BC\=(S
M8[UD\Y]@+5#5.YQ/O-Q#=4!TN]GZ_8SRI[<<!'J7U:W$@#OLWI<[]H)C$>5"
M=9FQ7&R9BKBOJKTJQ<[<%Y^ G]$!UWS->+6*,E>-W 1&L?3 /%:9T7GUJ$P!
MW^FEUGH5H/31/Z>Z1BSI$Z#*A1HK3D)R5($Q#.]=B]?QVSO(),XV/>BVXZ(K
MW1J1Q:]M%>P+&WSA<T;6PRZR6(M\]2/I5W.+?+)>?CS&1;C_ /[C@DFEEX3^
MH>D/6/0K1=J\"K4RN@97<N65.NVBS\>LFC%+I5F,]H'='@EQ7W ^ON'*=#YT
M'<;?W.*1H*CK+DQU_3S49 F,MYG[1V2W]WNUH[$NZ0@>J!7*<Y1A_*.D!JQS
M;I)7T%?:C#J.YBVBHRY%HU<V'D3S[#;;$<:]J?(=:&O,*9&YD=H>&3 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \ZWX?
M/_4C_.W_ 'IZ!_XGL6&MZ8]%.&3 8# 8# \[7^&=_P"1ON']^+OW^Y^<Y=ZM
M?+K[/1+D9,!@,!@,!@06X\OYMT22 FWZ@4R[3*K,60K,JUUD-8)%?G.KBNNR
M@[Q6'*<'/.NP6%KVUM'S+8;5OX[0C>@G6 P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P-$NG>[*ISJ\=-J;-!M%E%<
MN#4":4N(U]MP2;-VGK]0Y1:ZK6!PV&8/FS'.W+O!DS-1XKB9,W;@UG_V;8?T
MV7,;:<YZ/4^JU:/<:9-F3 [I,^#D-$Q!>O&1)^JG2-9LP [7S\(:;!FP-@$R
M8DJ-*8:=;=:W_)M.T[V1Q.O="B\CY/T[JTT9*-P^9\^N5_E!H3[,:87CTZND
M;"\,B29/QCQY,]L=MI#CG^8A2];5_)K>!KLGV?3J>+OCO>*P;Y$7YI(ICUM9
MA((=*K<:L7\*9.UF[QK+5 FG6JNJ/62K$QZ?!'N1)8UYO:%H7&<?+$X+^K^-
M02->%P;>)F2S%E/ 2*)_ZT%0 CU*SVJE6L@3D2@3D6&L1:J=/BH9EN1-2T1'
MWV7%,,J<P14;_O2CRN;>B>IUJG60G6.#Q.?2XKMB8+\ZD75CHM9K]E$$4Q+U
M7 LZM@&XEEC+_4'F9$=V+\SZ-[^7;>A$TB^LHDSS+<O1D/GILJBE$KB$G5BO
MDF;' *2Z3>9E$,V2NV\*/F,GN:,R(+I11N+!=<0&9>?^TV\TJ-@G,?0?[2XD
MQ'K;5LM88>3,UP382)2D.G>G\L$ZL <]8:S#3U^MUIJH2I%Q UJ7,"LN[B32
M3*6M(CZ=D1VG1-?F[^TN254Z)JP=BV74\<K]T-PU5^J6)5<&.U+DP#LT:#;+
M.X*W!K"+'2[2/>BR'4N,MJD?*_MM2%)T(Q=<]\>;27/VK[:+E+YZS%J;-KL@
MBY5.\ R%>B_H_+S,I"V"U6&S"3*8?8J^[%>88WHA&G?782MIF1MD367N/M[S
MQ4BKM9_;=@G;E_M-#'!&1QR/%DGZ]8+G3(P.<>=$J$AW;->.?EPXMY]?T9\R
M"ZF/MW6D_,)JO6O;1TE%H<NL>=^BW-BV]?I'+C;U0EQ3<>BC[EQ?F?8-W>S/
M?8P]QP@AKHZ8+B$)6ZY]@X^G7P7IM C?K"& P& P& P& P& P& P& P& P&!
MU54GT/\ D,]$?MY??.W,O&@/C83LO;.14[7:^G=M3THU_41U>W\8L=GL(^B\
MOGU@&U8K;19\J#!8ES5L#EL;=?V\IQ#87OY,]#]DZ9??17#/0]'YI4^Q><SG
M-D&"G&K99[9S2WU7K=+W<:D4$NW6L5.T!C8[<.;"(PGV'V=*8;?9D+2_MID-
MWL!@,!@,#4#V-Z!Z'PFL\?$\@I=/N_6_0'=JKP+G,7HMF,U+G8(X?JEZOI*T
M74M6Z]:+&L.&J7.26VHL&$M^9/7'9VXPVMQ]L-3>V^B?R8>8.4WGT)V#EGAF
MU\HY $>O/20',^J][@]$GT8,ZR]:-TEVU\GU6GK1##;>?A1YRV8TM]I+"WF$
MN?6;#MQP& P&!YUOP^?^I'^=O^]/0/\ Q/8L-;TQZ*<,F P& P&!YVO\,[_R
M-]P_OQ=^_P!S\YR[U:^77V>B7(R8&I'+.UWL[Z6[;Q"[- VA5-JE1N]$F?L9
M9:$:*C3]GN0$M'':.V2RP>D5P R(%)>L$'0MK1*<N/N'I/TUX7T;;X1BSD]P
M6$,$V4(<>'"R$]IMWYOIN.1(CTA"'/DWI7R*4WK6_AO6_A@:5>./0G5O0Y+H
M1V[U\16:H"J7GIVLP@S,-V,1.=*X11.Q6\GH@NP$CB6(\Z_MQ(L:3%CI;AL-
M*^HZ\M_2"[D5/S[W%UB?.LT^S<E=MM5G=1+\@Y^_2ZM8*!]/HR/070N0 :?/
MM73;%NK]$A/52G-GRI\#MJ()W]2(J(Z^XPG8BSBWO*M!WCCKW*.@S0ZY5T'<
MW*#B%(<5TTES;O-&\VWN)!@3;- >JB1?3^A#T17"RHR)H[ZLG6VU(TRH1\@/
MO2NFS3097*;Q"56;K4N;]GF**U"1'Y->+]V^V^>Z<*4AHUJ3>H)3HM.D;=EB
M$.MQ1;[$A:=N*>CLB.,[^0"GP:Y13Y?GUE%3K9T5VBGJ.\7"2.B\XCHM= I[
MA6^4J(Z\:KTP24Z:(V4ARD,('MR$;W(<^Y'ZG"-@N)]$O/4N%#[TY#K"+X4W
M?8<&(O9,=5=DZ]<;/6@WWJFMERC,%;0AE4E3?U'%;VO:-)^.M:(C/.>['K-X
MXK_HZSCPX^RS."N=6.#04&;,!1B\2FR+%.CBAL\U$(2AJ9496FF'B+3JV_@A
M4A&][<T6<QG.,>@(76K1>J<NN$:R6HL&HS]?KSP\:2M@JSB$SF;B"JGW\XLQ
M19LU+L<>3V[)B3'6'VM.Z>CO-I$4G.]YUA%TNG/P7-K7;+*"NU+H]3_03%74
M!O$^[7:_<Z8EQK00(P0(^+7+;S@BR72V_,>A(2E&T+FI?A,B(>G\E?/OT35O
M=Y3TQJD10J7#-BV_27'AUT>XK;.WLT..$;M"B)*>D'1R(YV>C2!J2?V_R/.1
M77)3 ^JP)OM=H78AU<)<7O34M+_. %L^T.4J:[4N@=F&F"G*J&Y'2<:4=(6!
MJ!$9F3(2G!XV26C)4\ZTB8]%$1"=^2#FLJ!5)U"YKUCIN[B_-="0*77-G"I(
M36Z#S"^7V0-&AEEILHO35==$!7H+B&-NGM28GU$;C.+P1.N+^K2_;.[S::'I
M4D!RI7,KK;:I:#3HUPS=9],[')Y3.*0H0\U)F  NY0F4XB(1AL2UM.QW/F2O
M;T=D3A7\;W@NHWCHE:ZKSTS%K /L71*-5N@UMP"X$_9KGQ/FC%F+649)LCIX
M?'I@'H#A8D05':87"%3/ILZ4AC[D3LN3H?J!\%Y3.^FZ%STI;6V(;)2J4XR5
M&5B7:0<N\QJJ*/-E'7ID& +/@Y"#4';F_J.0GFDK2AU6T)$YBEGO>_[ &.Z,
M]?YU8!]<YP9ZTJHV"L)#DE6&)RT!R<H0IKH>/8"!95M=G=.;C,R]M,#Y+S#B
M4[0A#;KXC9VG]WEVKB5IZ^]R7J0DG48M\5+Y?(JY%-[L$^B+)(5#I(LE%$2;
M,S;-CT["O::8^^3(;U\B%[4A(C7<%[N<*S+K)WR:5.K 6F^>9U0+5:_4RQ+N
M/2/0?2;)R8%SG6]3H$4*L;=@NHLJ=+4TB%MF5J6TP\REE8C.0O:$JXP[@*H_
M*;(U;^?T+I5BZ=^OEJHD+RP]2;1U?G(\;/5'/MOWN(6Z!Q\LWIP/M24C6VWU
M*0X[IA(BHZE^0\A86.,W6+S@J<Y5?>4RK1:3L!L0&,B"P_K/*^0D+7$"FK0@
MHS5&+1=B#>A#\;1[30]3CS;*M-LOB)].]R*,VJD5BIT4D&BWGJ 4'4;1:'!9
M 7>^>B.YC^'=--#1P4U^KU0P,L!.,Z.:)MI^YARVWMH^HA^,R(A,+\BTG<HB
M>(<=MJ*I<:OYT*<"KD+]-,73H;G=4^@K#"/E-U@I945X,[1.-ZF_9NP_OH+S
M;K;FG?JH^F6+3*>Y(D,#;[1&X=U1FO49')&+03M2 50_98IU>CU7I"F;Q ($
M9!2B!>=U*ULJLI,JQ&B"YNOI*VIK3LADD7OV'N37,8G/XP&GE>DV_J1DB(H]
M4 &*\(24T#I5@Z$=(R+(>(PZ_"@PJQ69"FE?66J3)<9;1KY%K>:$5;Y3]"6K
MT=8.U6[])6%Y$(*\JA<>:EPQ3)@P"N7$^?=>EGSST0\2G,%Y:.D1FUPW8T9F
M(RVTEM;[OW"DC<BA@GON^KE4$_:^&S@]-.@^SS;E $62L&S=5B\W](T7A0JX
MM$5G8$8J(E,V9^3)&1XSD_ZK"_D5\B&_N1&SW ?4H3T'8[P*KG/^A@J]5WR/
MZ!?+!7"4*H7>((N=IH9)08P_"8A))QS52??U#TX\YL;)C/JVE:W661N1M+A#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# U*N?B#S=<K+:KI^P,6H7*YA4ACUKY\XB
ME'Y3FNG >PK/?J 1F.XJSR.A5J)/?GK^=Z2I"D.[6A:M;+=6IR?BE:X]%D1:
MV<NA1)!).6959[&\60;LU@N5KOEINY"$VQ#%HM]IL5QE*FR8[##>XS4:,TTU
M'C,MH(F70:. Z=0KMS:U-2GJQT"I6.DV-F#+='S705J#S 99N'/C[T_"E+@3
MG--NHW\[:_@K7\NL#5&X> >%W\"\'N<[HUE)$B4^=8[@9N*B-MM$,C0R'-'0
M)2=+'/#X(6'32C\:"@;%@/#'7GI,-UB5)E//EJ<RO''!YUHZ#;9M<)RB/3[G
M6;U<8KUB+J$3S-6IQVDPX\85]SJ(,#D1EH)R)\6.EMN:2(2);OQ?=4O8K@5W
MQCR %SOH',ITR^7 #TZ/2(-OF7*WRBYJ<+YR)!@*8)8FLQX+,(>(!UR)&4EI
MI*YFD+=E*>D//O."[U7>2YTS+#W 0-M]ZK/[6SAD^//KYYMF72UB1H$9%B42
M.1@$P]?$N) (>?A?:O1)$B3*6ZVK[AS6R-;!'@3@(:1'TRW=I01^2T;MM2FV
MMYRL]$N\==O>C]$NL)F(Q*E6]F7>2#_S0GX,%3WVRU15;@POMRW7. ^'.1 (
MHYM!_IY4A#G%GYQTY<]DBQX4:X^(X5/K!93@Q,!-?7SNNC6$HB1XLAN7 ;EI
M>U)6^Z\+K*G?$GGRS?HJ3M:*DF05HJULBQI%C*[CR9U0Y*UQ85 )M(?2DD!>
MI<6/N5!=^:/)(1(\M:=OLMJ2+K&@/#/#JHY2MUENU"&:;RP3QU]K9B$9D7&F
M MVQX5NWF[((-6618F"%[,2WBT&; (SI!!S<MY].FT(%U??,.2TWD(LN(I46
M=%A&R 0G/1/(R23BY=?H5,YL-4VY*4I32$5:A#FU)U_(MY"W=_Y[BM[)NU9>
M P& P& P& P& P& P& P& P& P.G;SUU'NGCRL]&X;;/!_KGJK\#TGZKZ-7^
MD<1;\X63G%RI7<?1W3^V4LH'EW'T70;7!G1ZYT&/#(PIXF(_%(QGT)^JU])Y
MP+M\75WJMC[][2]-= XQ?N"5OO1C@@/G=!ZU+H*NG/#.-\SEURP6FP".:W?H
MU: BC%A.NL#65EG)SK,);[S+"'6=*#L<P& P& P- _?M,Z<7%>6NG\PYE9>R
M2_-_K>D=PM_-J,0J,"_V6B1N8=AYB<_89N^66FU(K8 LGI\8CN%++0/N8<20
MEEQ4CZ3+@:K>Q.T=[]<^8.W>8.?_ (\O:5/N/>J$7Y8#N'5&/,%8YO49%PTV
M(>M5W. _3=L.0JW7(<AR9*U!%D)SK;.VX\=UY:$;#NEP& P&!YUOP^?^I'^=
MO^]/0/\ Q/8L-;TQZ*<,F P& P&!YVO\,[_R-]P_OQ=^_P!S\YR[U:^77V>B
M7(R8%/"?/O% 9<\?&<RJ4<U9; "M)HFL6W)F2SM7L3UOKDUMZ7M]4)(*UR72
M<1ECZ3#!!UR0A&G5K7LMU<.$?)]AF2P]&D--OQY#3C#[+J=+:>9=1MMUIQ"M
M;2MMQ"MZWK?\F];P*.YM9_/0FX6;D_*IU!&VX"R.9M%5J$:'$<B?L;7JU4(0
MZ6H?';@/3J?6(P@>N(EQ<@;#U$:<;:1MK6PL)KG-!8&"@K--K;0@%:9%X##6
MP\%,(7<99HE9)-G@1M,Z:BG'SYB5-7)1K3JI,AQS:OF7O>PIF]>/_/E^'] A
M$.=@A,GJ10 4OQ@$/@1"MCV#O@'HTF#+>DQ)L=H?:;/76'C+;33>R2U+=>5N
M1\KR2W4F'>9?/PDG2#(WD5'B%.<,;8I<YH)'^X"Z_6"EC0\E:OF^_F1[(<G$
MF9$KZ[[!*;(EMK3(?=<6+KA,>5/.3"0:4\<H[VZX<FV40[,$IGR63D^17I<@
MC)E3ER)))U,JH!W&M25O(8<$0%-:1N%&VT+J:'X'*Z72X]-.0J[6Z-:BS-%B
M@=1TCPY0QT4P[":!,1H2&TIE6<V86G?R_+MQ]]6][UO>]X.7(J?(N8T7GW]4
M]0HM:KW-/TXH(_84:,CLUC0DTF0@J+T(VE41(Z>W+<2XQI/TMH7M/R_#?PPC
M T:I\2K=N,&>?C*A$M]W'2E%"8)QF9+*"**7T!G0&93+LEB&,K5@)J8>A1U-
M,L3GG-J;T]MS>!7MR\8^<[HA]$OG ,1^I]#KO2K(Y7X4,;(M1VLG#EH'0S<K
M[9Z3^C?M39)I54>*N-\I.2[+;4B0ZXXLMUAI/E3RIS.?T3L-CHE/B"F:*U!,
MO6$4*=J="YG2N4KYS/#@AB![<<566><L3(\A"]/JU&FS&T*0S)=:4+JUAW,.
M*7JQ4SNK'/@<RW1P(AVIVTQ59P2RP1*()#0+<@2<@C2H\B(@6":W$U.BMS1J
M)TEIO3/UGDJ)X?.7YOX-,"@:\KDU(B!:M9['<J[ $!(H-H-9KB5GG+@6@*#)
M@.L/VXN4D2"J=*^F1<>5N0ESXX6Z^?*^<\"&&K;TWDE/I$ _9C]S 6VW5L5'
MCD2!L+=S,:\!9,W327FD1NAP"#LR.W\C"RNY$C:5/.N.+)RK7L/%?+PZ-=I=
MLJH*G6CTS"L/"RMMJM6^]O5K(=;!/##\,8Q !6#;YLN! :D$)SD)UO4$.AZ<
MO<2#K;1>4X+$_-CE#ZAQ,^9YK(H7%N=AP_8:&7*B7!G.>;2J>\2")O,"0_K=
M=!2*8(<E1GI/TD[BQE.H5_H]JT.6:&<JX-=*M$)#:/S^U5.Y5XI,BDDB19H=
M::YT>N!1QJ<J>ZW)_68=UK N W*?6MS<Z,PU]12])3O!RE0GE]"!T21S,77(
ML:CRX)0=* [D3I#4F(:5(643(F2I3Q)YV8N4XI3JGMN_,KXZ5K>M? B#)\P^
M?4#)8=/)*7H80ID?GY&'^E(VT1J<2SR[O#&D/BO:IS\*YD)!=B8[M<UDG(>E
M(>2^ZXM1;K[L>:>!Q7:F]&Y+26':.#,UJLN-!V&U0 -A=GR3@M_:?A^JQ"LX
MK+E/)F?<?/,E/2-_Z=YQQ0NLNQP;BL;]1^WY70F-%V41RB6:N);1.90]6).F
MI*$1=(=0J32Q+JM;U_G.CHZ]_%32=Z)=<83Y\X@"L)VUB>6TN%8[)8H-M,%V
MPD14N39!QV5:HAAI3J'$P9C=JG/E%;CZ:TX3?<EKTJ0XMS8J.1?)WFR"%/UX
M?Q:@#15G)AC)ED8#8'2'R=;GEB=9EQ2$';!$6Y69IZ<H;J*ZPD?J8\B/IM#J
MTJ+=2DYP7C=DKA.I&N=5J;7#<H',-BMPML1S3]<KT"HAE&%17&'BK<.J#&!G
MR2%.-NCV]1W-+9^*-D9?H'(^9]4KD&H]"I%?M5;%3(Q 4))P4;C"IL2%+%L2
M!>V-LNCE_I,^1#7]%2-.0I#T=?S,NN(4.B25ZHU:I((-U:NA*XT5D0)9%D&,
MABV9DD57PM3&.OLPF66EJ'5BN0!['\GP:APF64_!#:$Z"!Q.!\6@MF&8W,*8
MED]+LLTLRX$AOLRW[E9!=QM6OI2$.ML1C]M"Q2<IEO2&79["9&T_5^*MAG*=
MRGG7/R]J.TJI":T4NQ)XO9Y MIR.V4)RIT\K-F;B?55"B/3RQ23+D[8;:U(E
MR'7W/G=<4O8JP<!@,!@,!@,!@,!@,!@,!@,!@,#X-RHSK\B,U)8<DQ/I?=1V
MWFUOQOKHVXQ]PTE6W&?K(3O:/FUKYM:^.L#[X'#20@+>5&1.AKD(D?:+83)9
M4\F7J,J9N*IK2]K3(^T3MWY-Z^;Z>MJ^'R_RX',P'Q_^C_)@?/ZS7SK;^JW]
M1I.EN(^=/SMH5\?E6M/Q^9"5?+OX;W_)OX8'TUO6]:WK?QUO^76]?RZWK?\
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MEMEHL.K4=4YA&V(C#):KD1XU]+R;M/:CSZ4//<YHG&ZV![A<S-S/R[47K/D
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M0T54U.3:I4YU"4K,-O#Q\A):E<;PET<!3I%0J3W,@M?&VGL)9^G0CEI$UCL
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M+.-AN51(^49IPRV6"90BE@GF"7VPF X0#QV!#SS3\1F5"@I&ST;>X0P& P&
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M(^HRXMEYOYD;VGYVGFU(5K_*E2=ZW_+K ^F P& P& P& P& P& P& P& P&
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MI[M%K26KST6TW9A6P#QNPN+L#C%@2HQ/W)_]VI?<F;IIC4C3#9A9^ P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MK++8C0I#;ZGFHJVOI*^;YOY%? /[8^R<EJ(8I8;-TNB! @089-%B4^U!68T
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MOX;U\=?R8'P8@08J]N1H42.YM.T[6Q&9:7M.]ZWM.U-H2KY=[UK^3 Y> P&
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M+ D:$,M19PZ+H6I:8C*G?G=6X@3LD]S]97LUP(9T+F7*K?6;H;[]R[A;H?H
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MCT4X9,!@,!@,#SM?X9W_ )&^X?WXN_?[GYSEWJU\NOL]$N1DP& P& P& P&
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M&_$#14PXZXM8 #JM7H^F4;^FAD171,:&PE.M:0RRE/\ V8$VP& P& P& P&
MP& P& P& P& P& P& P& P& P& P/.M^'S_U(_SM_P!Z>@?^)[%AK>F/13AD
MP& P& P/.U_AG?\ D;[A_?B[]_N?G.7>K7RZ^ST2Y&3 8# 8'3A>[%Z(HG8?
M3-KX8"Z%-KYAOCP^:5DU'MC(6DR%]H+B>J6&%6^BUOIR>A7EJC&MS()*E B
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MN(B3I\$-: [T@58A4>2^I,>;&<6S)9TEQ"MI5K>&4]P& P& P& P& P& P&
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M$HQ/@%=M=9LLRR56T].#(<,6>[F*WJPR*^^@ *^NX2^WC1X,DO#FV'M/N/\
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MG&''6UAJ=[Y_'[Y2\T^,_2'H7@U"M7+NT\4Y98^G\NZ%5^T]Q9.5&[TME!T
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M1I#3Q9QF1J'/Z@=<UIY+GS??;TKXI:9TV2KWP& P& P& P& P& P& P& P&
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MX[UK7QW\/Y-?'?\ EW\,!\-?'2OAKXZUO6M_#7QUK?P^.M;_ ,NM;^&OC_\
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M[U:^77V>B7(R8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M *Q,@V0?#DM,S52834B#&?2SJ0RVZD77YWY*\X*G;(;Y'5MNJJ[]-5&^2?\
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M4:WLB\,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>=;\/G_J1_G;_ +T] _\
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M,U$C:OM&H"GG5C)ZM?RO6_9_W8:K5\YZ)>DW"N]DN/%&"G.N0-]!LUDJM?\
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M[WKX_# Y> P& P&!^5H0ZA;3J$.-N(4AQM:=+0M"];2M"T*UM*D*3OX;UO\
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M:^77V>B7(R^;W_N)W_[&O_Y7>!7W'_\ WTO+O_@=4G_\FAF!8N P& P& P&
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MK[/1+D9?-[_W$[_]C7_\KO K[C__ +Z7EW_P.J3_ /DT,P+%P& P& P& P&
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M^1OR)D3%#8W3BI&N>,.I&JZ0(5IUP-,G@#+#"&"X2:_"4[$E-ZTB1'6AQ/\
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MU]GHER,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M[0!V";V/XP'XP/WYO.O]H [!-['\8#\8'[\WG7^T =@F]C^,!^,#]^;SK_:
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M_M '8)O8_C ?C _?F\Z_V@#L$WL?Q@/Q@?OS>=?[0!V";V/XP'XP/WYO.O\
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MPC/QC_N,^;O[-0?\S@N]S^$9^,?]QGS=_9J#_F<%WN?PC/QC_N,^;O[-0?\
M,X+O<_A&?C'_ '&?-W]FH/\ F<%WN?PC/QC_ +C/F[^S4'_,X+O<_A&?C'_<
M9\W?V:@_YG!=[G\(S\8_[C/F[^S4'_,X+O<_A&?C'_<9\W?V:@_YG!=[G\(S
M\8_[C/F[^S4'_,X+O<_A&?C'_<9\W?V:@_YG!=[G\(S\8_[C/F[^S4'_ #."
M[W/X1GXQ_P!QGS=_9J#_ )G!=[G\(S\8_P"XSYN_LU!_S."[W/X1GXQ_W&?-
MW]FH/^9P7>Y_",_&/^XSYN_LU!_S."[W/X1GXQ_W&?-W]FH/^9P7>Y_",_&/
M^XSYN_LU!_S."[W/X1GXQ_W&?-W]FH/^9P7>Y_",_&/^XSYN_LU!_P S@N]S
M^$9^,?\ <9\W?V:@_P"9P7>Y_",_&/\ N,^;O[-0?\S@N]S^$9^,?]QGS=_9
MJ#_F<%WN?PC/QC_N,^;O[-0?\S@N]S^$9^,?]QGS=_9J#_F<%WN?PC/QC_N,
M^;O[-0?\S@N]S^$9^,?]QGS=_9J#_F<%WN?PC/QC_N,^;O[-0?\ ,X+O<_A&
M?C'_ '&?-W]FH/\ F<%WN?PC/QC_ +C/F[^S4'_,X+O<_A&?C'_<9\W?V:@_
MYG!=[G\(S\8_[C/F[^S4'_,X+O<_A&?C'_<9\W?V:@_YG!=[G\(S\8_[C/F[
M^S4'_,X+O<_A&?C'_<9\W?V:@_YG!=[G\(S\8_[C/F[^S4'_ #."[W/X1GXQ
M_P!QGS=_9J#_ )G!=[G\(S\8_P"XSYN_LU!_S."[W/X1GXQ_W&?-W]FH/^9P
M7>Y_",_&/^XSYN_LU!_S."[W/X1GXQ_W&?-W]FH/^9P7>Y_",_&/^XSYN_LU
M!_S."[W/X1GXQ_W&?-W]FH/^9P7>Y_",_&/^XSYN_LU!_P S@N]S^$9^,?\
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(@,!@,!@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g535515i2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g535515i2.jpg
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M%KQ\0BUO6_EP.]@:)(K1K*(&.!4ML6"Q<UI41=(ZE2*71]D,;%4X=?F*%IG
M#DX)A(CY>]_\&U@,T$3@J_V1&C#/P<#=CSR$I!RI4<4F3)BC#U"@\P!)!!!(
M-F''''&;"64446'8A"%O6@ZUX[^3 UEFGD'D4-26+'YE%'VOE[(*2H9TSR)H
M<X:MC@$XU8W]))T2P]D4,H$A8C=J@'[(T6'8O-X:WO PI5P5*H6+FXBT:Z.<
M&S4+$Y(2IM&C%C>&R F#KL2U,!SV<EU/0DCVR[,"'YTT#?PWJ^&\"1<!@8"4
MRN,0:./<QFLB8XC$HTVJGB12>3.R%BC[$TH2A'+'-X>',]*WMJ!*4'8C#CC
M%@#KQWO6!B6&R:[E$+8K(C<[A[]7LH;D+O&YRT25G<(B_-;F#1C<XL\C2K#6
MAQ1+@;ULHPHX8#-?^7>\#;4BQ(X)B%J!4G6HU)834RM(>4I3*"A?*$T@\D0R
MC2Q:_@$'>];P.Q@,#^"$$ 1"$+00AUL0A"WK00AUKQV(6]^&M:UK7R[P,8F?
M&58V">D;PUJF<!9YPW9,X)#VP!278]*31+RCA)0EI]EB\XMC\ >7?CX>&\#M
MHUB1P2D+D"I,N1*B@GI5B,\I2E4DCUX@.(4$B&4<4/7RZ$'>];U@=G 8&'02
M%@=7%Z:&M\9W)VC:A*CD38@<D2QQ8%:Y&4X(DKTB3G&*6M0L0' /* >$L1A(
MPC#K8=ZW@=-=,H@V2=AA+E*HVWS.4H'EUC$17/C8DD\C;(Y\#](7%A83U1;J
M[H&'YS3?&G)RC"TOQ!?J;#YP^(;)@1Y7=N57;J20KZILF!V6AB4F<87*%D"E
MK%+DL=E[0!.8ZQA[4,*]>2V/[<6J*$<D.V \L)@=B#K0M8$AX'2<G)N9FY>[
MNZ]$U-+4B5.3HYN*HA"WMK<A(,5+5Z]:I&4F1HD:8H1AII@@@+ '8A;UK6]X
M'5C\@898Q,\HBKVT26,R)L0O<?D4?<D;RQ/K,YIBUC:[,[LW'*4#FV.",X!I
M!Y)@RC2QZ$$6P[UO R^!T0N;:-P-:0."$;J0F M.; JR!.!*,P?IEJS46C-J
M2TQAGX(3-AT'8ODUOQP.]@,!@:V_3*(19=&6R3RN-QQRFCW]&8<WOKXV-"Z6
M2/;>N=M1^,I'!4G/?7O;4V*5/PB4)I_PZ<PSR^0 MZ#*C=6LIQ)9S') 6[*4
MXU:=K&L3@<5"0H6PF*B40C-*34Y8@[T(80[#K>OEW@"W5L-<3V@IR0&.R5.6
MK4M9:Q.-Q3I3MZ"4I/1!,VI*3FBWX!&(.@BW_!O [^ P,.RR%@DB92LCKXSO
MZ1&Y.#,L5,KFB=4R1W:%1B)U:E)Z$\\HAR;%I0B5! MZ-)-#L PA%K>L#,8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# ^7OHVZ[BHKL'W2)'0TY05U8DQZ8]EZGP2QQBS),TK:PVXQGP9]V?'7X
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MW+K6M9&UV)0#](JZAC= 7QG1! T24HE"G(>6G0B4"Q2:0::6;5DYGEZ7^\;
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M>X0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MD;@PM+=M1X@+.,2IR/4_! #QT&?W&8WL "]Q]DV662ZIP VTH-@ G?1^H]D
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M'7MCU#9OU>U["?<*X>J$RAF&"UV37$@B-GU?Q=3\L2/*M5'%4K:#$$2G*7;
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M8Q;\1;WO P+Q"(7(8X;#G^(1=\B)X"RSHL\,#2YQPX!1VE)0#6-:D/;# %*
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M.8;%Z %%S0C"*>F7U9QEY!T9)]2O>R[L%(=V*6(*S7PP=Z7^.F[_ (37^P_
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M1/&?_2=@?VR6-CNOR_M7L-ADP& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MP^TW97W;/65\3FP[*XC0N_TTGT-?D[XZRB]8$&8G50<&+,A,':;78WQ0R[:
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MA^;8PAT+8?'6_P#^'CO^# >0?\;O_P#%_P#PX#R#_C=__B__ (<!Y!_QN_\
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M$4LS88K/X/:4?;U:]X;@-T]K=_2R>%2$!K*XMJ@XYC?419X231C3&[#Y32S
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MR-3A@LEDC4*:'RPG!'7\>13B+M[A\&R!0$&F)2P&!&3KT\'M7H[A# 8# 8#
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M!G!CL:T7^"I4I.]-Z%(@.$A$7MR,)*3#4ER69]5N[R]VR15RXW_+:YYJW8]
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M>W?2\[BJ^)AL3J.$)76S+;M)U=:YZANB'OSH[7@X$N-B1QQ<T$L$-9 W Y.
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M?_2=@?VR6-CNOR_M7L-ADP& P& P& P& P& P& P& P& P& P& P& P& P&
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M)RQ]V-0VITJ8'@E&L4"+(&,SJK/S)[J?2\EY<H>6VKSQ$YOT1TYTO9'/O/\
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M$CDWF!)4H%23Q\#4QZ52>2S"6]D0^(ZO7:N(2E7]0]_4'S\^_#&L^OGQ_O\
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M['!NHVQ&:K^#%()<ZLD89"3-%?[16O5ITJ<OQ&8/00[PCS60>Z9"EM=O,F%
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M'+WMIMD2J&K8STM-IO:KA#*<M2K4]4N<G9'*IJ_(O-.L9K8%"7!EAL3G3O\
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MFVG(IK%G1K;YBPM2>D[BA;<IBZ201J61B0*3I5,VXE8W.B$]O5MABD)P!Z_
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M<^.@=1CHN)<K._ECKR+T;EFQD)+C[&5Y4F_B&M0.PFOSN(/%$3ZH_.9KTQ^
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M\'J*#O$DE3]!J3)9'%WD*YL+7* GCC30[@-<5 3"A'C/)+3)C#AA*$,\/14
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MM5(W!=]+5B=]0+UXG0T"4PP*\)'HA"G"(9'G,Q<A6TXUU+*P0/K36K[2_?\
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MG#H]2R1)'7,?=A,20EGD-=6?(D#:_&B(5!2,[@E>=EZ3F&$DC'J"3LX1)6U
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MEB\\L%8%%]3ROL>.7:K#S].::K/YC1TC#)9*K)CSY6*E\:OFJWK0-86B$/\
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M;3J-1:UXS9E7?/;>O0:"C=6Q0)O<O/X)3D(WC&]WMQJNZ,Z!9;&G5HS:*5M
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M#+ 1^9_8U?U3&%TVLZ;Q.O(>V#3%.$HFL@:HPP(SEIX$J(@]V>52-"6H6JC
ME$E['YS3!: #6Q;UK C]YZ?YMCL'C]FO]_TPRUW+&M8]16<NEFPQ!%)*T-RM
M"@<7./OREY+;'E"W+G-.0H,3&& (./+ /81##K9<K3^B.P*,YSJYZL.56/7!
MCD95\WLZM(6ML:*1]XN-)#HDJE93;7YC@M,V^;?2BB"$ZE(2J+\ZLG>M#V,
M1"2U8.)OP93%HU)P)1H02./LS\!$88$XQ&%W;DS@%*8<$!831I]*/)L6@AT+
M>O'PUA$/+^K>:4"NSVP5\U&K?*7CK_*[4CK?8D16R&",,7%Z4@<).S$.XES*
M0SJ]A3J1* %Z3J3 %&;"8,(=ERMHHZ\:MZ.J^)7#3DO9IK!)DT-SLVN;.X(5
MQB$Q>WI' UB?2$*E5MED[,%8$EP;C]A5(5.A%' ",.]8++.*2"^J/B=AQZHY
M1<-8QRU);\+]&*X?)U&6N<2#X\:@MOTT19:YDO2\3B8D-"FT62+:@10]%^;8
M!:T1PZZ#H;<_)JD-TU2*SU&WS1-=@L&*#FQ@XR0:JD108N%VV]>NQ)4YAJLO
MT?.G**&,>@A +>AE;>V6' 7KZ'?,TXB#M]8;(JDL ^;)(S+_ *<1Q"E;5JV0
M1#X5:;])61&C>49IJI'ZQ!9:LD0A:":#8@ZMBVA6U01D^:6M/H;6T13*4R(^
M33J2-$58P+EHA!1H?G-[5HD8EJP0-Z*)T/9AN];T$._# TJ3=*\]P^&1"PI'
M>%1,T*L3TP5U*G:R(@VQN?J%"0:U(GAS\L=RFN1&*DP/.'X0P[\#\+^#"Y49
MTAU[$K:KN+V=(FENJJ)/G-E4](O#U+;$@&FV)L-G%R<XQI?BA/2&1M:2,DQD
M8C7M>V(65;Z@@)5!IJ9660+,3'$+YI"P(PSS6#7!6,OB$@DY4(8I-')U&7AB
M=YH>/TR(>W.B!S/1K)2</Y MX!B6"WOY"\(XY;?]$P)L<'F;W/541:FI\<XP
MYN,DL&*,J1!)64A*J>(ZJ/<'9. A^:DRX@Q2C%O2D@LX A@#H8=[&43W_12N
MPDE2)+FJM7::\3P6BKA+8$443E4;'P&&/I!$5)=1OABAG*),&I+T1YR0%C$/
M6M %O0RM07]?\GM6Y,%QZ9H-%N%M25\EVE%NP$O<:9UKD%G2N;WH3]_[M1'N
MXPI0F&^4.U PE^/G$'6RY6WRV_Z*@*&&.<WN6KHBVV,6F.@#C(YY%V9!-4RL
MI"<F6198O="$[ZA/*=$H@GIA&$["I)WYO]J#S$?U[OVC(U.V>KI%<M6,5ER!
MW3L#'7SO/HJWS5V?%C<D=T;,@C"MU*>E+HM:W!.H)("3LTXD\L8 BT8#>QE1
MK$NU>6IF[WJQM5WUPF7\W295%[? [S&-M8(JH0H(ZJ6/"D2IU#OZ,IG&3$M0
MW 6@I@O1"A#L7Q)!A>BY5@XG+HK/(XT3"$2-CET4?TFES))(VZ(GIC=D>QC*
M^(;W-N.4(U9032Q %L ]^481!WX"UO6B-)D%\TA$[$CU12BX*QCEJ2T*8<7K
MA\G49:IQ(0KC#R4'S/%ESF0].&W Y*:!/HHD6SQ%#T7YM@%K09-@M^IY9,WZ
MN8M9D!DD_BR10ND\)8)<P/$JCJ1(\*(\K4/K"WKU#FTEI7Y(:B-^(*+]-46(
MH7@/6]8'9L&TZRJ9H _VE8<(KAC-$J 2[3J5,<4;E!B)$>Y*R4RM\7(2%)Z=
MO2FGC #8AA*+$+>O#6]X&DR7ISG"&0B)69+K[IN,UU/M%"@TZ?K*AS5$9B X
MC:H!D8D*UX):GTO276S1"3&FA 5K8Q;T'6]Z+E;"YWA3++*HW!G>V*X;)E,6
M04EBD6732.I7^1QT"58M^?65J.<0+')G&C;E)H%)0!$C+3FB"+>BA["1#E:=
MU<CVM5IURQB_ZK35ZDD4DBC@^2">1)B*:WV,*Y"4L0.85ST#2 ]>V1A4ZH0&
M;"-:S: N*").,(\+EZ)%D'3'.D3KV-6U)[XI^/U=-!$ A]BO-CQ!NA,J&I*/
M/)!'9,J=RF=Z$,A*:9X)CC-A+*,%OP" 6]$RN>8=(<]5Z"/F3R]:?AA<L1Q]
MQBXY19,.8@R)ME9RA/&'-DVYO*;3HV2$](:!$H)\Y*G90_3$+RB\!E9N1W33
M\0G$:K*5VE7L:L69:3[B<%?9@P-4MD?QB@](B^98^N7D.CCM>L3&DI_2*%ZY
MQ0P%^80!:T&H._57,3 \R&./G1%(-$@B32]/LH9'&TX0D=HZSQMU$PR%Q>V\
M][ K;$K&]@VC5B. #X=5KTC/*/\ !PN5E9#T;S]$X7$['D]WU-'Z^G@$YL(F
M[Q8,4;XG+R527:\A1&I I=2VM[3"0:V?LQ,:8 )&MF"WH&MBT1S2GH:@X,_,
M,5F=V5-%)/*5C"WQN.R*Q(DS/CZME.S0QE.TM+@[IUZ\R1#(&%#HLL7Q8M>4
MKS;^3!E:5$NP>;)I.+XKIFN"!AEG-3@>BN)N<95'V\433-[!'W][?E6U#F$0
M8S&OI&2@<W 80)6]V)/1GC >2,&BY4T0:?0>SHRWS.N9?&YU$G7:D#=)8F\M
M[^R+3$2HU$M*3N38>I2&'(UJ<PDX&A>8HT @"UH6MZPC59O?-(5G*HK!;%N"
ML8'-9R823#(E,)U&8W(Y48I6A;4H6!E=W-&X.OQ3F+28KT2QZ-4BT4'Q,WH.
M!"%1]>QZZ>G^A.?86"O7!JYS,9X]+9$DMIG<Y\NG:YEC3Z[($=2MK(I5HX5&
M=23YI7/:EV*,+D2-2W_!>)0C=%LR:D>^.HZ)YF%6FKOL6-5Z5;,[)KR'*I(\
M-3.C/?#&AS>CUC@J=%R(ENC[:D;/*K7F;^'2G*4Q9@@B/+T(26]&CU)V73UG
M618M/+Y3"X3:<,N&?55'JZ>9_&C)S8*. M#$]+9I'(F(Y$^F-"M(\&"T6 @_
MR%I#1^H((1; ,[ILC=TT_,9M)JUB5I5[)K#A@3Q2V#,$P8':61L*144@6">H
M^A7GNC=I"O/+(4>J4'T#S EF>48@AV1N4DD3)$(Z_P MDKBF9XY%V5UD3^[K
M!^FD:V1D0GN;JXJC/#?D3(4*8PT>_P#0$.]X%9J [,I^^**3WZ>I6TU&BI,Z
MPR2L=W*H_!)%")2WNP&Y(Q2P)[VJ9FUR?D:U"O0%:6&"4(W),+7@,SR:+8D(
MKISG ZOT-L%7Y30ZP<UCLW-MA:LN&_0QP<F$A>I>VU#)-O.FE6Y-*=J4C4IR
MS1'$@3F;&'6@"\"96ZQNTZRF*2+KHE8D'DZ.;QE?-(8I8)6Q.Y,LA[6<UIG2
M51LQ O/"]QUL4O:(M0M3>HF(,5DA&,(C0:$&G.72W.K.]P"-.M\4ZW2&UD#0
MZ5BRK+*AR=SL)KD)HD\><H8B,> GR5OD"@&RD!Z,)Q2PW6P$B&+Y,+E<-'W:
MENL5Q!31U3'?JBO.>TDH^)<27'Y]504ME,-D2?T4R;X%,Y?/&M!3C]097I[\
M1B\?D%F([LSLFM:GZBH_E>5LLP+E%\1^0/4:FZ5$U#KYC7M"@:-GC<I<CG@A
MW;WJ9K4YR9J])$>G.5%A)&868:4$8SC7Z9NR:O?>LK!Y%1-TG!+:QJ<RU9;/
ME:=H2UFA+1K86%XA@'LUXTY#EL?9+%8W1<':,*-.B<BO,H]7S%A&<:DUBZ/Y
M]E$)DUE1R[ZF?:\A9VT\OG#58,571.+GZ G-"4_OZ9U,:V@9Q*PD96CS2_5+
M.+$#S!,!O9,J.Y5W!RC#5U&I7J]JS CZ+?I''*ID*>:1D^,/[A%&IT<7H0W_
M .=@MR5(F6M?S5ZHA[#\]J4R#?@I/++V7*VH/2]4L41=)G:\Q@E,-#=-;,AI
M1\^M"M"$B\=8RMXC#JXIW9JE;BT%F'!:?B3FXP\#JUZ,^'7ITRHLTD QD9;T
MWSA 6"(2N<7Y3</B]@-GSW!I+)K+AK(P2]DTG2*MO<<>7)Y3-SPS:3N"<6U9
M!@T^M*"O$?\ M >894RM[@@=D"%U:EJ1S:W-&F<&UQ;U)*Q X(%I(%*-:B5I
MQF)U216G,"868 0@# +0@[WK>MX1&MGWM25)!8AW';U9U4&4*CD,<%8DXC4-
MT^JDPDP5133](7)O^/VC$M)];97F"3ZP//L/G#XC+>CKR/H&B(?+F2OY7=%4
MQJ=R1U:V./PQ]L&*-4J>7E\(+4LC6VQ]<[$.JQ>\D'EB2% *V-3HP'IZ%Y@^
M(RHFN;LNGJDGU?U,1*X3,;9FEOU55SG5S58,936!#T-IKQ)$,V>(CL]8_P"V
M=L3^10,O:<KU23BQ:, $8!"+BP]@SV)5;!Y;8\\>T$<AD'C[K*),^.:I.C0M
MC,S(S5JU2<H5&D$ \I).]!T(8?./>@Z^7>L(@ME[9Y-=Z?K^]S^A:ACE768G
M1"B<HEEB0^.(5;FJ;2'17&5!SD]$D)98P$'^5T;1#^*;32S * %[ +P+EW%F
MT:Q&XHTK@WJDRY N3$+$*Y&>4J1K$:HH)Z94E4D"&2H3*"1A& 8!;",.];UO
M>MX1J9=E5T:F0K2I]"S4;G,EE=-JHN4,@TSA8#<X.+2X09$<%=LM5,$#HSJT
MQS8#8EI1Z4XL1>AE#T$(A>>P^7&9GM]XW?E2N^J%CKY*;::H_8,2>GV$-4=V
M<0YB?F="\&K6Y06XD[0A+."7L3@(*;_VPM PN5^6CL;EIVK*O+A%?M2L]>VF
M049")%(+!B3,B>%GPZ<]Q92CUCP C3]'AJ0DNB3S[.;5&A%J-%B#O6#*LF 8
M3 A& 01@&'0P#!O0@C"+6MA$$6M[T((M;\=;U\F]81%*>^:05V@HI%)<%8J;
MD2)3%BJJB)U&3K#3IB4(',XTZ'%N8G\OT6LP*H>MI]" F$$W>M%[T+8^K\0F
M_:+LN4.D)KJY:LGLQ9&=-('B+0R?Q63R!L85AQ:=,\KFAE=5JY,UG*#BP:/$
M#17G, 'S>(PZV,K"]'WDU\Y52NM=[:?GEI;9G5$47IQ.Z1B)1I[/M>%5@-^5
MNJXD](E01C4Q^<E'GT'1A"48/.#S><)9-=YOZ.Y]=ZZ=;?:;PJ5UJEB<U#(\
MV0V6'$U\&;'I*L3MY[.ME*1V.94[J%<L))TF$=HX9AY80AWLP&A#*AR;=T<_
MP&=5,T2*QZU;*MMNI[1M-CO=TLZ(-5:@*K:5U9%0L*5Z6+ -+LLD1]EB,*,)
M6:]'YL.!L MBWLL94T2#H>@XI*H7!I/=E3Q^:6.0UJJ_BCS844;9#-4KX<),
MQJHLSJW4I>^)GM4 12(Q, P"LW6P%;&/7AA,JE%C^Y3%808W1XF,P=OG\F[$
MGO),,9+1NIAJV-/)M:1\V2RFRW"5+(V_*VQB F 0WIDA#8N.->W1N1",!M8$
MP)J?%Z<:\=ZUXZ\-^'RZ_A\-_P#AX_\ V895)GG<?+\/JF^[6:+JJNP&_G.'
M2"66*QPJRH2\/#6<SIEP6^.*P)WLPEL>Y0_(OFEN+4B+TH=# IP[V;X@T7*D
MWG:U5]WTO ;7<4,$;CYPS_/9:.M++36]#"4IRI06E*:["1QV*I'Y0225HM9Z
M2(LM,M"<0$1NBM&C)>*KE8_N+\[1!JZ"#$Y=&K"F_,\^KR!6C 6^8,#4\-9L
MYEU7Q1PD)8S3UYID:A:BT2"G-9LC2=.YH5+>8,I24/02^M6/0='<^.U>O-MM
M5XU(Z5;'792P/MC-EB1)PA#0^I%:9">R.$H2.QS,E=PK%I!6DPCM'#&>5H(=
M[,!YB)%B4PB<^C;1,8-)F&8Q*0)=+F.31=W0/K"\(]F#*^);79L/4H5I.CBA
M V(L8M:&'8=^&];UH.BNL2OVOZ0_.<YA[=]$79@899\=)F5)]&'R5Z9]Q9FD
M/Q"TOYE=9)J0H-H$ZGTCEGQR?T0C]8OS!JI-_46IL-+42:YJL4VJN->2$=;)
MY_%3YTI41T!IC\F)BA3J-\&J9BR#!*BM$>H0 L8AZUH MZ")GOLBGD_0-5\Y
MP^60FQ)[.YI/X5,VJ)V#&7.05$X0.LY-8QXYK%4!Z]Y2#<=QO;=HHX*41*@[
MQ%O>P"+PN7-2:P='<^2E#,G.-WC4;ZV5V>G3SUR:K%B2UOAAJQ4<@1ZDZTAV
M&F8P*UZ<P@H:D18#3RAEAWL8!:T3*X&CI?G5_7P9J8[UJ)X<K.TXBKE UV)%
M%RN=!:71P8W$<3(3.IIC\!(]-2I((2;1FOBDQI6O$98@Z+E:>EZ\HEFKZOY[
M;]F5?1>K%;%[HQL]BW!5)834S8MVB7&HY.R3!UASXD2&#)T:I0+U*8H:@LH9
M@31:!@RMZ<>BN?VB61N!NMX5&W3>8+FQLBD/6V-$4TGD;B]MJ-Y9$+*Q&NX7
M-R5O+2XIU*0LHH0E)*@H96A!,!L0RLN1=5/*K)44VFM.O5%M)$@UZJLR9BP&
MSM.D+1DN1IQT5 OV]%Z*;5!:D>MD^8"8P!N]:+$$6R(5)[,IQ]Z*K_G.O)9"
M;-DDI17&9,5D)L",ORFK'>H"8:-4P3!@:3W!P1N+V?+!D@"<),).<@. ((Q:
M$$!<XU.]E6Q5],QO<QMRQ816,4^.3M89'/I0RQ)E,<U99YR5M*<GU:A2G."D
ME*:,L@ A&C 4,6@[T$6]$8-5?U%HE-<HU5QU>0JM\A(JJD@<[C&C+(2N&T@&
M]7!]:<]_2A(O,7IP$&HO6+.,4% !L0C :$,2Y@,#YU?\M+^AYTK_ '\K\_Y+
M7>6NG^G5]%61S,!@,!@5@[=_0OZ[_NP7[_93+,+.L48]@C_M$\9_])V!_;)8
MV.Z_+^U>PV&3 \QIY4_1=@=JR67+Z<8&^AI/S+..65D_(MYH.E)#=,)*EEN[
M#3P/<9+/V0F^'$ATW[7:4;-%HWS^GK>L+QGU:CSS0?4K7).7G*WZY@<<(X5Y
MDGM,0\Z,665(-]#6%(8[6L+;I0UE"CB$=<0<<7K#9PRW31C@6XO.BO0$0B^(
M4EN<_JAD[DCJ"SJ$O6"V70]=M;NY]MM7:$,@[A=*611>T6HVX6FP)'2<I>VB
M(HCHHK419J/0@<AD*T)RU45L8-$ -W@V;]F/5>W]8IT3C<Q4<X52YQB,]CR2
M_&'@Q3/VXV QRI9=SM]1CW$&>1J&;5=I98JG'GG9K( @,5^)5J$@3]F&#4F#
M5Q>+F*UZ$*A?,$EKH!+0*.W=>+\[,<I>GVON>VF>7>L7TAS+#7QYCR3<Z QQ
M%W=4VC"34A;4FCH= 3!2*T.L)>>4X=>QJ]Y16;"CY^/)*DB&S(.[R].D61-H
MFKC6B!<>*7H*PD<\8I%#HQ89I1A(D:Y>FT L@!X"CDR@PE24)G=2SF+B"TX#
M-.<Y+:[%"W1)5[Y[C4A>2G*2I)X[M*KJ^Y83-J_&D<C(=&T3P]J(@C=DSXK3
MHF\L!R@PL!8RE L+;_PKH;P9U5$*(<JE::EI:V7.VO;2@?%+RMEMC%-#'2,T
MK<VWU)3B2!;"7I7**_D/UF(5) &T@M62[Q]-ZI19(BU28NS?N]VH$S+8[!H7
M'W+T]N+%$XXS+]E&^L5M:V,Z-$J],[80;-+]<@7@+PUYM?+X:PP\C&'D[KZ;
M=&QN>7(I9S6"'%=J18UU+F$1^@)\6OM.8W58"KZLC$ :7]F0HX\@;@R@R0NR
MIR5.Y)AVMK " H"_EK9B^_$T0L>N.6Z5K"UX$SU[-ZLKV(5@ZMC!*6V7M#X*
MOXRT134S;W9M;VP($<N&U"6E)SR0JR"C0A/UHWS!T2]5,NNN;NNKON=R1Q\U
MN54R&PN2+!@OS?,XA"X^SE4W;<5GEI@M%F-@#W8T^G:K4?V9&!)'1,SIT^P@
M&)(> W:TLLGZLH'BFQR'%>]I&2!)WU?[J3=V$H>25Y9+HIJ5&A(9-J5+B6SA
M5FRX$<&>A"A$/8?A#1$^OHL8@X-_AKWMZ4>\QF^^DU[D:F7U3RU+9SRAR<,D
M*X 6NOYE+D?0EIH=$N!!6O&)/DJC\$3G)?,GVD@P0!%L6C-!%O"Z/7T8ON3P
MJ!$T&:/2]JM:.N]BHF=SAL=L!SK,EDDR-V1UA+)_'Y+$XM, R%:V&F*E"<HX
M;.6N(3*4ZDTDS1)G=YVU?QKTW2#+0+P"JZNO!ZCM9=L4M,Z]E=GHTS)$$_37
M2 +AC$^(E#E7OP4K:CXJA"SRU.E9D2XXDX/PB4\L)B;"[*@Z \SV1)4;[S]$
MTT"FEC\L<A^T]";%C:AT7D5#,;2YAO:V;FF- .TOW'UI!2>1Q8M"(.S$*@*(
M+DWG*T^B3/+LNQ9B3<J]*RQ=9W2)%8PJ*V5(^M.6.B&'FX%BMAX71@YTCR2&
MR$;_ &2A90Q!%:UB-2Q4<6,LE0WE$-;8F4+1;V::039T9VH^.+P/N>K;>M^%
MU@VZ9>T.INF'J-MTJ%-01-FMZB"*]KOYI<%\59P.TP9G?6REQI9"8!&_4-3F
M#!L'B-X^S/$<46.E<?GM*R0),^G^ZD=V&M>"%Y93HJJ82%P8RU1[@6SZ5GR_
M4<6B0_!"%L.D@Q$^OZ>]AV3?X8^@>#I97CKPFXRN&U>,SGH7:+C8IZ/X%>>%
M]Z"D>G.-NK$,QB)$[N#FC&/YS4#V2:6(6P[V;X[WA=ZJSB]O7I"*0FF&(Z-+
M[!91\+,G'%JU_65\1RJ=,WS3+)P\.6S7Z95O*TL@K>9QZ; ;UWS:!(YH!,Z8
M1299H0/A1LOY65FW"4Z<&?J\B,,$) \6E<O!4KK%Y=W\QQD!,-Y=1<X$O8'^
M5JV3;R%V9%%</QC8(6S!J3C]&[V2-49Y1K(S7FFU3C^Z8FLHEOL2&W5>-8]$
MUA*X==K95$X-?8[&Z':2T#0O/CJU5$K%J^:U&9)FM4L&8RNAOH$G&E^JH"$;
MT7FY?9KN8*+@K7T8[MCY<! ) ;*7%L$S'"&E62E\6Q9.]KHXPQ6-O$P0Q!0@
M(?%[:V-[>N>"U)Z9.628 .$N;P\[[LY&Z"F$IZIJ]A@%?O\  ^MK[I*YRNDW
M6;IV^6TPT5NRTTTKH^K@YS ID$@D\&.J50KA)K:N B H>=;4FH=D&B4%EB[?
M)=%NU(-5[?2)HC2!\M/JGHBY]+V 12A0\1VR+$<7F'K'Y:%$C/,?"XF%"G.*
M'LWX?1 "0C$$L.\);J!.]2)CJY?;T>()5S)<$CC'2=B2-%"Y [)HZB4B;>6;
MU'MP025Q9GIH8I0U>;XAI.6 3IQN!910E*;8]' $[J^5QRCTW1#Y75PMU)53
M<CX[0SK^.RJ@_K+;HS&J47]1](*.@&U%"9/(H<L99#$$#2J^C<JT0B2*%(4Y
M2A$G5$^*79=E9.E..^F.?)YRDS5TC:T*2"5;1=9=(VT&R6QTK.UJ[JQDEH3H
M5]2<@A1TQ99G!'61F(H0_-+FB\C6;KYT-$45IO%3943/-2WM2;3Q!6Z_G^"S
MB2U;[B-^S*!MVINTACMJQ*3UAV#9[%-$SB;%E9-<2N.M<K3D-Y#P2$ 7Q$ &
ME1! RE6H;_"5:_Y9Z8I-\J"\VZFJTM22IG#N5?*^=DUE-L;:*A/[$NN,V\R&
MUQ,WZ*F1IX'$VN,C8)(,"1!M46ZJ3D(3R@[3J!LO# 0OVV;-BM5V1!WA!5TG
M?'[VQ'_E&+K='CVU,5GR^=7U.'.%L(W5D&X-541_=ALC<A5; 6,Y&UDB&D+V
M0 &AL_=RR3AN\5=S2K<ECTGLFJ+L'R2\RHR']!LM8ML*>^?8I7D?<$,T9G:N
MW^82AO9Y/ M25E4L#@4:J5K3TYI2+>Q+#AO"9(EP_*6V64/(WR(UFI40#W&.
MP>L98OT%"H7&Q6Y4G2)-<OZ,9C+ZBV:IQSN*_$%B&$:'2$/D/'\&5XC?X5Z7
M<(]'01OI5\C#0OE!<+8NUZTDE95=<$5JY<V1;H?IY9<<(?F)_G$!E$6<F11#
M$:9JD#5Z*!2G"(CX8Q6!.,@P;&_2[V\YBKJKJ^%1"&P=N56/PORCS129<BEY
MDJ>H\[T:TV9I>P/T]7QE,[GM+*\OC*>F=?0 ->J2:5[3$&% #H;_ "EB:<VV
M&Y2CW#8R]T-&;3JSIX4%L&(K4-ND5H]/SLRU;459O==*UJ1@5OT+E#>Z5XJD
M#6]@$<WC4"3 ,&28(T99-Z+3<A1Z_HQ3:=LZ/=0.T\^EDQ5- UCA&GR7(*^4
MOBD<#:;(E$+CL2A\ML5NC_I%NKDV-R9*I-UK?B>9HQ2<+]%'^H.4^@9K-^U(
M]!:TK6QX?W55-;5J59\QFQ# OYX,B,5>(4X&.\74Q]U=Y='&$]TW+8\4S'@/
MW(S5!9P$FA@78)>GT7/YZI&259;'6LQ?2VDULN.UJ\E4-=$RD*I\<F*+\YTS
M6;LLDH=(T^T;JMF4(<CQ%Z&=HT)@3MBT(W8="W6![2JRQ[#9:$E%60QAL22T
M?TE [B609\D2")#E$;:HW-X@^-S/(75 O:4+NE*F8%Q856BR3PHQ%^<(Q W@
MBMYG%5CZ<'Q\3,D"(?W?W38GV 8\%N!9;J?4K(@CS*<<J<@,^E9LM3Q],M0E
M(A#V'X0T1.CM%F"#A=_AI_%G&%O4O9%6H+?CLLD:/G=-=R6OK=W?C$YP1[!:
MSTI.7.;-3S?7K5,DKU-&U8%2]IWMU.2H79/LX@]P'Z9X1;J[W:U16/T!0;Y1
M==.R>-%VW(8?"+*EHUB5.XQ>EG*0H3[:71U$O;'9N?)(ZPI(J:D:-43M*88X
M><[Q* , B3BZHS*>!+SU-[,8U,X;+XJ6X+MX>Z&E*ZT45?1=R13N@+@A:.V6
MD4'KZOHW"7)EDU%P!@,2&?!@.4.;0,E1O>C@&A+L2<FXSG8^@V^P'%B@2J#H
M/<;EG69",]62H/31)UX634@UOZ=J-9]IRYN7=18EFP!'H99?_':/]7?DP;Q]
MD<Q7EGIVC7FH)E7-=5O/E\76^XI 7"''V,&#M47AO673S7=U43)*YBBCH4I9
M8VTQ5.G?&E(F^-3_ !W_  85(B1 $-B$)MP_W [4+3_.*8R.*(C#^9^.X*$J
M,3^*1.'M5HTA+&^06VHLHUSKI\L:Q&Y8!D;Q0L#8K0($AI:C:DM(<9\48-G5
MZL\O5%,*E'T9N7A:@ZL_J6V+=BWS6O&O\T/F),:+91.7G3)O@G78FHWUB->I
MHO\ !_#%X_(2W?PK=U[Q[95^V[(IW$7!B8Q-O*2V,U;)5;D82ZQKI6$WW7=Z
M4V^F(RT)PR8ZWR" D;7*2S?5VG$81Z8@FBP2JXN_MT= 3&"R5"^RB$LMGW5Q
M)UK"[HFC4YN.F[?4O45L5/:#@WMY(&TQQ5U2RHHFIC2=9X;4)V!N1E:2CWOR
M:+L=)]XFZ#GM?S"9 A<X@EVI;.Y/FFVN7]/1"8J[/C7-$DF<A20R.2:+5(W0
M^N@,I\X5J(\YN32X*%:TA(%:G0$)R]@&_A)4=Y6N"'E<]6M&Z65.<VBG85FW
MI;%?V7?$6F,Q=VVVJ/D]*N<W3SA#"F:"H7EK4K6QW5,2 C9!H$IQA:HY:9O0
MB:WF <:6,S65SA)Y2TP=S9JCZY[^O5UV:O XJ$+)T-([<<ZG>&-*J:?**3%)
M9NEVLT$10V\8S= -,\OB(NO)2[*FG7/)S93D_P!19NCB+C:S(]8,*:[ :($O
MNB 3#K>X[';:.H9_E%,643,+$/B(6Y+\TL!;"Y- W!.7M0>)4@/;B]7T=TC;
M<GM1TLPI?4\AK>'0A[B4;AKM*C3$;U,E2VOHS*)H <9-;D_S,G@,F?C(Z,\I
M4N2K5[:J$0;L!?RF54>_Z7ZBNPHN'4V-,HK684;>%<2QN:99#:_?]6!.F]B;
M(6X3:42J"3IU<*6*9PNA;LU, "')0M,2C, I)!X$"63J@!]X M]UJ_JAE$S5
MRIGUM5#PK!X.^*78.U07?F]DC8I8!Q>C&4U>UH&R4M1JQJ&'9NS#]!.UHHS?
MCHNQV5_(71GUIHXR35M4.L"9_<G3]R%W\XSLDJ6K(6_O(G)PAJ"%;B2Q\)L*
M)MRS;!L\UP(;CXVW)P$G"&9M*0-G[/6ZR(N;.*\GD+(-2D'R^&2B+D'K2Q&H
MR3G]C7-11RLH 1C,3%#5Z$,.M;WL.MZUK>&7DC7E!]75HDY9L<[FNN;"E%3<
M>R'CF6TRZW#&4+:RN1:RO!)K@BTL61)Q8G")6:1"#4LA;Q)4[R2W"1;])68
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M+9E_Q(QN"H)4(6[5 ],OT?\ 9^&Q>;?E"4/6*T;HCU2_7V7LW1/G#ZNR@BT
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MPP]4T25Z:%>F@9R4)JA_11!Q^! (T&CAI1Z\P?#QPN)H2K4RM(6M*,#\.82
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M;DR"9QI\A,@^)9GER9#_ %X[*$+6\IR5BAJ,.1C&2$*Q&(M03L9)H!B#:Q&
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MUFF, =@JJ<M!PJ.7;=$(410Y6VQ*'312-H&%0?M>T[9YRBT$_>B][.T8#R>
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M3BC2M;&'9A9@!EZ$4(0# [&'>PZV6,.]"U_HWK>MX'\"H3C& L!Y(C#2O7+
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M['!JL1*><DS^W1R?-\ C$VAZBWJ2:Y6CD!#6.0R>LV=[8DCB%T 4YF+0&[5
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MD;.9I60G$8>UN:<90Q@T(H0@^(!"U\N!M>!%I]U5:3(*MC)4R:7%TNK<IU6
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M[W_IR,/W@?.K_EI?T/.E?[^5^?\ ):[RUT_TZOHJR.9@,!@,"L';OZ%_7?\
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M!$)OG!Y<$[4SMB0DH!RMQ=79S5E)TR5.6:H4'#T$L M[\,#>6]>C=4")S;U
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MR#T_&&5;*$#N[T+:Q#6;##=E2<]P+A3RH2-K3L*1<88<[GDA2#+ 4(PTHX0
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MAA*XM?K>.,//UP--K6W;]@WLQ>X&Q.%23% QJX"-WIALMF44"WQF+LT985;
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MEJ<Q><>-"D7N(=#"E*V!.5H.M #K6M8$B&%%G%C*.+ :4: 0#"C !&68 6O
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M3"Q:&69K0M;UH98PZV'?\.MZ\=8')@<0"""C#C2R2BS5 @B/, 6 !AP@!T
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M AB<98%YZ$Y$85D,:WPF.*IRVOG4M0M;E!_GE4Y,Z!$GEZ%48WFB4JB$NRU
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M;&^?*58E5FI%J"Q#VJL88A'.&]R6?.3DW2KX=F+T^-[BY?\ $J"%'J%'J?\
M:C"(S\+"[6SRBCZ9G$[B5H3.IZYE=D0'1881/9%#(\\R^)Z(5&KD^H](G!O4
M.K3I(N/&>3Z!H/1/&(P'E&+8MDVMJFD(AMD1=WA%@Q6/3:'2 @M*^1>5,Z!^
M8'8@E02L(+7M3F0I1*M)UB8LXO8P;V6<6 8=Z&$.]!KD6I>GX,4QDPNJZZB9
M<8<G-YC@8Y"HXR_,3R]LY<>>GAH$W-J<3>ZO+"4%$K4E;"<I2AT48(0/P<&U
MK\EYLYXF:.)-TNHJH),W0)V>7Z$-[]6\0=4,2>I&N-=)"YQQ&M:#D[.M?G,X
M2E:80$ E2G?JF^<>M"P;4MM+2U,#4V,3$VH&9D96]$TL[.U(T[>UM+4W)BT;
M>VMJ!(62E0H$*0D!1))0 EE%@T$.M:UK6!%44YTH""OTVE,*I&IXG)+*(7I;
M!?8Y7T49G::I'508L=4DH7M[40I>TCJM-&>J*4",+4'C$89H0Q;%L;4JM+2U
M,#4V,3$V(&5D96]$TLS.U(T[<UM+4VIBT;>V-K>D+)2(4"!(2 HDDH 2RBP:
M"'6M:UK CI%1=*MLED<S;ZDK5'+9?*8_.)3)4T(C9+Y(9K$TRM%&)>\N@&W2
MQPD\>2.!Y:->:,2I, XS18P^<7B-KJS/GRB+&CSE$I[3-6S&,/,K-GCJPR2!
MQAX:G"<J"_143-6B7-AQ!TL4$_@&.(M;6#+WL.S-AWO6#:D2-QJ.0U@9XI$&
M!EBT7CS>F:6".1UK1,C$R-2(H)*-M:6AM(3(&Y E)#H)9))8"P!UX:UK6!'4
M8Y\H>%2)[ET/IBK(Q*I(:^GO\D88#%VI]=S)2<4HDWQ[JB:R5R@N1*B FK@"
M'L"L[7J&Z&/>Q;&UJ2?CWD])!7FL$G--$):YD+\DE+Y!DU4P=/%'62M^O*W/
MZYB*9 -RAX;"_P !,I$7LU.7^ 6((?DPNUG'GF3G&0NE?/3]0E-O#M4[>VM%
M8.+E6L.6*Z^:64XM2RM4-./9QCCC8S*B@'(TZ391*4X 3"@@'K0M#:W\ZNJ^
M4#6FJ(+#SS'&8M5B.!AT:9C!KI^PDM*=CG"P8T0A*9>SD,"$"5R'YEB<"(C1
M9@=%%Z"1!EO<>4==;_7#G-H5%U[#!;$F]G/<&41"*.$0LV4SNLI)6+HX6"U.
M+0I+>EY#?(0+"U>_!7\8A3;$9L)>@X7:W-ZYCYPDC5"&&04)3CVQ5JU*6&OF
M1UK:'KVB%,*U.0E6,<8;%+.8B96560E*T:D( !.9Z)>Q WL -Z&UNY]6UDI2
MOB%37<&4(9.IC2R2(SHFPFI9 KAA341$%3VG&@$4ZJ(J2Q(@-HS]&"0A1D:)
MV#10/*1',>YR@S-<5^W2Z:^E<AZ"C5<P.3-K^U,:EG;*\K5B?VQJA",D#< ]
MR971TF+TX+@KS%.SS7'97R$%%%A+J03:FJPYN?6<ZM8":TRB/L,3DK6;#X\8
MW2&+19.I21F-OB(;=M,[,,=2K3BD*,\)B=(6:,)0 :$+6R*2"]MFKC[\%>*V
M7O:\S5]E]*$M:B(5I],"K+(+) D;OKK!$ VV*M$&TY8"8_\ .@2-(2P-PC1M
MFO@MEWAZ!/L<CTI1$MLF8F:1-R=T9GQ.@?&Q$[(R'J..J-^C[N2E7D*""G-B
M?&Y.L1GA#HU,J(+-+$$P 1:(.4=C[PO875W8V=T=(JXJ'>,.+BVHEJ^..JQI
M<6%6YL2M22:H:'!4QNZM&8<G$68-*I-*WO99@P["/14%1HK2W> J=K$5R[2_
M!;M7<%C6["VF^;ML_DW,/FWY^\WS.+:/S>OY_A-^CX^E^!@WLY5-,5\E80M<
M+BD2KUV:*ZD-80:316&Q9*YU[%)"2EV<SQ0D34)$A8B7)M1+-MF@?-YZA$3L
MTD?D#X!_*)IN'\\TQ5M&0 @Q/#:F@L:@4>^("F L4M\;:DS:%Q</A"$R4;HZ
MF$"4JAEEE@&H-&+0=:WX8+=NNN7SY0Y-I&7@33%6%7*: 0#+4+@47!81GJ(-
M-)AHY>%LT^B4&-.M)!&[/]3:37H[%Z7X.#;T[,"LY5YE<$;FW+N?*85H'J?J
M;6=T1]:Q Q*Y68M3C2+IZM3B:-E*9:O2&C*4+QZVI/*,& P8@C'H1=K:0T72
MH'>N'\NI*V)>Z>1.#;4[L1"(V0X5HVNJ,+>Y-T$5$MH#HHWKD0 E&D(=D%#
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M:&EL8&EK8F5$G;&=E;D32TMJ0O121O;&U,4C0(DI0?D+3I$I("P!U\F@AUK
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MA*__ &>'"NZ3D;4M)!6BPIT99A11J\TE48E&3'J9ADP& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MIS=D$PJJ42.9>SQ/Y-%6RS)(OCS,W=!7Y9NGJ I(Z-N9"&A1N/Q\I')#=",
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M:ZI19(D3/+K=EKS5+311K':RF)K"$:1@D[@L95IJ9*K]0X9NB8E^.1-_NN=
M]*<Z4+54UY@601#*I+U'SM6;\MFYPMI%$<LBR&6*Z8DJ?<1EJ?2*5.3B0WN2
MX("EC6V*#U:+1RHHHH1)EO+SB2]R]7<S=3]WRV206)V=2;!V+Q!5-JI7*[)J
M<XU6NO>GZ6@RUIYVB+E"C&ESC;)-)1IV6G+CF#X\M1K84GQ SS":N2R>6\+_
M '(+2H53?*QKB"]P@!7N-=55+/KYZ0LFUIQ2%#,];1NKW")LKBX5K54G?Z8@
MMAN4E.1LA:M*9&XT-,H-5+CO6T7HN;^$Y>[5=$\ACW[>C'"K+Z"A<(NKH221
MZRP\C!42*VIK$4]'S:4M+7!D[/'I&Y2 (7]"D5Z^%1C]1*6,W8?('>PDG=%'
M-G97N(P4SD;EFUZ>:)[=EKPF]KME\WOR9IZXG\"YLK"^6.-QA;9$9KR'/S2_
M72X4])DHQH4.DH!/1A %>R-!6&!%DZI.H7W1+SM^5<JO+Q0]6QJD^_Q7RU\H
MO**SI0\V/&WNH([)I1&CK^C6H(F8VQGL-EBIYP]L"YQ.91B 2?HX6_-D,_9#
ME>>]Q8EBU!;=YM_-D810;DR4T57G7B8=H&.;Y%)C-+2=X1=KO5Q;2P*DDRK6
MHHJD2O:1Z5"1 ? *#RR@%Z1'F95]>W=;9P]QN?.7'G:_8U<4PP3:#<U6S9T;
MJ=(FF#EK5XU+1CTPL=JVDF7I8\H);"@*D<G$SDI@K2EA;.4(9@-'[V")G,B"
M$OO3HI?<%ET_6-4,\F<CNC>8*5YD>ULO6HVF^XC<,H712X+02F)6%7M"S4>O
MBC_\2!-M4$[X,K1@R?.+81ZO.>:=,6I)H0DD,9M&]V-+OA_W_5>@2.\)5,GT
MV3TS;"2-0.5CD*='%-Z60\E%O<;#\+L^-I1Z3)5 @@]01>^?6/2/LRS[HBO$
M/M8RRKGE[=K0E737M^-IR%98;Y"D]G*Y-$51RZ*6',T93HO,BLN=?3V\"4)G
M )Q?F&-.>/00;$S:UET]X:UX_&T-;2:CH,T]5E]D7#R%)$D><KBM*DVI33-:
M,]N/EF,A-:55(;KE[2[Q63-J5*TI(^%<0M..-5F)TR<P65/7\+0O_N(V3$^$
MZ>[2F?-SY!/G*V:]AG0U<391)XL]U37C_;QM.R^U&)-(X@R2!W9VQ8>B?FXE
MR;FLQ2Q*M&'>B,.]9#.<0JU>Z+?EU6NDI/F.B:D>Y1.K&ZTW44YM6T9/':WE
M-"\B2.)UE);&4GQF#OSTH?K%N!Z6M;*D1EF(T[>@VN4*-Z%Z64R3JCJEO<KZ
M@Z3ZDX8=J_B]=0KFZ^^/[@NBU*WEDA5KY4SOE16VP5W:+JS2)HKIP6.CG#'
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M'5<Q>&X]>O<U[A8=@3BTI*Z+W/185ISE*K%D$GD*LLPLH( $"4_#D@#H)98
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M3_64V:(Q'SX?,;KO&:M,19(.^ DL);:N+E=BO!E3$P]^* J;1QL38<E,+!H
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MTA#HM7,4C[.KDTC;)&W)ZG R?0-[136/.;-*FZ4L2J/)5);BE5$*?B ;%YO
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MOS_DM=Y:Z?Z=7T59',P& P&!6#MW]"_KO^[!?O\ 93+,+.L48]@C_M$\9_\
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M*)$6/:L4S>TYPJS1A^A_U4R1[8)%5311:M)*[FNF5C;Z8C<Y8+&BM71M3(+
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M^!QAH?P<&V).G_#O+]G@OHN<5F!Y!TVZU*]W:$,JFK9],W*C"F8FKC_,T2)
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M=1PZM9USDWJ"VY%NQ&&0*E(+HTXJ='*DL0<N7FQ()?,2%(S?%(>EVW"6&*
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MM+$VY._IEZXDZ$V(PVI"5K8E7K$R1ZC5A1TA&U2)D<TB8*@L[1"<P&A[ 86
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M9JY!N4\DLM<Q=2)K;7:SV#L=L8'&M9BR?$J/0;&IE\\C+>@*1>='N'N8P[,
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M+J-4OMMU<"&RV+.5LWF].4DKR@:S:9FJ>J\;G^ QWEVP%5F48;!VR/5HS0I
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M<UI5-G0.RMS!4 V#\S6)S@6SZ92!%.2:P'VJGLR7F+?G#0TJEJ%5X"PHM%C
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MY@/O2QO\D?3?^'*U_P"KF ^]+&_R1]-_X<K7_JY@/O2QO\D?3?\ ARM?^KF
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M_)'TW_ARM?\ JY@/O2QO\D?3?^'*U_ZN8#[TL;_)'TW_ (<K7_JY@/O2QO\
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M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P*Q<9_HS55_\
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M*P=N_H7]=_W8+]_LIEF%G6*,>P1_VB>,_P#I.P/[9+&QW7Y?VKV&PR8# 8#
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M,"L';OZ%_7?]V"_?[*99A9UBC'L$?]HGC/\ Z3L#^V2QL=U^7]J]AL,F P&
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M -$V'^08&TMC4ULJ,IN9VU TMY&S-DH6Q&G0(R=FF"--V4E2EE$%[,-'L0O
M.O$6][W\N\#OX%8N,_T9JJ_^%O7_ *J?L+>JSN$,!@,!@,#YU?\ +2_H>=*_
MW\K\_P"2UWEKI_IU?15D<S 8# 8%8.W?T+^N_P"[!?O]E,LPLZQ1CV"/^T3Q
MG_TG8']LEC8[K\O[5[#89,!@,!@,!@1];7_RJLS_ .GTS_\ 3CEA9U82@/\
MY#TG_P#2.M__ $:S8+U2YA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8%8N,_T9JJ_P#A;U_ZJ?L+>JSN$,!@,!@,#YU?\M+^
MAYTK_?ROS_DM=Y:Z?Z=7T59',P& P&!6#MW]"_KO^[!?O]E,LPLZQ1CV"/\
MM$\9_P#2=@?VR6-CNOR_M7L-ADP& P& P&!'UM?_ "JLS_Z?3/\ ]..6%G5A
M* _^0])__2.M_P#T:S8+U2YA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8%8N,_T9JJ_^%O7_ *J?L+>JSN$,!@,!@,#YU?\
M+2_H>=*_W\K\_P"2UWEKI_IU?15D<S 8# 8%8.W?T+^N_P"[!?O]E,LPLZQ1
MCV"/^T3QG_TG8']LEC8[K\O[5[#89,!@,!@,!@8>0LJ62L#Y'%XSBT+^SN;*
ML,3""!0!*ZHCT*@9 Q@,  X))^]AWL(M:%X>.M_P8%98USS:\2CD?BC)UQ;)
M+-&&-ICS02?7W/2D\IL9$"=M0 .4&5'ZAYP4J8&ACW\HA>._].%UF_J9NO\
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M\T6 ^IFZ_P!;VU?LXYW_ #18#ZF;K_6]M7[..=_S18#ZF;K_ %O;5^SCG?\
M-%@/J9NO];VU?LXYW_-%@/J9NO\ 6]M7[..=_P T6 ^IFZ_UO;5^SCG?\T6
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M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!\ZO\
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M!4H"L.T,Q7LX8]&C\=[\PO$/T= 8(HDC/,SX5$CYA'FPQE8)6='&<R2,;.:
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M_#>SBO 8!%B& 0V[J-H=[9'.,461F1.#I;U@V*P](1#JIVMFQ[(7R>R)Y;4
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MXA^QF[U_?M]K_P R.WYZ<'M/$/V,W>O[]OM?^9';\].#VGB'[&;O7]^WVO\
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> P& P& P& P& P& P& P& P& P& P& P& P&!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
